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1. INTRODUCCIÓN   
1.1 Las micotoxinas: una cuestión importante de seguridad 
alimentaria. 
 La contaminación de los alimentos y de los productos agrícolas 
por varios tipos de hongos toxigénicos (moldes) y de micotoxinas es un 
problema grave. A pesar de décadas de investigación, la infección por 
mohos sigue siendo un problema difícil (Munkvold 2003).  
 Con el termino “micotoxinas” se define un grupo 
estructuralmente diverso de compuestos, la mayoria de bajo peso 
molecular, producido principalmente por el metabolismo secundario de 
hongos filamentosos, los cuales bajo condiciones adecuadas de 
temperatura y humedad, pueden colonizar alimentos y piensos, 
causando graves riesgos para la salud humana y animal (Soriano del 
Castillo et al., 2007). Los principales hongos micotoxigénicos 
pertenecen a tres géneros: Fusarium, Aspergillus y Penicillium, que en 
determinadas condiciones favorables (temperatura, actividad del agua y 
humedad relativa) pueden colonizar y posteriormente contaminar con 
micotoxinas, los alimentos y los piensos (Paterson y Lima, 2010). 
 Son numerosas las matrices alimentarias expuestas a una 
contaminación directa por micotoxinas: oleaginosas, frutos secos, frutas 
secas, verduras, especias, café, cacao y cereales, éstos, en la base de la 
nutrición mundial (Richard, 2007).  
 En la Tabla 1 se indican las principales species de hongos 
micotoxigénicos más importantes y las micotoxinas más comunes 
producidas por ellos.  
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Tabla 1. Algunas micotoxinas más comunes relacionadas con los hongos 
micotoxigenicos (adaptada desde Paterson y Lima, 2010).  
Hongos Micotoxinas  
Aspergillus carbonarius, A. ochraceus  Ocratoxina A (OTA) 
A. flavus  Aflatoxina B1 (AFB1), AFB2 
A. parasiticus  AFB1, AFB2,AFG1, AFG2  
A. niger OTA, Fumonisinas (FBs)  
A. terreus, A. clavatus  Patulina (PAT) 
Fusarium culmorum, F. graminearum 
Nivalenol (NIV), 
Deoxynivalenol (DON)  
F. equiseti Zearalenona (ZEA) 
F. cerealis, F. poae NIV 
F. sporotrichioides Toxina T2 (T2) 
F. verticilloides (=F. moniliforme) FB1 
Penicillium expansum, P. roqueforti PAT 
P. verrucosum OTA 
  
 Además, la colonización fúngica y la posterior contaminación con 
micotoxinas puede ocurrir en las diversas etapas de la producción de un 
alimento o pienso: en el campo, después de la cosecha y durante el 
procesado, almacenamiento (depósitos, silos, etc), tratamiento y 
transporte (Binder, 2007).  
 A nivel mundial, aproximadamente el 25% de los cultivos se ven 
afectados por micotoxinas con enormes pérdidas económicas anuales 
(Gutleb et al., 2002). 
  Las micotoxinas pueden causar una respuesta tóxica cuando son 
ingeridas, inhaladas y/o absorbidas por los animales superiores (Richard,  
2007). Las micotoxinas también pueden entrar en la cadena alimentaria 
a través de la carne u otros productos animales como la miel, los 
huevos, el queso y la leche de animales que han consumido alimentos 
contaminados por micotoxinas 
(http://www.efsa.europa.eu/de/topics/topic/mycotoxins.htm).  
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 Desde el descubrimiento de las AF en 1960 y los efectos 
perjudiciales sobre la salud animal y humana, las normativas de los de 
organismos competentes a nivel mundial, como el FAO/WHO, Comité 
Mixto de Expertos en Aditivos Alimentarios (Joint Expert Committee on 
food Additivies-JECFA) y europeos como la Agencia Europea de 
Seguridad Alimentaria (EFSA, European Food Safety Authority; van 
Egmond et al., 2007) han establecido niveles máximos permitidos de 
micotoxinas en alimentos y piensos. En la actualidad, se conocen  entre 
300 y 400 micotoxinas de las cuales la Comisión Europea ha fijado el 
contenido máximo únicamente de unas 20 micotoxinas en varios 
productos alimenticios y piensos (EC 1881/2006).   
1.2 Fusarium spp. and fusarotoxins  
 Several Fusarium species are widespread pathogens on small-
grain cereals (soft and durum wheat, barley, oats, rye and triticale) 
around the world, including all European cereal-growing areas.  
 Fusarium spp. are responsible of roots and crowns desease, 
known as Fusarium head blight (FHB), which affects kernels, single ear 
spikelets or entire heads and scab of the kernels. The reduction in crop 
yield is often estimated between 10% and 40% (Bottalico and Perrone, 
2002).  
 Mycotoxigenic species isolated from FHB of wheat in Europe and 
main mycotoxins produced are shown in Table 2.  
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Table 2. Mycotoxigenic species and their produced mycotoxins, isolated 
from FHB of wheat in Europe.   
Species 
Geographical Identification  
(Europe) 
Mycotoxins 
 North/Centre South  
F. graminearum +++ +++ 
DON, NIV, ZEA, 
AcDON, FUS 
F. avenaceum +++ ++ MON, BEA, ENS 
F. culmorum +++ ++ DON, ZEN, ZOH,NIV 
F. poae ++ + 
NIV, BEA, DAS, FUS-
X, ENS 
F. equiseti ++ + DAS, ZEN, ZOH 
F. tricinctum + + MON, BEA, ENs 
F. cerealis + ± NIV, FUS-X, ZEA, ZOH 
F. 
sporotrichioides 
+ ± T2, HT2, T2ol, NEO 
F. acuminatum ± ± T2, NEO 
F. subglutinans ± - MON, FUS 
F. solani ± - - 
F. oxysporum ± - ENs 
F. proliferatum + + FUS 
F. temperatum + + ENs 
AcDON = Monoacetyl-deoxynivalenols (3-AcDON, 15-AcDON); BEA = Beauvericin; 
DAS = Diacetoxyscirpenol; DON = Deoxynivalenol (Vomitoxin); ENS = Enniatins; 
FUS-X = Fusarenone-X (4-Acetyl-NIV); HT2 = HT-2 toxin; MON = Moniliformin; 
NEO = Neosolaniol; NIV = Nivalenol; T2 = T-2 toxin; T2ol = T-2 tetraol; ZEA = 
Zearalenone; ZOH = zearalenols (α and β isomers); data collected form 
Gäumann et al. (1947), Bottalico and Perrone (2002), Logrieco et al. (2002), 
Scauflaire et al. (2012).  
 
 DON, NIV, other trichothecene derivatives, FBs and ZEA are the 
most common Fusarium mycotoxins, which can frequently occur at 
biologically significant concentrations in European cereals. These 
compounds can occur naturally in cereals, individually or in 
combination, depending on the producing fungal species (Jelinek et al., 
1989). Maize is the most susceptible crop to Fusarium mycotoxins 
(particularly important are FBs) contamination, while wheat and barley 
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are subjected to contamination of DON, NIV and, at lesser extent ZEA, 
T-2 toxin and related trichothecenes.  
 Fusarium spp. are capable to produce, under determinate 
environmental condition, hexadepsipeptidic structurally related 
mycotoxins, such as beauvericin (BEA) and enniatins (ENs) and an 
isoprenoid mycotoxin, fusaproliferin (FUS). These mycotoxins have been 
called by Jestoi et al. (2008) “emerging” mycotoxins since, there are 
limited data worldwide about their toxicity, occurrence, and 
contamination levels. Nowadays, “emerging” mycotoxins are called also 
“minor” mycotoxins to distinguish them to the majors or “traditional” 
Fusarium mycotoxins, like trichothecenes, ZEA or FB.  
 In the last three decades, data about their toxicity and 
contamination have been continuously growing up. Thus, due to the fact 
that an intense toxicological evaluation of certain mycotoxins (DON, T2, 
HT2, ZEA, FB1+FB2, AFs, and OTA) have been carried out, the European 
Union (EU) has set (or will set in the near future) the maximum 
permitted level of these mycotoxins in food and feed (Jestoi et al., 
2004b). As far as the minor mycotoxins (BEA, ENs, FUS) are concerned, 
maximum permitted levels have not been established yet due to the 
lacking data related to their occurrence, contamination level, and 
toxicity (Jestoi et al., 2008). However, it is one of the main topics in 
progress by EFSA 
(http://www.efsa.europa.eu/en/topics/topic/mycotoxins.htm). 
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1.3 Minor Fusarium mycotoxins  
 1.3.1 Beauvericin 
 BEA is a cyclic hexadepsipeptide that was originally isolated from 
the soil-borne entomopathogenic fungus Beauveria bassiana (Wang and 
Xu, 2012) and produced by several strains of Fusarium (Logrieco et al., 
1998).  
 BEA consists of three D-hydroxyisovaleryl and three N-
methylphenylalanyl residues in an alternating sequence. In the BEA 
structure the three aromatic amino acids are linked by peptide bonds 
that form alternate links to intra-molecular ester lactones to form a 
depsipeptide structure (Figure 1). 
 BEA affects human and animal health, due to its contamination 
of food commodities like corn, rice and wheat (Leslie and Summerell, 
2006). Main strains of Fusarium fungi that are capable to syntethize BEA 
are shown in Table 2. 
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Figure 1. Chemical structure of beauvericin. 
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 1.3.1.1 Biological properties  
 BEA possess a wide range of biological properties. BEA is a well-
known insecticidal compound. Insecticidal activity was investigated 
against several model organisms such as: Calliphora erytrocephala, 
Aedes aegypti (Grove and Pople, 1980), Spodoptera frugiperda (Fornelli 
et al., 2004), Leptinotarsa decemlineata (Gupta et al., 1991) and 
Schizaphis graminum (Ganassi et al., 2002). 
 BEA is an antibacterial compound. This biological activity have 
been demonstrated against human, animal and plant pathogenic 
bacteria, both Gram-positive and Gram-negative (Castelbury  et al., 
1999; Nilanonta et al., 2000; Meca et al., 2010a; Xu et al., 2010). 
Human gram-positive bacteria sensitive to BEA are Bacillus pumilus 
LACB101, B. cereus, B. mycoides, B. sphaericus, Paenibacillus alvei, P. 
azotofixans, P. macquariensis, and P. pulvifaciens, P. validus, 
Enterococcus faecium, Yersinia enterocolitica, Listeria monocytogenes, 
Clostridium perfringens, Mycobacterium tuberculosis, and the 
anaerobes Eubacterium biforme, Peptostreptococcus anaerobius, P. 
productus and Bifidobacterium adolescentis. The gram-negative 
bacteria sensitive to BEA are Escherichia coli, Salmonella enterica, 
Shigella dysenteriae and Pseudomonas aeruginosa (Castelbury et al., 
1999; Meca et al., 2010a). Moreover, antibacterial activity of BEA was 
reported by Xu et al. (2010) against six test bacteria (B. subtilis, 
Staphylococcus haemolyticus, P. lachrymans, Agrobacterium 
tumefaciens, E. coli and Xanthomonas vesicatoria) by in vitro methods. 
 BEA is an antihelmintic compound (Pleiss et al., 1996) and 
inhibits Plasmodium falciparum proliferation (Nilanonta et al., 2000). 
The toxicity have been reported also against Artemisia salina (Hamill et 
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al., 1969). Antifungal activity have been proved. BEA in combination 
with miconazole and ketoconazole has been considered to have 
synergistic antifungal effects against Candida albicans and C. 
parapsilosis. However, C. albicans showed flucanozole-resistant effect 
(Fukuda et al., 2004; Zhang et al., 2007). Moreover, phytotoxic activity 
of BEA was reported in tomato protoplasts (Paciolla et al., 2004) and 
maize roots of tolerant cv. Lucia (Pavlovkin et al., 2006).  
 1.3.1.2 Biochemical activity  
 The ionophoric property seems to be the cause of BEA toxicity. 
Ionophores are compounds that are able to transport small ions across 
lipid membranes. They can be carrier type (Ojicius et al., 1991) or 
incorporated into both mammalian cells and synthetic membranes 
forming a cation-selective channel (Kouri et al., 2003) and uncouple 
oxidative phosphorylation (Wallace and Starkov, 2000). BEA, as 
ionophore, is capable to promote the transport of mono- and divalent 
cations through membranes leading to toxic actions via disturbances in 
their normal physiological concentrations. The ability to create pores is 
not, however, excluding the ability of BEA to act also as a carrier 
(Jestoi, 2008). 
 These ionophoric complexes usually consist of one cation and one 
ionophore (1:1); in addition, BEA forms a sandwich-structure with a 
molecular ratio of 2:1 with cations, enabling the complex to span the 
membrane (Kouri et al., 2003).  
 Moreover, it have been proposed that BEA interacts with cell 
membranes (ionophoric activity) which causes an increase in the 
intracellular Ca2+ concentration. In some mammalian cells, BEA induced 
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cell death involved Ca2+-dependent pathway, by which BEA induced a 
significant increase in intracellular [Ca2+] that leads to a combination of 
cellular apoptosis and necrosis responses (Jow et al., 2004).   
 The mechanism(s) underlying BEA-induced [Ca2+] increase and 
the direct evidence of BEA as ionophore affecting extracellular Ca2+ 
influx have not yet been clearly understood, however the cytotoxicity 
related to Ca2+ flux have been demonstrated (Jow et al., 2004; Lin et 
al., 2005; Chen et al., 2006).  
 The potential mechanism of action of BEA is reported in Figure 2.    
  
 
Figure 2. Mechanism of action of BEA. Dashed arrow indicate those 
mechanism that are still unclear. MMP = mitochondrial membrane 
potential.  
 
 The influence of BEA on physiological cell ion balance involve 
several ions, as indicated by the electomechanical and –physiological 
observations carried out on isolated smooth and heart muscle 
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preparations of guinea pig: BEA affects the calcium current with effects 
on contractility and interacts with the Na+ inward and K+ outward 
currents (Lemmens-Gruber et al., 2000). In isolated rat mitochondria, 
BEA induced a concentration dependent drop of mitochondrial 
membrane potential (ΔΨm), uncoupled oxidative phosphorylation, 
induced mitochondrial swelling and decreased calcium retention 
capacity of the mitochondria. The mitochondrial effects were strongly 
connected with the potassium (K+) ionophoric activity (Tonshin et al., 
2010).  
 BEA also formed non-covalent products, i.e. interchelate with 
DNA with different stoichiometrics (1:1–1:10) with no preferred base 
sequences (Pocsfalvi et al., 1997). It have been also proposed that when 
the membrane damage is large enough, BEA-molecules can enter the 
nucleus and gain access to DNA. DNA-BEA–adduct formation takes place, 
and damaged areas of DNA are fragmentable by calcium-dependent 
endonuclease (Pocsfalvi et al., 1997). 
 In rat liver microsomes, BEA is one of the most powerful and 
specific inhibitors of the ACAT enzyme (acyl-CoA: cholesterol 
acyltransferase). ACAT enzyme catalyzes the conversion of cellular 
cholesterol and long chain fatty acyl-CoA to cholesteryl ester, playing 
an important role in cholesteryl ester accumulation in atherogenesis and 
in cholesterol absorption from intestines (Tomoda et al., 1992).  
 1.3.1.3 Toxicological activity 
 In vivo studies about BEA toxicity are scarce. Table 3 shows in 
vivo studies with BEA collected in the published literature.  
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Table 3. In vivo studies of beauvericin. 
Animal Dosage/Route Observed effects Reference 
Mouse 
Oral 
Intraperitoneal 
LD50 ≥ 100 mg/Kg b.w. 
LD50 ≥ 10 mg/Kg b.w. 
Omura et al., 
1991 
Broiler 
Oral  
1.43 mg/Kg (BEA) + 
9.8 mg/Kg (DON) + 
1.04 mg/Kg (MON) 
+ 0.105 (FB1) feed 
No negative effect on live 
weight gain, feed 
conversion rate, blood 
parameters, growing and 
meat quality. Increase 
heart weight 
Leitgeb et al., 
1999 
Duckling 
Gastric 
intubation/100 
mg/Kg b.w. 
No 7-day LC50 obtained at 
doses up to 100 mg/Kg 
b.w.  
Vesonder et 
al., 1999 
Turkey 
Oral 
0-2.5 mg/Kg (BEA) 
+ 0-2.4 mg/Kg 
(MON)  
No effects on growth, 
carcass and meat of 
quality 
Leigeb et al., 
2000 
Broiler 
Oral  
12 mg/Kg (BEA) + 
2.7 mg/Kg (MON)  
No effects on growth, 
carcass traits and 
composition. No residues 
in selected internal 
organs and meat quality 
Zollitsch et al., 
2003 
Pig 
Oral bolus  
0.05 mg/Kg b.w. 
- 
Devreese et 
al., 2013 
b.w. = body weight.  
 
 BEA exerts a cytotoxic activity against several human and animal 
cell lines. Different endpoints and different cell lines have been chosen 
to assess BEA cytotoxicy. Table 4 summarizes the type of cells, the 
toxicity endpoint, the time of exposure and the median inhibition 
concentration (IC50) determined by in vitro methods. 
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Table 4. In vitro cytotoxicity studies on beauvericin, as determined by different toxicity endpoint, times of 
exposure and cell types.   
Cell lines Cell types Assay  Time of 
exposure (h) 
IC50 (µM) Reference 
 
A549 Human lung carcinoma  SRB 72   1.43 ± 0.27 Lee et al., 2008 
  MTT 24  4.5 ± 0.35 Lin et al., 2005 
BC-1 Human breast cancer SRB  24   10 > 20 μg/mL Nilanonta et al., 2002 
CHO-K1 Chinese hamster ovary NR 
 
24  
48  
72  
17.22 ± 1.20 
6.20 ± 0.06 
3.80 ± 0.18  
Ruiz et al., 2011b 
MTT 24   
48  
72  
similar to NR 
IC50 (not shown) 
NR 
MTT 
24  17.22  
12.08  
Ferrer et al., 2009 
Caco-2 Human colon carcinoma MTT 24  
48  
24.6  
12.7  
Prosperini et al., 2012 
CCRF-CEM Human leukemia  MTT 24   2.46 ± 0.12  Jow et al., 2004 
GLC-4 Breast adenocarcinoma MTT 72 1.88 ± 0.03 Dornetshuber et al., 2009a 
GLC-4/adr ABCC1-, MVP-
overexpressing subline 
MTT 72 2.06 ± 0.29 Dornetshuber et al., 2009a 
HCT-15 Human colon carcinoma  SRB 72 1.86 ± 0.12 Lee et al., 2008 
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Cell lines Cell types Assay  Time of 
exposure (h) 
IC50 (µM) Reference 
 
Hep-G2 Human hepatic 
carcinoma 
Alamar 
Blue  
24  0.6 - 1.1  Ivanova et al., 2006 
BrdU 1.4 - 4.0 
HL-60  
 
Promyelocityc 
leukaemia carcinoma 
MTT  72   2.27 ± 0.04 Dornetshuber et al., 2009a 
  Trypan 
blue 
24  ≈15  Calò et al., 2004 
HL-60/vinc  ABCB1- overexpressing 
subline 
MTT 72 2.19 ± 0.02 Dornetshuber et al., 2009a 
HL-60/adr ABCC1- overexpressing 
subline 
MTT 72 3.23 ± 0.74 Dornetshuber et al., 2009a 
HT-29 Human colon carcinoma MTT 24  
48  
15.0  
9.7 
Prosperini et al., 2012 
KB-3-1 Epidermal carcinoma MTT 72 2.85 ± 1.02 Dornetshuber et al., 2009a 
  SRB 24 10 > 20 μg/mL NIlanonta et al., 2002 
KBC-1 ABCB1- overespressing 
subline 
MTT 72   3.79 ± 0.20 Dornetshuber et al., 2009a 
MDA-MB-231 Alveolar epithelial cell MTT 72 2.4 ± 0.79 Dornetshuber et al., 2009a 
MDA-MB-
231/adr 
ABCG2- overexpressing MTT 72 4 ± 0.76 Dornetshuber et al., 2009a 
MRC-5  Human fetal lung 
fibroblast 
Alamar 
Blue  
24  4.7 - 5.0  Ivanova et al., 2006 
BrdU 0.6 - 22.2 
NSCLC A549 Human non-small cell 
lung cancer 
MTT 24  4.5 ± 0.35  Lin et al., 2005 
Table 4. Continued. 
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Cell lines Cell types Assay  Time of 
exposure (h) 
IC50 (µM) Reference 
 
PK15 cells Porcine kidney MTT 24  5.0 ± 0.6  Klarić et al., 2010 
  LDH 48  6 Klaric et al., 2008 
  Trypan 
blue  
24  6 Klaric et al., 2007 
  Alamar 
blue 
24  12 Uhlig et al., 2005 
SK-OV-3 Human ovarian 
carcinoma 
SRB 72  1.39 ± 0.16 Lee et al., 2008 
SK-MEL-2 Human skin melanoma SRB 72  1.47 ± 0.17 Lee et al., 2008 
SW1537 Small cell lung 
carcinoma 
MTT 72 3.17 ± 0.03 Dornetshuber et al., 2009a 
SW1537/2R120 ABCC1-, MVP-
overexpressing subline 
MTT 72 3.53 ± 0.74 Dornetshuber et al., 2009a 
SW1537/2R160 ABCB1- overexpressing MTT 72 3.00 ± 1.1 Dornetshuber et al., 2009a 
U-937 Monocytic lymphoma Trypan 
blue  
24  ≈30 (CC50) Caló et al., 2004 
Vero cells African green monkey 
kidney fibroblast 
MTT  
NR 
 
24, 48, 72  6.25 - 10.02  
6.77 - 11.08 
  
Ruiz et al., 2011a 
  SRB 24  10->20 μg/mL Nilanonta et al., 2002 
XPA, XPAcorr, 
XPD and 
XPDcorr 
Skin fibroblasts  MTT 72   2.0  Dornetshuber et al., 2009b  
NR = Neutral Red; MTT = tetrazolium salt; SRB = Sulforhodamine B; LDH = Lactate dehydrogenase; IC50 = 50% inhibitory 
concentration; CC50 = 50% cytotoxic concentration. 
Table 4. Continued. 
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 Oxidative stress is deﬁned as an imbalance between production 
of free radicals and reactive metabolites, so-called oxidants or reactive 
oxygen species (ROS), and their elimination by protective mechanisms, 
referred to as antioxidants. This imbalance leads to damage to 
important biomolecules, such as DNA, proteins and lipids and plays a 
role in the initiation or progression of numerous disorders, including 
atherosclerosis, neurodegeneration and even cancer (Finkel and 
Holbrook, 2000). It has been hypothesized that cellular damage 
produced by BEA could involve also oxidative stress. ROS generation and 
membrane lipid peroxidation (LPO) have been observed in cell culture 
of mammalian CHO-K1 and PK-15 cells exposed to BEA (Klarić et al., 
2007; Ferrer et al., 2009). Moreover, the involvement of the major 
cellular antioxidant, the enzyme glutathione (GSH) has been reported in 
PK 15 cells (Klarić et al., 2007).   
 Compounds that interact with the DNA of living cells and cause 
the loss of structural and functional integrity of DNA, involving a single 
gene or a group of genes, are defined genotoxic. The damage can be 
chromosomal, which includes the formation of micronucleus (MN), 
chromosome aberration (CA), sister-chromatid exchange (SCE), or DNA 
lesions such as DNA adduct formation, single-strand (SSB) and double-
strand breaks (DSB), alkali labile sites, cross-link and oxidative damage 
by ROS production. One of the most dangerous DNA lesions is the DSB. A 
single DSB can cause apoptosis (Barzilai and Yamamoto, 2004).   
 To evaluate DNA damage induced by substances in cell cultures 
in vitro, several genotoxicity tests have been developed. Single cell gel 
electrophoresis or Comet assay is a rapid and sensitive method for 
detection of DNA SSB, DSB and alkali labile sites, which are the 
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consequence of direct DNA damage or they occur as intermediates 
formed during the repair of DNA lesions (Singh et al., 1988).  
 Genotoxic activity of BEA has been evidenced by Klarić et al. 
(2010). Çelik et al. (2010) observed that BEA induced CA (chromatid, 
chromosome breaks and fragment), SCE and MN. Negative results were 
obtained by the Ames mutagenicity assay; however it was moderately 
toxic by the bacterial bioluminescence assay (Fotso and Smith, 2003; 
Kouvelis et al., 2011).  
 1.3.1.4 Occurrence in food 
 The natural occurrence of BEA in food and feed is reported in 
Table 5.  
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Table 5. Natural occurrence of BEA, ENs A, A1, B and B1 and other mycotoxins in food and feed.  
Samples Positive 
samples/total 
samples 
Concentration 
(μg/Kg) 
Co-occurring 
mycotoxins 
Origin Reference 
Barley  22/22 <3.8 - 9760 BEA, DON, 
3AcDON, NIV, HT-
2, T-2, ZEN, ENs A, 
A1, B, B1, MON 
Finland Jestoi et al., 2004a 
 73/73 <3 - 270 BEA, ENs A, A1, B, 
B1 
Norway Uhlig et al., 2006 
 27/29 <4 - 81 BEA, ENs A, A1, B, 
B1, MON, DON,  
3AcDON, NIV, HT-
2, T-2, ZEN 
Finland Yli-Mattila et al., 
2006 
 2/4 4870 - 361570 BEA, ENs A1, B, B1 Spain  Meca et al., 2010b 
 4/5 27500 - 149000 ENs A, A1, B, B1 Tunisia Oueslati et al., 2011 
 7/8 18000 - 220000 EN A, A1, B, B1, FUS Morocco Zinedine et al., 2011 
 4/15 19.4 - 2029 DON, ENs A1, B, B1, 
HT-2, T-2 
Czech Republic Rubert et al., 2012 
Cereal 
based 
products 
36/61 0.1 – 30  BEA, EN A, A1, B, B1 Portugal Blesa et al., 2012 
 5/9 510 - 268540 BEA, ENs A1, B1 Spain Meca et al., 2010b 
 21/68 100 - 795000 BEA, ENs A, A1, B, 
B1, FUS 
Morocco Manhine et al., 2011 
 27/27 25100 - 464300 ENs A, A1, B, B1 Tunisia Oueslati et al., 2011 
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Samples Positive 
samples/total 
samples 
Concentration 
(μg/Kg) 
Co-occurring 
mycotoxins 
Origin Reference 
 113/116 6 - 2532 ENs A, A1, B, B1, 
DON, DON-3-β-D-
glucoside, NIV 
Czech Republic  Malachova et al., 
2011 
Grain-
based 
products  
30/30 <0.6 - 170 BEA, ENs A, A1, B, 
B1, MON, DON, 
3AcDON, NIV, T-2, 
HT-2 
Finland, Italy Jestoi et al., 2004b 
Maize 13/14 5000 - 60000 BEA, MON Poland Logrieco et al., 1993 
 12/12 1800 - 36890 BEA, MON Poland Kostecki et a., 1995 
 4/6 5000 – 10000 BEA, FB1 Italy Bottalico et al., 1995 
 6/22 <1000 – 520000 BEA, FB1, FUS Italy Ritieni et al., 1997b 
 2/5 500 BEA, FB1, FUS USA Munkvold et al., 
1998 
 10/10 8 - 1734 BEA, FUS South Africa Shephard et al., 
1999 
 4/4 7.6 - 238.8 BEA, FUS South Africa Sewram et al., 1999 
 1/22 3000 BEA, FB1, FB2, FUS Slovakia Šrobárová et al., 
2002 
 3/99 120 - 450 BEA, FB1, FB2, 
MON, ZEN 
Switzerland Noser et al., 2001 
 25/28 2470 - 813010 BEA, ENs A1, B, B1 Spain Meca et al., 2010b 
 6/31 8000 - 445000  BEA, ENs A1, B, B1, 
FUS 
Morocco Zinedine et al., 2011 
 2/3 17000 - 29600  ENs A, A1, B, B1 Tunisia Oueslati et al., 2011 
Table 5. Continued. 
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Samples Positive 
samples/total 
samples 
Concentration 
(μg/Kg) 
Co-occurring 
mycotoxins 
Origin Reference 
Maize and 
maize-
based 
products 
19/209 13 - 1864 BEA, FB1, FB2, OTA Croatia Jurjevic et al., 2002 
Fresh 
maize 
and grains 
76/80 
 
nd - 2598  BEA, ENs A, A1, B, 
B1 
Denmark Sorensen et al., 2008 
3-month 
old maize 
silage 
18/20 nd - 218  BEA, ENs B, B1 Denmark Sorensen et al., 2008 
Nuts and 
dried 
fruits 
15/74 nd - 23300 BEA, ENs A, A1, B, 
B1 
Spain  Tolosa et al., 2013 
Oats 73/73 <3 - 270 BEA, ENs A, A1, B, 
B1 
Norway  Uhlig et al., 2006 
 1/1 <4 - 23 BEA, DON, 
3AcDON, NIV, HT-
2, T-2, ZEN, ENs A, 
A1, B, B1, MON 
Finland Jestoi et al., 2004a 
Oats flour 171 4180 - 388380 BEA, A1, B1 Spain Meca et al., 2010d 
Rice 1/1 3170 - 814420 BEA, ENs A1, B, FUS Spain Meca et al., 2010b 
 53/70 3600 - 448700 ENs A, A1, B, B1, 
BEA, FUS 
Morocco Sifou et al., 2011 
Rye  13/13 <1.3 - 6900 ENs A, A1, B, B1 Finland Logrieco et al., 2002 
Sorghum  3/3 72450 - 480000 ENs A, A1, B, B1 Tunisia Oueslati et al., 2011 
Table 5. Continued. 
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Samples Positive 
samples/total 
samples 
Concentration 
(μg/Kg) 
Co-occurring 
mycotoxins 
Origin Reference 
Wheat  14/14 1 - 18300 DON, 3AcDON, NIV, 
HT-2, T-2, ZEN, 
BEA, ENs A, A1, B, 
B1, MON 
Finland Jestoi et al., 2004a 
 80/80 <3 - 5800 BEA, ENs A, A1, B, 
B1 
Norway Uhlig et al., 2006 
 9/9 <0.6 - 170 BEA, ENs A, A1, B, 
B1, MON, DON, 
3AcDON, NIV,  T-2, 
T-2, ZEN 
Finland Yli Mattila et al., 
2006 
 13/21 2300 - 225370 BEA, EN A1, FUS Spain Meca et al., 2010d 
 13/13 30600 - 180600 ENs A, A1, B, B1 Tunisia  Oueslati et al., 2011 
 12/25 2000 - 105000 ENs A, A1, B, B1, 
FUS 
Morocco Zinedine et al., 2011 
Baby food 16/23 < 1 (LQ) – 1100 BEA, ENs A, A1, B, 
B1, B4 
Italy Juan et al., 2012 
 18/45 nd - 149600 ENs A, A1, B, B1, 
FUS  
Spain Serrano et al., 2012 
Whole 
egg 
85/112 nd - <1.12 BEA, EN B, B1 Finnish residue 
control programme 
Jestoi et al., 2009 
Egg yolk 169/367 nd - 7.5  BEA, EN A, A1, B, B1 Finland Jestoi et al., 2009 
Feed  3/3 100 - 3000 FB1, FUS USA Munkvold et al., 
1998 
Feed 14/52 10 - 18000  - South Korea Lee et al., 2010 
Table 5. Continued. 
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Samples Positive 
samples/total 
samples 
Concentration 
(μg/Kg) 
Co-occurring 
mycotoxins 
Origin Reference 
Pasta  11/25 <1 (LQ) - 106 BEA, ENs A, A1, B, 
B1, B4 
Italy  Juan et al., 2012 
Organic 
and 
conventio
nal, fresh 
and dried 
pasta 
103/144 0.5 - 979.56 BEA, ENs A, A1, B, 
B1, FUS 
Spain, Germany, 
Italy, Portugal 
Serrano et al., 
2013a,b 
Tiger nuts 8/47 21.6 - 4440 μg/g BEA, ENs A, A1, B, 
B1  
Spain Sebastià et al., 2012 
 11/35+48 2.5 - 161 BEA, DON, AFB1, 
AFB2, AFG1, AFG2, 
OTA 
Spain and unknown 
origin 
Rubert et al., 2012 
 
  
 
Table 5. Continued. 
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1.3.2 Enniatins  
 Enniatins (ENs) are cyclohexadepsipeptides composed of 
alternating residues of three N-methyl amino acids, commonly valine 
(Val), leucine (Leu), and isoleucine (Ile), and three hydroxy acids, 
typically hydroxyisovaleric acid (Hiv). In Figure 3 the chemical structure 
of ENs object of this study is reported. ENs are produced by several 
strains of Fusarium (Table 2). However some species of Verticillum 
(Nilanonta et al., 2003), Halosarpheia (Lin et al., 2002), and Alternaria 
(McKee et al., 1997) can also produce ENs.  
 
O
N
O
O
O
R1
N O
R2
O
O
N
O
O
R3
 
EN R1 R2 R3 
A CH(CH3)CH2CH3 CH(CH3)CH2CH3 CH(CH3)CH2CH3 
A1 CH(CH3)CH2CH3 CH(CH3)CH2CH3 CH(CH3)2 
B CH(CH3)2 CH(CH3)2 CH(CH3)2 
B1 CH(CH3)2 CH(CH3)2 CH(CH3)CH2CH3 
Figure 3. Chemical structure of enniatins. 
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 1.3.2.1 Biological properties  
 ENs have been showed to exhibit a wide array of biological 
activities. Several studies investigated the insecticidal activity of ENs 
(individually and in combination; Grove and Pople, 1980; Strongman et 
al., 1988; Mulè et al., 1992; Ciancio 1995; Pleiss et al., 1996). This 
activity has been confirmed in the blowfly C. erythrocephala, in the 
mosquito larvae (Aedes aegypti), in the spruce budworm (Choristoneura 
fumiferana) and against Meloidogyne javanica (Grove and Pople, 1980; 
Strongman et al., 1988;  Ciancio et al., 1995). However, no insecticidal 
activity of EN B was found by Mulè et al. (1992) against larvae of 
Galleria mellonella L. EN A showed an anthelmintic activity 
against Nippostrongylus brasiliensis, Trichinella spiralis, Heterakis 
spumosa and Haemonchus contortus Rudolphi (Pleiss et al., 1996; 
Jeschke et al., 2006; 2007).  
 ENs exhibit antibacterial activities against Mycobacterium 
tuberculosis, M. tuberculosis H37Ra, M. phlei, M. paratuberculosis, 
Bacillus subtilis, S. aureus, S. aureus CECT 976 and CECT 240, E. coli, E. 
coli CECT 4782, Clostridium perfringens CECT 4647, C. perfringens 
CECT 4647, Enterococcus faecium CECT 410, Salmonella enterica CECT 
554, Listeria monocytogenes CECT 935, Yersinia enterocolitica CECT 
4054, Pseudomonas aeruginosa CECT 4628, Shigella dysenteriae CECT 
584 (Gäumann et al., 1947; 1950; Vesonder and Golinski, 1989; 
Supothina et al., 2004; Meca et al., 2011a; Sebastià et al., 2011).  
 Growth inhibitory activity was reported in human malaria 
parasite (Plasmodium falciparum K1; Supothina et al., 2004).  
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 The antifungal activity of EN B have been confirmed by Meca et 
al. (2010c) on several strains of  Beauveria bassiana (CECT 20499,  CECT 
20191, CECT 20412) and Trichoderma harzianum T22.  
 ENs produced necrotic lesions in potato tuber tissue (Herrmann 
et al., 1996) and on knapweed leaves (Centaurea maculosa) when 
exposed with acetamido-butenolide (Hershenhorn et al., 1992). 
Combination of EN A + EN B showed decreased level of leaf and root 
development, wilting of shoots, necrosis of leaves and loss of turgor 
(Gäumann et al., 1960; Burmeister and Plattner, 1987). 
  1.3.2.2 Biochemical activity  
 A similar pattern for ion transporting through membranes 
reported for BEA was proposed also for ENs. The primary action is the 
ionophoric property, which enable ENs to form stable complexes with 
cations, and transport them into the lipophilic phase (Logrieco et al., 
2008). The ability of the ENs to form complexes with alkali metal ions 
and increase the cationic permeability of membranes has been 
previously documented (Benz, 1978; Ivanov et al., 1973). In particular, 
cations transport by ENs in liposome seems to involve a mobile carrier 
mechanism which is selective for K+ versus Na+, requires two EN 
molecules and is realized by a “sandwich”model (Kamyar et al. 2004). 
ENs form both 1:1 and 2:1 EN:cation complexes with alkali, alkaline 
earth, and various transition metal ions. The probability of the 3:2 
conformation is much less than the two other conformations 
(Ovchinnikov et al., 1974). It is suggested that electronic, inductive or 
steric effects could indirectly stabilize the 2:1 complex. Cation 
selectivity was ranked K+ >Ca2+ ≥ Na+ >Mg2+ >Li+. In addition, the 
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transport efficiency appears to be related to the hydrophobic trait of 
the EN molecules (Kamyar et al., 2004). 
 The inhibition of the activity of ACAT by ENs has been 
demonstrated (Tomoda et al., 1992). Recently, it was shown that ENs 
inhibit one of the major multidrug efflux pumps such as Pdr5p in 
Saccharomyces cerevisiae cells at non-toxic concentrations (Hiraga et 
al., 2005). The inhibition mechanism is clearly different from its 
function as ionophores (Hiraga et al., 2005). This property of the ENs 
may be important for the clinical use in combination with 
chemotherapeutic drugs. 
 ENs and BEA interaction with membrane- located ATP-binding 
cassette (ABC) transporters, especially with ABCB1 and ABCG2 
transporter suggests influences on bioavailability of xenobiotics and 
pharmaceuticals (Dornetshuber et al., 2009a). 
 The mitochondriotoxic properties of ENs have recently been 
demonstrated in isolated rat mitochondria (Tonshin et al., 2010). The 
mitochondrial effects were strongly connected with the K+ ionophoric 
activity. ENs induced K+ uptake by mitochondria. Moreover, they 
decreased the calcium retention capacity of the mitochondrion matrix 
leading to the ΔΨm collapse via permeability transition pore (PTP) 
opening (Hoornstra et al., 2003; Tonshin et al., 2010).  
 1.3.2.3 Toxicological activity 
 Few studies have been developed in vivo. Table 6 illustrate in 
vivo studies carried out with ENs A, A1, B and B1.   
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Table 6. In vivo studies of enniatins. 
Animal Dosage/Route Observed effects Reference 
Guinea 
pig, 
rabbit  
3 × 50 mg (EN 
A)/subcutaneous  
no changes in blood, 
urine or organs; EN A 
was not metabolized but 
remained intact under  
the skin 
Gäumann et 
al., 1950 
Mouse 6 × 1.0 or 0.5 mg/Kg bw. 
(EN A)/ oral and 
Subcutaneous 
No toxic effects Gäumann et 
al., 1950 
Rat 2 mg No toxic effects Bosch et al., 
1989 
Mouse 1.25–40 mg/Kg b.w., 
(every 
8.hour)/intraperitoneal 
Death in 2–5 days (10–40 
mg/Kg bw.), reduced 
weight, no anti-HIV 
activity 
MCKee et 
al., 1997 
Pig 0.05 mg/Kg b.w. 
Oral bolus  
Absorption  
EN B>B1>A1>A>BEA 
73.4, 35.2, 11.6 and 6.8 
ng/mL, respectively. 
Devreese et 
al., 2013 
 
 Cytotoxic activity has also been observed in several cell lines 
exposed to ENs. The type of cells, the toxicity endpoint, the time of 
exposure and the IC50 determined are summarized in Table 7.  
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Table 7. In vitro cytotoxicity studies on ENs A, A1, B and B1, as determined by different toxicity endpoint, 
times of exposure and cell types.    
Cell lines Cell types Parameter Time of exposure (h) IC50 (µM) Reference 
 
A427 Human lung 
cancer  
MTT 72 1.61 ± 0.14 Dornetshuber et al., 
2007 
A549    4.08 ± 1.04 Dornetshuber et al., 
2007 
Caco-2 
 
Human colon 
adenocarcinom
a 
NR 3, 24   EN B: 10 ± 3.8 - 2.1 ± 
0.4 
Ivanova et al., 2012 
  MTT 24  EN A: >30 
EN A1: 12.3 
EN B: >30 
EN B1: 19.5  
Meca et al., 2012a 
  MTT 24, 48  EN B: > 30  Meca et al., 2011a 
  MTT 24, 48  EN A: - ; 9.3 ± 0.6 
EN A1: 12.3 ± 4.3; 2.7 ± 
0.8 
EN B: - 
EN B1: 19.5 ± 4.1; 11.5 
± 5.3 
Meca et al., 2011b 
 
 
  MTT 24  EN A: >30 
EN A1: 12.3 
EN B: >30 
EN B1: 19.5 
Meca et al., 2010d 
  MTT 72  ENmix: 1.99 ± 0.09 Dornetshuber et al., 
2007 
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Cell lines Cell types Parameter Time of exposure (h) IC50 (µM) Reference 
 
CHO-K1 Chinese 
hamster ovary 
MTT 24, 48, 72 EN A: >7.5 - 3.33 ± 0.22 
EN A1: 8.8 ± 2.29 - 1.65 
± 0.06 
EN B: 11.0 ± 2.65 - 2.80 
± 0.16 
EN B1: 4.53 ± 1.23 - 
2.47 ± 0.29 
Lu et al., 2013 
C6 Rat glioma MTT 3, 24 ENmix: 2.5 – 10 Watjen et al., 2009 
GBL1  Human 
Glioblastoma  
MTT 72  ENmix: 2.65 ± 0.3 Dornetshuber et al., 
2007 
GBL2  MTT 72   ENmix: 2.29 ± 0.05 Dornetshuber et al., 
2007 
GBL3  MTT 72   ENmix: 2.55 ± 0.14 Dornetshuber et al., 
2007 
GBL4  MTT 72   ENmix: 2.33 ± 0.3 Dornetshuber et al., 
2007 
GLC-4 Breast 
adenocarcinom
a 
MTT 72 ENmix: 2.4 ± 1.53 Dornetshuber et al., 
2007; Dornetshuber 
et al., 2009a  
GLC-4/adr ABCC1-, MVP-
overexpressing 
subline 
MTT 72 ENmix: 1.41 ± 0.83 Dornetshuber et al., 
2009a  
HepG2 Human hepatic 
cancer 
 
MTT 24, 48 EN A: 26.2 ± 7.6; 11.4 ± 
4.6 
EN A1: 11.6 ± 5.7; 2.6 ± 
0.6 
Meca et al., 2011b 
Table 7. Continued.  
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Cell lines Cell types Parameter Time of exposure (h) IC50 (µM) Reference 
 
EN B: - 
EN B1: 24.3 ± 6.3; 8.5 ± 
3.7 
  MTT 3, 24  ENs A1, B, B1 10 Watjien et al., 2009 
  Alamar Blue 
BrdU 
 
24  EN A: 7.3-9.4; 1.6-2.5 
EN A1: 11.7-18.1; 2.6-
4.2 
EN B: 206.7-435.9; 0.9-
1.1 
EN B1: 9.2-36.0; 2.8-3.5 
Ivanova et al., 2006 
HL60 Promyelocityc 
leukaemia 
carcinoma 
MTT 72   ENmix: 1.74 ± 0.2 Dornetshuber et al., 
2007, 2009a 
HL60/vinc ABCB1 –
overespressing 
subline 
MTT 72   ENmix: 2.4 ± 0.14 Dornetshuber et al., 
2009a 
HL60/adr ABCC1 
Overespressing 
subline 
MTT 72   ENmix: 2.1 ± 0.12 Dornetshuber et al., 
2009a 
HT 29 Human colon 
adenocarcinom
a 
MTT  24, 48 EN A: - ; 8.2 ± 1.8 
EN A1: 9.1 ± 2.2; 1.4 ± 
0.7 
EN B: - ; 2.8 ± 0.9 
EN B1: 16.8 ± 4.3; 3.7 ± 
0.7 
Meca et al., 2011b 
HUVEC Human MTT  72  ENmix: 7.89 ± 0.214 Dornetshuber et al., 
Table 7. Continued.  
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Cell lines Cell types Parameter Time of exposure (h) IC50 (µM) Reference 
 
endothelial 
cells 
2007 
H4IIE Rat hepatoma  MTT 3, 24  ENs A1, B, B1 1-1.5 Watjien et al., 2009 
KB-3-1   
 
Epidermal 
carcinoma 
MTT 72  
 
ENmix: 1.95 ± 0.12 Dornetshuber et al., 
2007; Dornetshuber 
et al., 2009a  
KBC-1 ABCB1- 
overespressing 
subline 
MTT  72  ENmix: 1.77 ± 0.04 Dornetshuber et al., 
2009a 
MDA-MB-
231 
Alveolar 
epithelial cell 
MTT 72 ENmix: 2.36 ± 1.57 Dornetshuber  et 
al., 2007; 2009a 
MDA-MB-
231/adr 
ABCG2- 
overexpressing 
MTT 72 ENmix: 3.18 ± 1.70 Dornetshuber et al., 
2009a 
MGC Human 
glioblastoma 
MTT 72  ENmix: 3.04 ± 0.58 Dornetshuber et al., 
2007 
MRC-5 
 
Fibroblast-like 
foetal lung  
 
Alamar Blue 
BrdU 
 
24   EN A: 3-5-3.8; 0.6-0.8 
EN A1: 5.9-6.9; 1.1-1.4  
EN B: 1.9-9.8; 1.9 3.6 
EN B1: 4.5-4.7; 1.2-1.4 
Ivanova et al., 2006 
OS 9 Human 
osteosarcoma  
MTT 72 h ENmix: 3.55 ± 0.77 Dornetshuber et al., 
2007 
OS 10   MTT 72  ENmix: 2.10 ± 0.15 Dornetshuber et al., 
2007 
PK-15 Porcine kidney 
cells 
Alamar Blue 24   EC50 41 μM 
(EN A+A1+B+B1) 
Uhlig et al., 2005 
SAOS Human MTT 72  ENmix 2.13 ± 0.07 Dornetshuber et al., 
Table 7. Continued.  
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Cell lines Cell types Parameter Time of exposure (h) IC50 (µM) Reference 
 
osteoscarcoma  2007 
SW1537 Small cell lung 
carcinoma 
MTT 72 ENmix 2.16 ± 0.12 Dornetshuber et al., 
2009a 
SW1537/2
R160 
ABCB1- 
overexpressing 
subline 
MTT 72 ENmix 2.69 ± 0.6 Dornetshuber et al., 
2009a 
SW480 Small cell lung 
carcinoma 
MTT 72 ENmix: 4.00 ± 1.12 Dornetshuber et al., 
2007 
U2-OS  Osteosarcoma MTT 72  ENmix: 1.77 ± 0.24 Dornetshuber et al., 
2007 
U373 Human 
glioblastoma 
MTT 72  ENmix: 4.88 ± 0.09 Dornetshuber et al., 
2007 
T98-G  MTT 72  ENmix: >10  Dornetshuber et al., 
2007 
VM 8 Melanoma  MTT 72  ENmix: 3.19 ± 0.85 Dornetshuber et al., 
2007 
VM 18  MTT  72   ENmix: 2.67 ± 0.08 Dornetshuber et al., 
2007 
VM 22  MTT 72  ENmix: 1.75 ± 0.15 Dornetshuber et al., 
2007 
VM 33  MTT  72  ENmix: 9.65 ± 0.13 Dornetshuber et al., 
2007 
VM 25  MTT  72   ENmix: 2.72 ± 0.11 Dornetshuber et al., 
2007 
VL-8 human lung 
cancer 
MTT 72  ENmix: >10 Dornetshuber et al., 
2007 
Table 7. Continued.  
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Cell lines Cell types Parameter Time of exposure (h) IC50 (µM) Reference 
 
V79 Chinese 
hamster 
fibroblast 
NR 48  EN B: 4.4  Behm et al., 2009 
WI-38 embryonic 
fibroblasts 
MTT 72  ENmix: >10 Dornetshuber et al., 
2007 
NR = Neutral Red; MTT = tetrazolim salt; SRB = Sulforhodamine B; LDH = Lactate dehydrogenase; IC50 = 50% inhibitory 
concentration; EC50 = 50% effective concentration. ENmix = 3% A, 20% A1, 19% B, 54% B1.  
Table 7. Continued.  
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1.3.2.4 Occurrence in food 
 ENs A, A1, B and B1 have been found in food and feed, 
worldwide. The natural occurrence of these ENs is reported in Table 5.    
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1.3.3 Fusaproliferin  
 Fusaproliferin (FUS) is a bicyclic sesterterpene consisting of five 
isoprenic units, which was originally isolated from a pure culture of 
Fusarium proliferatum (Santini, 1996). FUS is produced by different 
Fusarium spp. reported in Table 2. 
 Fusarium-strains that produce FUS usually produce also deacetyl-
FUS (Da-FUS) in a ratio of 3:1 and acetyl-FUS (Ac-FUS). The structures of 
FUS and related mycotoxins are shown in Figure 4. 
 
O
OR2
OR3
OR1
 
 R1 R2 R3 
Da-FUS H H H 
FUS H H CH3CO 
Ac-FUS CH3CO CH3CO CH3CO 
Figure 4. Chemical structure of fusaproliferin, deacetyl-fusaproliferin 
and acetyl-fusaproliferin. 
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 1.3.3.1 Biological and toxicological properties  
 The Ac-FUS form was three times more toxic than FUS. However, 
the deacetylated form shows limited toxicological activity compared to 
FUS (Ritieni et al., 1997a). Moreover, it is an inactive precursor of the 
FUS rather than a breakdown product (Ritieni et al., 1997a). The non-
covalent interactions between single- and doublestranded DNA-
oligonucleotides and FUS with 1:1 stoichiometry have been reported 
(Pocsfalvi et al., 2000), which may partly explain the teratogenic 
effects. The interchelatation was not reported to exhibit any base 
sequence preference in the DNA, suggesting an electrostatic type of 
interaction.  
 Cytotoxicity by in vitro methods was also carried out in human 
(Logrieco et al., 1996) and lepidopteran (Fornelli et al., 2004) cell lines, 
confirming the cytotoxicity of FUS (IC50 of 60-65 μM and approximately 
of 70 µM, respectively). Teratogenic effects, pathological changes and 
mortality was produced by FUS and Ac-FUS on chicken embryo (Ritieni 
et al., 1997a).  
 Opposite to BEA, antibacterial activity against E. coli and S. 
aureus was not observed with FUS (Meca et al., 2009).  
 1.3.3.2 Occurrence in food  
 Occurrence of FUS in foodstuff can be observed in Table 8.
Antecedentes bibliográficos 
 
 
38 
 
Table 8. Occurrence of fusaproliferin and other mycotoxins in food and feed.  
Samples Positive 
samples/total 
samples 
Concentration 
(μg/Kg) 
Co-occurring 
mycotoxins 
Origin Reference 
Feed 2/3 500 - 30,000 FUS, BEA, FB1, FB2 USA Munkvold et al., 
1998 
Maize 9/22 6,000 - 500,000 FUS, FB1, BEA Italy Ritieni et al., 
1997b 
 2/5 100 - 300 FUS, BEA, FB1, FB2 USA Munkvold et al., 
1998 
 3/4 8.8 - 39.6 FUS, BEA South Africa Sewram et al., 
1999 
 9/10 7 – 62 FUS, BEA South Africa Shephard et al., 
1999 
 8/22 <25 - 8,200 FUS, BEA, FB1, FB2 Slovakia Šrobárová et al., 
2002 
 1/31 600 (mean 
value) 
FUS, BEA, ENs A1, B, B1 Morocco  Zinedine et al., 
2011 
Rice 3/70 300 – 19,600 FUS, BEA, ENs A1, B, B1 Morocco Sifou et al., 2011 
Wheat  4/31 2,000 (mean 
value) 
FUS, BEA, ENs A1, B, B1 Morocco Zinedine et al., 
2011 
Baby food  8/45 700 – 1,700 FUS, ENs A, A1, B, B1 Spain Serrano et al., 
2012 
Cereals 
based 
products 
5/64 2,470 – 3,170  FUS, BEA, ENs A1, B, B1 Spain Meca et al., 
2010b 
 7/68 1,900 – 7,400  FUS, BEA, ENs A1, B, B1 Morocco Mahnine et al., 
2011 
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Samples Positive 
samples/total 
samples 
Concentration 
(μg/Kg) 
Co-occurring 
mycotoxins 
Origin Reference 
Conventio
nal and 
organic, 
dried and 
fresh 
pasta 
19/144 <0.05 - 8.2 FUS, BEA, ENs A1, B, B1 Spain, Germany, 
Italy, Portugal 
Serrano et al., 
2013a,b 
 
Table 8. Continued 
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1.4 In vitro cytotoxicity of individual and combined mycotoxins 
 1.4.1 Cytotoxicity studies  
 In vitro methods are widely utilised for screening and ranking of 
mycotoxins. In vitro toxicology and in vitro data obtained from 
mycotoxins studies have already been considered in some instances for 
risk assessment purposes (Eisenbrand et al., 2002). Cells respond rapidly 
to toxic stress by altering, for example, metabolic rates and cell growth 
or gene transcription controlling basic functions. The ultimate 
consequence is the cytototoxicity that is considered primarily as the 
potential of a compound to induce cell death (Lombardi et al., 2012). 
Table 9 shows some of the biological endpoints for detecting 
cytotoxicity in cell culture. 
 
Table 9. Biological endpoints for detecting cytotoxicity.   
Endpoint Endpoint measurement 
Cell 
morphology 
Cell size and shape, cell-cell contacts, nuclear size, shape 
and inclusion, nuclear vacuole formation, cytoplasmatic 
vacuole formation 
Cell viability 
Vital dye uptake, trypan blue exclusion, cell number, 
replacing efficiency 
Cell adhesion Attachment to culture surface, cell-cell adhesion 
Cell 
proliferation 
Increase in cell number, increase in total DNA, increase in 
total RNA 
Membrane 
damage 
Loss of enzyme, loss of ions cofactors, leakage across cellular 
membrane, leakage from pre-loaded cells 
Antecedentes bibliográficos 
 
 
41 
 
 Numerous bioassays using cell culture techniques have been 
described for the characterization of BEA, ENs and FUS, such NR assay, 
the MTT, the trypan blue dye exclusion assay, Alamar Blue, BrdU and 
SRB assays (Table 4 and 7). The in vitro MTT and NR assays measure cell 
proliferation and survival. They are the most used for preliminary and 
mechanistic cytotoxicity studies of BEA (Table 4) and ENs (Table 7) in a 
great variety of mammalian cells (Jow et al., 2004; Lin et al., 2005; 
Dornetshuber et al., 2009b; Ferrer et al., 2009; Watjen et al., 2009; 
Ruiz et al., 2011a,b; Lu et al., 2013) and insect cell line (Fornelli et al., 
2004). The MTT assays is based on the capacity for viable cells to 
metabolize a tetrazolium colourless salt to a blue formazan in 
mitochondria. The amount of formazan product produced by the 
dehydrogenase enzymes was directly proportional to the amount of 
living cells in culture. The NR assay is frequently used to evaluate the 
viability of cells. NR is a water soluble, weakly basic, survival dye that 
accumulates in lysosomes of viable cells (Ferrer et al. 2009). 
Compounds that injure the plasma or lysosomal membrane decrease 
uptake and subsequent retention of the dye. 
 1.4.2 In vitro effects of combinations of mycotoxins  
 Several mycotoxins, either from the same or from different 
fungal species, occur simultaneously in plant products. However, its 
implication for food safety assessment is generally not known. There is 
relatively little information on the interaction between concomitantly 
occurring mycotoxins and their consequence for the toxicity (Speijers 
and Speijers, 2004).  
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 The Commission Regulation (EC) 1881/2006 and its amendments 
set maximum levels for certain contaminants in foodstuffs as for certain 
mycotoxins including some Fusarium toxins (EC 2006). However, these 
maximum levels have been established taking into account only the 
presence of individual mycotoxins. Hence, to take into consideration 
toxicological “mixture” effects derived from mycotoxins into 
implementing human risk assessment is needed (Tajima et al., 2002; 
Speijers and Speijers, 2004).  
 Toxicological studies about the effects of mycotoxins mixtures is 
of a great interest in order to find out whether they could interact 
among themselves and produce a synergistic, additive or antagonistic 
effect. There are considerable research works about interactions 
between mycotoxins in cell cultures, especially for Penicillium [OTA, 
CIT, penicillic acid (PIA), PAT)] and Fusarium (DON, T-2 toxin, ZEA, FB1, 
BEA,…) mycotoxins. These scientific works investigated the joint action 
of two or more mycotoxins combined in a mixture and exposed to 
different types of cells. Several mathematical methods have been 
applied in order to assess their interaction (Bernhoft et al., 2004, 
Heussner et al., 2006; Kouadio et al., 2007; Klarić et al., 2008; Ruiz et 
al., 2011a,b). One of them is the isobologram analysis. Isobologram 
analysis was introduced almost 30 years ago by Chou and Talalay (1984) 
for drugs combination effect studies. Recently, it have been applied 
successfully to determine the type of interaction between two or more 
mycotoxins from Penicillium or Fusarium in vitro (Bernhoft et al., 2004; 
Luongo et al., 2006; Luongo et al., 2008; Ruiz et al., 2011a,b; Lu et al., 
2013).  
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1.5 Mycotoxin-induced oxidative stress 
 1.5.1 Reactive oxygen species and oxidative stress 
 Oxidative stress is defined as an imbalance between production 
of free radicals and oxidants or reactive oxygen species (ROS), and their 
elimination by antioxidant mechanisms (Finkel and Holbrook, 2000). One 
of the key players in the production of oxidative stress are the reactive 
oxygen species (ROS). Molecular oxygen is involved in ROS production. 
Molecular oxygen is a biradical which contains two unpaired electrons in 
the outer shell. The reduction of molecular oxygen by one electron at a 
time results in reactive intermediates that can cause oxidative stress. 
These ROS are the superoxide anion radical (O2
•-), hydroxyl radical 
(HO•), hydroperoxyl radical (HOO•), peroxyl radical (ROO•) and alkoxyl 
radical (RO•; Halliwell and Gutteridge, 1984).  
 The generation of ROS is due to a large number of physiological 
and nonphysiological processes as well as is due to normal cellular 
metabolism (Halliwell, 2011). Over 90% of oxygen consumed by living 
organisms is used to produce energy by oxidative phosphorylation with 
operation of the electron-transport chain via a four-electron mechanism 
leading to ATP and water production. Addition of one by one electron to 
oxygen molecule leads to ROS forms which include O2
•-, HO• and O•1/2 
(Starkov, 2008; Figure 5).  
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Figure 5. Stepwise reduction of molecular oxygen in biological systems 
leads to ROS production.  
 
 Even though the generation of ROS is an inevitable aspect of life 
under aerobic conditions, high levels of ROS can be generated by 
exogenous sources (Finkel and Holbrook, 2000; Bouaziz et al., 2008; 
Chaudhari et al., 2009; Ferrer et al., 2009) which perturb the normal 
redox balance and shift cells into a oxidative stress state. If constitutive 
antioxidant potential is high enough the level of reactive species quickly 
returns to an initial steady-state level. On the other hand if the 
constitutive antioxidant potential is not high enough to counteract the 
excess of ROS, many cellular components, such as DNA, RNA, proteins 
and lipids, are damaged. This leads to cellular toxicity (Ziech et al., 
2011). However, the extent of oxidative needs to be excessive to 
damage most cells or organs by this direct pathway, as the antioxidant 
defense is strong and can be regulated or induced.  
 Oxidative stress plays important role in the etiology and/or 
progression of a number of human disease (Finkel and Holbrook, 2000). 
It is associated to atherosclerosis (Schulze and Lee, 2005), Alzheimer's 
and Parkinson's disease (Keane et al., 2011), cancer (Valko et al., 2006), 
diabetes mellitus (Houstis et al., 2006), inflammatory diseases (Koek et 
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al., 2011), psychological diseases (Maes et al., 2011) or aging processes 
(Finkel and Holbrook, 2000).  
 In recent years, intracellular fluorescent probes with variable 
specificity have been employed to assay the generation of intracellular 
ROS species in real-time. One of the most frequently used is the 
fluorescent probe, 2’,7’-dichlorodihydrofluorescein diacetate (H2-
DCFDA) that facilities the rapid identification of the chronology of 
mycotoxins-induced injury in cells at reduced cost and time (Liu et al., 
2007; Bouaziz et al., 2008; Ferrer et al., 2009).   
 1.5.2 Oxidative lipid damage: lipid peroxidation 
 Intracellular ROS generation in the hydrophobic compartment of 
a cell can produce lipid oxidation. As result, biomembranes may be 
peroxidyzed and consequently damaged.  Massive cellular damage 
initially induced by ROS-mediated oxidative stress has been associated 
with LPO. LPO is one of the pathways involved in cell viability reduction 
induced by mycotoxins (Ferrer et al., 2009).  
 A general and important consequence of membrane LPO is the 
production of toxic aldehydes stemming from oxidative fatty acyl 
degradation. One of these adehydes is the malondialdehyde (MDA), 
which is a biomarker used to prove that LPO has occurred.   
 One of the most prominent assay currently being used as an 
index for LPO in biological system is the measurement of the 
thiobarbituric acid reactive substances (TBARS; Ferrer et al., 2009). This 
assay is based on the formation of a red adduct (absorption maximum 
532 nm) between TBA and MDA raction as shown in Figure 6.  
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Figure 6. The chemical reaction between TBA and MDA that yields to 
the MDA-TBA adduct.   
 
 Mycotoxins could lead cells to the state of oxidative stress 
(Kouadio et al., 2005; Bouaziz et al., 2008; Chaudhari et al., 2009). No 
in vivo studies are available about the generation of ROS and induction 
of LPO by ENs, BEA and FUS, and very little data is available regarding 
in vitro methods.  
 By in vitro methods it have been demonstrated that BEA 
produced prooxidative effects increasing LPO and ROS production in 
porcine kidney cells (PK15; Klarić et al., 2007) and hamster ovarian cells 
(CHO-K1; Ferrer et al., 2009). These findings suggest an involvement of 
oxidative stress in BEA toxicity. Regarding to ENs, Ivanova et al. (2012) 
reported that EN B produced ROS generation in Caco-2 cells. On the 
other hand, Dornetshuber et al. (2009b) found that no ROS generation 
was produced after ENs mixture exposure.  
1.6 Antioxidant defense systems 
 1.6.1 Intracellular defense system  
 The cellular response to the formation of ROS includes many 
defense mechanisms. Oxidative stress can be prevented by the action of 
+2 
MDA TBA MDA-TBA adduct 
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enzymatic and non-enzymatic antioxidant defenses. The enzymes that 
provide the first line of defense against superoxide and hydrogen 
peroxide include superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPx; Matés, 2000). Superoxide dismutase (SOD) 
and catalase (CAT) act in concert to inactivate superoxide radicals (O2
•-) 
and hydrogen peroxide (H2O2), respectively. SOD catalyzes the 
dismutation of superoxide into oxygen and H2O2, and CAT is responsible 
for inactivating H2O2 into water and oxygen. GPxs ezymes can be 
divided in selenium dependent and selenium independent GPxs. The Se-
dependent GPxs are capable to reduce H2O2 and organic 
hydroperoxides. The Se-indipendent GPxs are inactive with H2O2 and 
only catalyzed reduction of organic hydroperoxides. GPx enzymes play a 
critical role in the defense against oxidative stress (Cnubben et al., 
2001). If H2O2 escapes degradation by catalase or GPx, it can react qith 
iron to form an innocuous hydroxyl anion and a highly reactive HO• via 
Fenton reaction (Barbosa et al., 2010). Glutathione (GSH) is an 
intracellular antioxidant compound that is considered as a second line 
of antioxidant defense (Cnubben et al., 2001).  
 GSH (γ-L-Glu–L-Cys–Gly) is an endogenous tripeptide and 
represents the most prominent low molecular weight thiol (up to 5–10 
mM) present in cells. GSH and its related enzyme, such as GPx, 
glutathione reductase (GR) and glutathione-S-tranferase (GST) are one 
of the most important antioxidants in the body. GSH, that is present in 
its reduced form, in presence of oxidants is oxidized to glutathione 
disulfide (GSSG) by the GPx. The GSSG is a substrate for GR that 
catalyzes its reduction by NADPH leading to the regeneration of GSH, 
that is available to react with free radicals and hydroperoxides. The 
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GSH is involved also in cellular detoxification by xenobiotics, such as 
mycotoxins. The GSTs are thought to play a physiological role in 
initiating the detoxification of potential alkylating agents (Maran et al., 
2009). These enzymes catalyze the reaction of such compounds with the 
cystein-thiol (SH-group) of GSH, creating products that are more water 
soluble. The detoxification process could increase the concentration of 
GSSG and decreased the reduced form (GSH). The metabolic pathway of 
GSH is represented in Figure 7.  
 
 
Figure 7. Metabolic pathway of glutathione. 
 
 Overall maintenance of cellular  GSH and cellular redox status is 
a dynamic process achieved by a balance between the rate of GSH 
synthesis, GSH/GSSG efflux, and GSH utilization. The ability of cells to 
regenerate GSH (either by reduction of GSSG or new synthesis of GSH) is 
an important factor in efficient managing of oxidative stress within the 
cells (Rumora et al. 2007).  
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 Few studies have been demonstrated on GSH depletion after BEA 
exposure (Klarić et al., 2007) no report data related to GSH or its 
related enzymes activity have been found in published scientific works.  
 1.6.2 Antioxidants from diet as protective system 
 Antioxidant compound can be provided exogenously through the 
diet or supplement. These antioxidant compounds include vitamins (C 
and E), flavonoids, carotenoids, phenolic compounds, etc. Phenolic 
compounds, or polyphenols constitute one of the most numerous and 
widely-distributed groups of substances in the plant kingdom, with more 
than 8,000 phenolic structures currently known. Polyphenols are 
products of the secondary metabolism of plants with an aromatic ring 
bearing one or more hydroxyl substituents (Urquiaga and Leighton, 
2000). Polyphenols are widely distributed in fresh fruits, berries, black 
tee, red wine, purple grape juice, medicinal herbals, daily nutrition 
supplements, etc. constituting an integrate part of the human diet 
(Lombardi et al., 2012).   
 They exhibit a wide range of biological effects as a consecuence 
of their antioxidant activity, such as cancer-preventive, oxygen radical 
scavenging, antiproliferative and anti-inflammatory activities and 
stimulate the immune system. In particular, dietary polyphenols can 
protect cell constituents against oxidative damage limiting degenerative 
diseases associated to oxidative stress (Lombardi et al., 2012).   
 Most frequently studied polyphenols are resveratrol, quercetin 
and its derivates (Fig. 8); they possess antioxidant, antitumoral, anti-
inflammatory, antiplatelet, and vasoprotector activities (Barcelos et al. 
2011). Quercetin is a major polyphenol ingested daily by dietary intake 
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(20–100 mg; You et al. 2010). Pterostilbene, an analogue of resveratrol, 
has also been shown that has beneficial healthily properties. It possess 
antiproliferative, anti-inflammatory and antioxidantive effects, and 
presents antihyperglycemic, anticholesterol and hypolipidemic activities 
(Zamora-Ros et al. 2008; Chakraborty et al. 2010). The antioxidant 
activity of polyphenols has been widely investigated, but also their toxic 
and genotoxic effects. Due to the contradicting results about their 
ability to protect mammalian cells from cytotoxicity, studies on the 
level of safety are of great importance. During last decade, several 
studies have been carried out about the potential protective effects of 
polyphenols against mycotoxins effects on cell culture (Hundhausen et 
al. 2005; Sergent et al. 2005; Choi et al. 2010; Barcelos et al. 2011). 
Antioxidant effects of polyphenols and its glycosides have been 
previously demostrated as in vitro as in vivo after mycotoxins exposure.  
 
 
Figure 8. Chemical structure of (a) resveratrol, (b) quercetin, (c) t-
pterostilbene. 
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 1.7 Impairment of cell proliferation: the cell cycle distribution   
 The cell cycle is the entire process by which a cell undergoes cell 
division. It involves several processes in the nucleus and encompasses 
signaling pathways from plasma membrane receptors to the cytoplasm 
and vice versa. Cell cycle is a potentially “dangerous” process. When 
cells enter the cell cycle, there is no way back: they undergo cell 
division or they die. Therefore, if a xenobiotic compound blocks the cell 
cycle at one or more phases, cell can undergo apoptosis or necrosis. Cell 
cycle phases are: the G1 phase, where cells are preparing for DNA, RNA 
and protein synthesis, the S phase where DNA is synthesized, the G2 
phase, where cells are preparing for mitosis and finally the M phase 
(mitosis) where two daughter cells are generated. Cells can remain in a 
quiescent phase (G0 phase) and they need growth factors to enter the 
G1 phase.   
 It have been demonstrated that mycotoxins can disturb the 
normal cell cycle distribution by their anti-proliferative effects on 
several cell types, with an accumulation of cells in one or more phases 
of the cell cycle (Juan-García et al., 2013a). This is due to the 
activation of different cell cycle checkpoint that ensure the orderly 
progression events and prevent aberrant mitosis in response to a range 
of events, including DNA damage (Visanji et al., 2004). The measure of 
DNA (in each phase of the cell cycle) is one of the most wide spread 
application of flow cytometry. It can provide useful information 
regarding the cytotoxic action of several substances. The most accurate 
method of measuring the relative number of cells in different phases of 
the cell cycle is to pulse-label with propidium iodide (PI) which binds to 
DNA by intercalating between the bases with little or no sequence 
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preference and with a stoichiometry of one dye per 4.5 base pairs of 
DNA. Cell cycle assay was performed by using PI fluorochrome in 
different cell lines exposed to BEA, ENs and other Fusarium mycotoxins 
demonstrating that they can alter the cell cycle distribution (Juan-
Garcίa et al., 2013b).  
 1.8 Mechanism of apoptosis/necrosis cell death 
 The term apoptosis defined a genetically encoded cell death for 
the ordered removal of superfluous, aged or damaged cells (Kroemer et 
al., 1998). Necrosis is the accidental cell death that is the passive 
results of cellular injury (Vermes et al. 2000). Apoptosis is 
morphologically, biochemically and molecularly distinct from necrosis. 
Apoptosis is distinguished from necrosis by a highly organized mode of 
cell demise, followed by degradation of chromatine into 
internucleosomal fragments, a loss of cellular volume associated with 
cytoskeletal breakdown and blebbing of the plasma membrane. It also 
involves the activation of specific cysteine proteases (caspases) that 
catalyze highly selective pattern of protein degradation (Kroemer et al., 
1998). Subtle changes in the plasma membrane occur before it ruptures. 
Thus surface exposure of phosphatidylserine residues  (normally on the 
inner membrane leaflet) allows for the recognition and elimination of 
apoptotic cells by their healthy neighbors, before the membrane breaks 
up and cytosol or organelles spill into the intracellular space and elicit 
inflammatory reactions (Savill, 1996). During the process of apoptosis, 
mitochondria do not manifest any major ultrastructural abnormalities 
(Kerr et al., 1972). 
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 In contrast to apoptosis, necrosis does not involve any regular 
DNA and protein degradation pattern and is accompanied by sweilling of 
the entire cytoplasm (oncosis) and of the mitochondrial matrix, which 
occur shortly before the cell membrane ruptures (Kroemer et al., 1998).  
 Apoptosis and necrosis have long been viewed as opposed by 
antinomy, but it is now generally assumed that both forms of cell death 
constitute two extremes of a continuum. The same xenobiotic can 
induce apoptosis or necrosis at a low (subnecrotic) or high dose 
respectively (Kroemer, 1998). Even in response to a certain dose of 
death-inducing agent, features of both apoptosis and necrosis may 
coexist in the same cell. In addition, if not engulfed by neighboring cells 
or in cell culture, where phagocytosis does not usually happen, dead 
cells in the late stages of apoptosis may present necrotic features due 
to the loss of cellular energy and plasma membrane integrity. This 
process is called “apoptotic necrosis” or “secondary necrosis” (Zong and 
Thompson, 2006). 
 BEA and ENs to induce apoptosis in several cell lines (Juan-Garcίa 
et al., 2013b). BEA and ENs induced apoptosis that was evidenced by 
DNA fragmentation and nuclear condensation, apoptotic body formation 
and increased caspase-3 activity (Dombrink Kurtzman, 2003; Jow et al., 
2004; Lin et al., 2005; Klarić et al., 2008; Dornetshuber et al., 2009b; 
Watjen et al., 2009; Juan-García et al., 2013a).  
 The ionophoric properties is most likely related to the ability of 
BEA to induce apoptosis in several mammalian cells. It has been 
demonstrated that the transfer of Ca2+ from the endoplasmatic 
reticulum to the mitochondria is required for the initiation of apoptosis 
(Scorrano et al., 2003). The Ca2+ increase measured in ventricular 
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myocytes agrees with the apoptosis properties of BEA (Kouri et al., 
2003).  
 Moreover, the necrotic cell death have been also reported 
(Gammelsrud et al., 2012; Ivanova et al., 2012; Juan-García et al., 
2013a).  
 1.9 Mitochondrial membrane potential disruption  
 Mitochondria have been recognized for their role in mediating 
physiological processes and their involvement in signal transduction and 
regulation of cell proliferation and differentiation. They are involved 
also in cell death regulation, i.e. necrosis and apoptosis. Due to this 
role, mitochondria are vulnerable to the toxic effects of xenobiotics 
that interefer in the energy production. The outer mitochondrial 
membrane is permeable to many small molecules. Certain forms of 
stress, including xenobiotics, can make the outer membrane more 
permeable to the point that mediators of apoptosis (cytochrome c, 
activators of caspases, etc.) can escape into the cytosol, where they 
initiate apoptosis or necrosis and from where they can even be further 
translocated into the nucleus, where they can cause DNA cleavage 
(Elmore et al., 2007).  
 Apoptosis and necrosis induced cell death by cytotoxic agents 
involve similar metabolic disturbances and above all, mitochondrial 
permeability transition (MPT). Mitochondrial events of apoptosis and 
necrosis involve opening of a pore in the inner mitochondrial 
membrane, referred as mitochondrial permeability transition pore 
(MPTP) and the consequent dissipation of ΔΨm (Kroemer et al., 1998). 
Moreover, once the pores are open, molecules with a molecular mass of 
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about 1500 Da pass across the channel. The dissipation of ΔΨm results 
from the inequal distribution of ions (mainly protons) on the inner 
mitochondrial membrane. The ΔΨm disruption suggests that the proton-
moving force and/or the inner membrane permeability has been 
affected during cell damage. The dissipation of ΔΨm is a general 
feature of both cell death types. 
 Measurements of mitochondrial membrane potential (ΔΨm) is 
carried out by using lipophylic dyes, which pass through cell membranes 
and accumulate according to their charge. The alteration of fluorescent 
intensity can be determined by flow cytometry. Among these dyes the 
tetramethyl rhodamine methyl estere (TMRM), coupled with the 
carbocyanine monomer nucleic acid (To-Pro-3) have been used to 
determine ΔΨm (Juan-García et al., 2013a).  
 The disruption of ΔΨm have been demonstrated in KB-3-1 cells 
exposed to ENs mixture (Dornetshuber et al., 2007), and in Caco-2 and 
HepG2 cells (Ivanova et al., 2012; Juan-García et al., 2013a). The exact 
mechanism by which pro-oxidant mycotoxins induced pore opening is 
still not fully understood. At least two molecular sites of the complex 
contribute to this effect. The first site is a redox sensitive membrane 
dithiol group that can be oxidized by ROS (produced by mycotoxins), the 
second one remains undetermined.   
1.10 DNA damage  
 Cells are continuously exposed to endogenous and exogenous 
agents that damage their DNA (Barzilai and Yamamoto, 2004). The many 
types of DNA lesions that results from these insults are rapidly 
detected, with the subsequent activation of an intricate web of 
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signaling pathways (DNA damage response) that culminates in activation 
of cell cycle checkpoints and DNA repair pathways, or in certain 
contexts, in the initiation of apoptosis (Barzilai and Yamamoto, 2004). 
 Genotoxic compounds are molecules, both exogenous (such as 
mycotoxins) or endogenous, that interact with the DNA of living cells 
and cause the loss of structural and functional DNA integrity (Wang and 
Groopman, 1999). Generation of DNA damage is considered to be an 
important initial event in carcinogenesis. Moreover, a significant portion 
of the damage is caused by ROS (Barzilai and Yamamoto, 2004). In the 
last thirty years, several assays have been performed to determine the 
DNA damage in cell cultures after exposure to toxicants that allow to 
determine SSB or DSB. Among them, the Comet assay is capable to 
determine DNA damage in individual cells (Singh et al., 1988). The 
alkaline version of the Comet assay have been used to assess the 
genotoxic potential of mycotoxins (Klarić et al., 2010). The Comet assay 
have been used to determine DNA damage in different cell types 
exposed to Fusarium (BEA, Butenolide, PAT, DON; Bony et al., 2006; 
Schumacher et al., 2006; Klarić et al., 2010; Yang et al. 2010) and 
Penicillium (OTA; Simarro Doorte et al., 2006; Klarić et al., 2010).  
mycotoxins. These mycotoxins showed an increase in DNA damage 
depending on the concentration tested.  
1.11 Bioavailability studies of mycotoxins 
 The intestinal mucosa undergoes continuous cell replacement 
from the stem cell compartment localized in the intestinal crypts. Toxic 
effects from substances in the intestinal lumen can affect either the 
stem cells in the crypts (affecting the renewal capacity of the tissue) or 
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the non-proliferative differentiated cells (Sambruy et al., 2001). In 
addition, the intestine has an important role in the bioavailability of 
mycotoxins, as well as other xenobiotics.  
 Release of the contaminant from the ingested product in the 
gastrointestinal tract is a prerequisite for uptake and bioavailability of a 
contaminant in the body. The term bioavailability describe the 
proportion of the ingested contaminant in food that reaches the 
systemic circulation (Versanvoort et al., 2005) and exerts toxic effects 
in human body.  
 Bioavailability studies can be performed in vivo (in experimental 
animals and humans) and in vitro by using in vitro system which try to 
simulate physiochemical conditions of the gastro-intestinal tract. In 
vitro systems are a good alternative to the in vivo techniques for its 
lower cost, less variability, and determination of test conditions, 
although is not possible to complete reproduction of physiological 
conditions, and applications of the results are more limited than in the 
in vivo methods. In recent years, the use of cell cultures have been 
widely employed to assess bioavailability (Sambruy et al., 2001). During 
the past few years, Caco-2 cells monolayer (CCM) have been widely 
accepted by pharmaceutical companies and by regulatory authorities as 
a standard permeability-screening assay for prediction of drug intestinal 
permeability (Grajek and Olejnik, 2004). Caco-2 cells have been 
established in 1970 from human colon adenocarcinoma, with the aim of 
performing studies on cancer mechanism and related cytostatic 
therapies (Fogh et al., 1977). Caco-2 cells showed a spontaneous 
differentiation pathway leading, in two or three weeks, to the 
formation of a monolayer that express several morphological and 
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biochemical characteristics of small intestinal enterocytes: a cylindrical 
polarized morphology, with  microvilli on the apical side, tide junctions 
between adjacent cells and expression of small intestinal hydrolase 
enzyme activity (i.e. sucrose-isomaltase, lactase, aminopeptidase N- 
and depeptidylpeptidase IV; Sambruy et al., 2001). The more 
differentiated human intestinal cell line can be grown and allowed to 
differentiate on microporous culture supports made of polycarbonate or 
other similar materials. The culture support, form a two compartments 
system where the apical (AP) medium is separated from the basolateral 
(BL) medium by the microporous filter insert (Figure 9). To utilize this 
system for transport or bioavailability studies, the integrity and 
functional closure of tight junctions has to be monitored before and 
throughout the experiments. This could be achieved by measuring the 
trans-epithelial electrical resistance (TEER) of the cell monolayer. The 
determination of TEER is simple and rapid to perform and it is generally 
measured utilizing a pair of Ag/AgCl electrodes that, placed into AP and 
BL medium, measure the electrical resistance of the filter and cell 
monolayer and is expressed as Ω cm2. Phenol red exclusion also is used 
as a measure of monolayer integrity. This method measure the passage 
of phenol red through the monolayer (Halleux and Schneider, 1991). 
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Figure 9. Graphical representation of in vitro trans-epithelial transport.   
 
 Overall, some but not all small intestinal functions have been 
shown to be expressed in the differentiated Caco-2 cell line, leading to 
the conclusion that these cells, because of their tumour origin, may not 
represent a single cytotype, but exhibit some biochemical 
characteristics of normal adult intestine, others of foetal colon, and 
others of normal adult colon (Harris et al., 1992). Despite these 
limitations, up to now the Caco-2 cell line has proved to be the best 
model for studies of intestinal absorption and transport of xenobiotics.  
 As regarding to the bioavailability studies of mycotoxins, Caco-2 
cells have been previously used to assess their  transport through the 
monolayer (Caloni et al., 2006; Videmann et al., 2008; Burkhardt et al., 
2009; Meca et al., 2012a,b). Moreover Caco-2 cells have been used to 
evaluate the duodenal and colonic bioavailability of ENs (Meca et al., 
2012a). To simulate  colonic bioavailability, Caco-2 cells were grown in 
symbiosis with some bacteria characteristics of the gastrointestinal 
tract (Lactobacillus animalis CECT 4060T, L. casei CECT 4180, L. casei 
rhamnosus CECT 278T, L. plantarum CECT 220, L. rhuminis CECT 
4061T, L.casei  CECT 277, Bifidobacterium breve CECT 4839T, B. 
Antecedentes bibliográficos 
 
 
60 
 
adolescentes CECT 5781T and B.bifidum CECT 870T, Corynebacterium 
vitaeruminis CECT 537, Streptococcus faecalis CECT 407, Eubacterium 
crispatus CECT 4840 and Saccharomyces cerevisiae CECT 1324). 
1.12 Bioaccessibility studies of mycotoxins 
 Human exposure to mycotoxins is principally via ingestion 
(Peraica et al., 1999). It is therefore important to be able to assess the 
amount of mycotoxins that is potentially available for the absorption in 
the stomach and/or intestines. The term “bioaccessibility” describes 
the fraction of a contaminant that is mobilized from food matrix during 
gastrointestinal digestion and theoretically subsequently available to 
intestinal absorption (Versanvoort et al., 2005).  
 Bioaccessibility can be determined by in vivo and in vitro 
studies. In vivo animal studies present the great advantage of providing 
information on a whole organism, including all organs and their 
metabolic functions (Marques et al., 2011). On the other hand, in vivo 
feeding methods, using animals, although providing the most accurate 
results, they are time consuming and costly. Thus, much effort has been 
devoted to the development on in vitro procedures (Boisem and Eggum, 
1991). In vitro digestion models provide a useful alternative to animal 
models by rapidly screening food ingredients. The in vitro digestion 
method would provide accurate results in a short time (Hur et al., 
2011). However it is important to consider the inherent complexity of 
the process (Fuller, 1991; Coles et al., 2005). During the last decade, an 
increasing interest in the use of in vitro methodologies, such as in vitro 
digestion models that simulate the human digestion process has been 
observed (Avantaggiato et al., 2003; Versanvoort et al., 2005). These in 
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vitro models attempt to recreate the aspects of human gastrointestinal 
physiology, in the mouth, stomach and small intestine compartments, in 
order to enable bioaccessibility of contaminants. In these models 
chemical composition of digestive fluids, pH, and residence time 
periods typical for each compartment are simulated (Versanvoort et al., 
2005). Moreover, they are simple, rapid, low-cost, and without ethical 
implications, although, in vitro conditions used, including differences in 
solid solution ration, the method of mixing, the pH values of the gastric 
and intestinal juices and their compositions can modified the 
bioaccessibility. Even food contaminants and food matrix could alter 
this process (Hur et al., 2011).  
 Several in vitro studies have been optimized and applied to 
assess the bioaccessibility of mycotoxins. In vitro digestion method 
according to Gil-Izquierdo et al. (2002), that included a three-step 
procedure simulating the digestive processes in mouth, stomach and 
small intestine is reported in Figure 10. Similarly, Versanvoort et al. 
(2005) applied the digestion process of three step procedure by which 
they analyzed the concentration of contaminats in the chime (intestinal 
content).   
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Figure 10. Schematic representation of the in vitro digestion model as 
reported by Gil-Izquierdo et al. (2002).  
 
 In vitro digestion model that simulated both adults and  children 
digestion has been used to assess the bioaccessibility of mycotoxins of 
human concern (Meca et al., 2012a,b; Raiola et al. 2012). The children’s 
digestion model was basically the same as that of adults 
abovementioned with slight modifications (the pH of the stomach, the 
3 g of spiked samples 
pH 6.8  
Mouth compartment 
3 min at 37°C in a stomacher 
Addition of 0.5g of pepsin (14,800 U in 
HCl 0.1N) 
2 h at 37 °C in an orbital 
shaker 
Stomach compartment 
pH 2.0  
 
5 mL (1:1 v/v) of pancreatin (8 
mg/mL)–bile salts (50 mg/mL) 
pH 6.5  
Intestinal compartment 
2 h at 37°C in an orbital shaker 
Centrifugation at 4.000 rpm 
during 1 h at 4 ºC 
Extraction and determination of ENs 
from the intestinal fluid (Bioaccessibility) 
 
6 mL of simulated saliva and 40 mL 
of water 
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quantity of pepsin, pancreatin and bile salts). On the other hand, an in 
vitro gastrointestinal model that simulates metabolic processes in 
stomach, duodenum, jejunum and ileum of healthy pigs by means of a 
multicompartimental dynamic computer-controlled system was also 
developed (TIM; Minekus et al., 1995; Avantaggiato et al., 2003; 2004). 
A schematic representation of the TIM is illustrated in Figure 11.   
 
 
Figure 11. Schematic diagram of the dynamic, multi-compartmental 
model of the stomach and small intestine1.
                                                          
1 A. gastric compartment; B. pyloric sphincter; C. duodenal compartment; D. peristaltic 
valve; E. jejunal compartment; F. peristaltic valve; G. ileal compartment; H. ileo-
caecal valve and sampling bottle for ileal delivery; I. pH electrodes; J. gastric secretion 
bottles with acid and enzymes; K. duodenal secretion bottles with bile, pancreatic 
juice, bicarbonate; L. secretion of bicarbonate to control the intestinal pH; M. pre-filter 
system; N. hollow fiber semi-permeable membrane system; O. water absorption system; 
P. closed dialyzing system (Avantaggiato et al., 2003). 
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  Kabak et al. (2009; 2012) proposed the simulated in vitro 
digestion model showed in Figure 12. They found slight decrease in 
bioaccessibility of AFB1 and OTA and AFM1 than those obtained in the 
previous model showed.  
 
Figure 12. A schematic diagram representing the in vitro digestion 
experiment (Kabak et al., 2009; 2012).  
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OBJECTIVES 
The general objective of this study was to further investigate the 
effects produced by minor Fusarium mycotoxins. Therefore, the specific 
objectives were to determine:   
1. Cytotoxic effects of individual fusaproliferin, beauvericin and 
enniatins in Caco-2, CHO-K1 and HT-29 cell lines.  
2. Cytotoxic effects of combined enniatins A, A1, B and B1 in Caco-2 
cells.  
3. Reactive oxygen species generation and lipid peroxidation 
production after fusaproliferin, beauvericin and enniatins 
exposure in Caco-2 cells. 
4. The cytoprotective effect of GSH and some polyphenols against 
enniatins and beauvericin cytotoxicity in CHO-K1 and Caco-2 
cells.   
5. The cell cycle, apoptosis/necrosis induction and mitochondrial 
membrane alteration after beauvericin and enniatins exposure in 
Caco-2 cells. 
6. The transepithelial transport of beauvericin and fusaproliferin 
and their relative bioavailability using the Caco-2 cell line. 
7. The bioaccessibility of enniatins A, A1, B, and B1 from artificially 
spiked grain-based products, by applying  an in vitro 
gastrointestinal model. 
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ABSTRACT 
Foodstuff is usually contaminated by more than one mycotoxin, however 
toxicological data are lacking as regards the effects in combinations 
compared to their individual effect. This study investigated the in vitro 
effects of enniatins (ENs) A, A1, B and B1, alone and in combinations, on 
Caco-2 cells viability by MTT assay after 24 h of exposure. Cells were 
treated with concentrations ranging from 0.9 to 15.0 µM, individually 
and in combination of two, three and four mycotoxins. Dose-response 
curves were generated for each mycotoxin and the isobologram method 
was used to determine the interactive effects of tested mixtures. 
Tested ENs produced significant cytotoxic effects both individually and 
in combination in a dose-dependent manner. IC50 values obtained for all 
individually tested mycotoxins ranged from 1.3 to >15 μM. In ENs 
combination tests, synergistic effect in Caco-2 viability  are observed 
for EN B+EN A1, EN B1+EN A1 and EN A+EN A1+EN B (CI=0.33-0.52). All 
other combinations showed additive effect at medium and high affected 
fraction with exception of lower fraction affected and the EN B+EN B1 
mixture that produced antagonistic effect (CI=1.76-10.36). The use of 
combination index-isobole method could help to better understand the 
potential interaction between co-occurring mycotoxins and may 
contribute to their risk assessment. 
Keywords: enniatins, cytotoxicity, interactions, isobolograms, Caco-2 
cells. 
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1. Introduction  
 Mycotoxins are toxic compounds produced as secondary 
metabolites by different types of fungi, belonging mainly to the 
Aspergillus, Penicillium and Fusarium, that are excreted into the 
matrices on which they grow, often food intended for human 
consumption or animal feed (Jestoi et al., 2004; Meca et al., 2010; 
Malachova et al., 2011). The consumption of mycotoxins-contaminated 
commodities is related to several chronic diseases in humans and in 
animals with many different adverse health effects, such as 
carcinogenic, mutagenic and estrogenic effects, as well as other 
systemic disorders (Speijers et al., 2004; Ruiz et al., 2011a; Kouadio et 
al., 2007). Some mycotoxins are also immunosuppressive reducing 
resistance to infectious diseases.  
Under favorable environmental conditions, Fusarium strains, produce 
cyclic hexadepsipeptidic mycotoxins such as enniatins (ENs) that are 
endowed with a wide array of toxicological effects, such as 
antibacterial, antifungal, antihelmintic, insecticidal, phytotoxic and 
cytotoxic, most likely related to their ionophoric properties (Kamyar et 
al., 2004). Several studies have recently indicated that ENs exert their 
cytotoxic activities in the lower micromolar range, in addition to being 
ionophores, through the induction of mitochondrial modifications and 
cell cycle disruption, finally resulting in cell death (Dornetshuber et al., 
2009; Watjien et al., 2009; Tonshin et al., 2010; Meca et al., 2011).  
The Commission Regulation (EC) 1881/2006 and its amendments set 
maximum levels for certain contaminants in foodstuff as for certain 
mycotoxins including some Fusarium toxins (EC 2006). However, these 
maximum levels have been established taking into account only the 
Resultados 
 
 
99 
 
presence of individual mycotoxins. Hence, it is necessary to take into 
consideration toxicological “mixture” effects derived from mycotoxins 
to implementing human risk assessment  (Tajima et al., 2002; Speijers 
et al., 2004).  
Toxicological studies  about the effects of mycotoxins mixtures are of a 
great importance in order to find out whether they could interact 
among themselves and produce a synergistic, additive or antagonistic 
effect (Bernhoft et al., 2004, Heussner et al., 2006; Kouadio et al., 
2007; Klarić et al., 2008; Ruiz et al., 2011a,b).  
Toxic effects of individual ENs in vitro have been previously carried out 
in different cell types, whereas very scarce information is 
available about their effects in combination as well as their potential 
interactions (Meca et al., 2011). Effects of mycotoxins combinations in 
vitro have been carried out for other mycotoxins and several 
mathematical methods have been applied in order to determine also the 
type of potential toxicological interaction among them (Tajima et al., 
2002; Heussner et al., 2006; Kouadio et al., 2007; Klarić et al., 2008). 
Some studies on combined effects of mycotoxins have been carried out 
using isobolographic analysis (Bernhoft et al., 2004; Luongo et al., 2008; 
Ruiz et al. 2011a,b) and interactive effects of mycotoxins combination 
have been demonstrated. The aim of this study is to investigate the 
joint action of the four Fusarium ENs A, A1, B and B1 and to assess the 
nature of toxicological interactions among them. For this purpose, ENs 
were tested individually and in two-, three- and four- ENs combinations. 
Taking into consideration that the major route to mycotoxins is via oral 
ingestion, Caco-2 cells, from intestinal origin, were used in this study. 
Caco-2 cells are considered a target human cells of the digestive 
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system, moreover, this cell line demonstrated to be sensitive to ENs 
cytotoxicity, as demonstrated previously (Meca et al., 2011; Ivanova et 
al., 2012). In addition, up to now, no studies about cytotoxic effects of 
ENs combination in Caco-2 cells have been carried out. Cell viability 
after 24 h of exposure to mycotoxins individually and in combinations, 
have been chosen as toxicity endpoint by using MTT assay; the method 
of combination index (CI)-isobologram equation was applied to 
determine the type of interactions.  
2. Materials and methods 
2.1 Chemicals  
 The reagent grade chemicals and cell culture components used 
were from Sigma Chemical Co. (St Louis, MO, USA). EN A (CAS#2503-13-
1), EN A1 (CAS#4530-21-6), EN B (CAS#917-13-5) and EN B1 (CAS#19914-
20-6) were form Enzo Life Sciences, (Switzerland). Fetal calf serum 
(FCS) was from Cambrex Company (Belgium). Deionised water 
(resistivity <18 MΩ cm) was obtained using a Milli-Q water purification 
system (Millipore, Bedford, MA, USA). Mycotoxins selected were Stock 
solutions of ENs were prepared in methanol and maintained at -20°C.  
2.2. Cell culture and treatment 
 Caco-2 cells (ATCC HTB-37) were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% (v/v) FCS, 25 
mM HEPES buffer, 1% Non-Essential Aminoacids (NEAA), 100 U/mL 
penicillin, 100 mg/mL streptomycin, 1 mM Sodium Pyruvate. Cells were 
grown near confluence in 75 cm2 plastic flasks at 37 °C in an 
atmosphere containing 5% of CO2 at 95% of relative humidity and  
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harvested with 1% trypsin. Absence of mycoplasma was checked 
routinely using the Mycoplasma Stain Kit (Sigma-Aldrich, St Louis Mo. 
USA).  
Cells were plated in 96-well tissue culture plates at a density of 3 x 104 
cells/well to perform the experiment. Four concentrations for EN A 
(0.94-7.5 µM) and five concentrations for ENs A1, B and B1 (0.94-15.0 
µM) were assayed. EN combinations (of two, three and four mycotoxins) 
were also assayed after 24 h of exposure. Concentrations ranged from 
0.625 to 5.0 μM for binary mixtures (1:1 ratio) and, from 1.25 to 2.5 μM 
for tertiary and quaternary mixtures, with a fixed ratio of 1:1:1 and 
1:1:1:1, respectively.  
For each ENs from initial solutions, serial dilutions in supplemented 
medium were prepared. Culture medium without ENs and with 1% 
methanol (MeOH) was used as control. After replacing the previous 
medium, the exposure solutions were added to each well and plates 
were incubated at 37 °C for 24 h. The basal cytotoxicity endpoint 
selected was the tetrazolium salt reduction (MTT).  MTT was measured 
according to Ruiz et al. (2006). Medium containing ENs was removed, 
cells were washed with PBS and 50 μL MTT were added. The absorbance 
was measured after 4 h at 570 nm on an ELISA plate reader Multiscan EX 
(Thermo scientific, MA, USA). Mean inhibition concentration (IC50) values 
were calculated from full dose-response curves.  
2.3. Experimental design of isobologram method 
 The isobologram analysis was used to determine the type of 
interaction that occurs when ENs were in combination. The median-
effect/combination index (CI)-isobologram equation by Chou (2006) and 
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Chou and Talalay (1984) was originally for analyzing drug combination 
effects. The isobologram analysis involves plotting the dose–effect 
curves for each compound and its combinations in multiple diluted 
concentrations by using the median-effect equation: 
fa/fu = (D/Dm)
m 
where D is the concentration of a product, Dm is the median-effect dose 
(e.g., IC50 or LD50, which stands for surviving population of cells that 
reaches 50%), fa is the fraction affected by concentration D (e.g., 
percentage inhibition/100), fu is the unaffected fraction (therefore, fa 
= 1 - fu), and m is the coefficient signifying the shape of the dose-effect 
relationship, where m = 1, m >1, and m <1 indicate hyperbolic, 
sigmoidal, and negative sigmoidal dose-effect curve, respectively (Chou 
and Talalay, 1984). Therefore, the method takes into account both the 
potency (Dm) and shape (m) parameters.  
 The medium-effect equation for a single compound can be 
extended to multiple mycotoxins. And the equation becomes: 
 [(fa)1,2/(fu)1,2]
1/m=D1/(Dm)1+ D2/(Dm)2+(D)1(D)2/(Dm)1(Dm)2 
Chou and Talalay (1984) introduced the term combination index (CI)x for 
quantification of synergism or antagonism for the two compounds: 
CI= D1/(Dx)1+ D2/(Dx)2 
Dx= Dm[fa/(1-fa)]
1/m 
CI=(D)1/(Dm)1[fa/(1-fa)]
1/m1+ (D)2/(Dm)2[fa/(1-fa)]
1/m2 
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where in the denominator (Dx)1 is for D1 ‘‘alone’’ that inhibits a system 
x%, and (Dx)2 is for D2 ‘‘alone’’ that inhibits a system x%. And, the 
general equation for n-compound combination at x% inhibition becomes: 
n(CI)x
 = 
n 
∑ 
J=
1 
(D)j/(Dx)j
 
 
= 
(Dx)1-n {[D]j
 
n 
∑ 
J=1 
[D]} 
(Dm)j {(fax)j/[1-(fax)j}
1/mj 
Where n(CI)x is the combination index for n compounds (e.g., 
mycotoxins) at x% inhibition (e.g., proliferation inhibition); (Dx)1-n is the 
sum of the concentration of n compounds that exerts x% inhibition in 
combination, {[Dj]/ ∑
n
1 [D]} is the proportionality of the concentration of 
each of n compounds that exerts x% inhibition in combination; and (Dm)j 
{(fax)j/[1-(fax)j]}
1/mj is the concentration of each compound alone that 
exerts x% inhibition. The CI <1, =1, and >1 indicates synergism, additive 
and antagonism effect of the combination, respectively; The types of 
interactions produced by EN combinations were assessed by isobologram 
analysis using CalcuSyn software version 2.1. (Biosoft, Cambridge, UK, 
1996-2007).  
2.4. Statistical analysis 
 Statistical analysis of data was carried out using SPSS Statistic 
19.0 (SPSS, Chicago, IL, USA) statistical software package. Data were 
expressed as mean ± SD of three independent experiments. The 
statistical analysis of the results was performed by Student’s t-test for 
paired samples. Differences between mycotoxins were analyzed 
statistically with ANOVA followed by the Tukey HDS post hoc test for 
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multiple comparisons. The level of p≤0.05 was considered statistically 
significant. 
3. Results 
 At 24 h of exposure, EN A1 showed an IC50 value of 14.8 ± 2.7 μM, 
whereas ENs A, B, B1 did not show IC50 value at the range of 
concentration tested. After 48 and 72 h of exposure, all mycotoxins 
tested showed IC50 values, with the exception of EN B. The IC50 values 
were 6.8 ± 1.6 μM (EN A), 7.7 ± 1.2 μM (EN A1) and 11.3 ± 2.3 μM (EN B1) 
after 48 h of exposure. After 72 h, the IC50 values were 1.6 ± 0.8 (EN A), 
1.3 ± 0.6 (EN A1), 2.8 ± 1.1 (EN B1) and 11.7 ± 2.4 (EN B).  As  observable 
in Figure 1, EN B showed the less cytotoxic effect on Caco-2 cells at the 
three times of exposure, followed by EN B1, EN A and ENA1 that resulted 
to be the most cytotoxic among ENs tested.  
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Figure 1. Dose response curve of ENs A, A1, B and B1 on Caco-2 cells after 24 (), 48 (----) and 72 h (·-
··-·) of exposure. Cytotoxicity values are expressed as IC50. Mean ± SD, of 8 replicates. p ≤ 0.05 (*), p ≤ 
0.000 (***) represent significant difference as compared to control values. 
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 Figures 2 and 3 represent the viability (%)-concentration (μM) 
plot of the ENs combinations. Reduction of cell viability (%) resulted in a 
dose-dependent manner for binary mixture tested in the following 
increasing order:  EN A + EN A1 (48%) = EN A1+EN B1 (47%) > EN A1+EN B 
(35%) = EN A+EN B (33%) = EN A+EN B1 (32%) > EN B+EN B1 (26%) (Fig. 2). 
Similarly, tertiary and quaternary mixtures reduced cell viability in a 
dose-dependent manner (Fig. 3). For all tertiary and quaternary 
mixtures, the reduction in viability was approximately 40% (Fig. 3) and a 
general additive effects was observed (Table 1). 
In order to investigate the type of interaction between ENs A, A1, B and 
B1 in their combinations, the CI-isobologram method have been applied. 
Results are summarized in Table 1. As assessed by CI-isobologram 
equation, antagonistic effects have been produced by all the 
combinations tested at the lowest fraction affected (IC5) with IC50 
values from 2.05 ± 0.88 to 10.36 ± 4.32. Whereas a general  additive 
effect (CI=1) has been produced by all mixtures through all the tested 
concentrations, except for the mixtures of EN B+EN A1, EN B1+EN A1 and 
EN A+EN A1+EN B. These combinations produced a synergistic effect (CI 
values ranging from 0.33 ± 0.53 to 0.52 ± 0.40) at the highest fraction 
affected. On the other hand, a moderate antagonism was produced by 
EN B+EN B1 combination at medium fraction affected (IC25) 
concentration tested  (CI values were from 10.36 ± 4.22 to 2.06 ± 0.71).  
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Figure 2. Cytotoxicity effects of individual EN A (-·--·- ), EN A1 
(······), EN B () and EN B1 (----) and all their binary combinations 
(). When binary mixture concentrations are 0.625, 1.25, 2.5 and 5 
µM, it means that concentrations of each EN in its combination is 
0.3125, 0.75, 1.25, 2.5 µM, respectively.   
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Figure 3. Cytotoxicity effects of individual EN A (-·--·- ), EN A1 
(······), EN B () and EN B1 (----) and all their tertiary and 
quaternary combinations (). When tertiary mixture concentrations 
are 1.25, 2.5 and 5 µM, it means that concentrations of each EN in its 
combination is 0.3125, 0.75, 1.25, 2.5 µM, respectively.  
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Table 1. Dose-effect relationship parameters and mean combination index values (as a function of 
fractional inhibition of proliferation) of ENs A, A1, B and B1 and their binary, ternary and quaternary 
combinations on Caco-2 cells, after 24h of exposure.  
 Dose-effect 
parameters 
    CI values 
Mycotoxin Dm 
(μM) 
m r IC5  IC25  IC50  IC75 IC90 
EN A 3.55 3.65 0.91           
EN A1 6.56 2.06 0.96           
EN B 7.91 0.77 0.97           
EN B1 7.22 1.21 0.99           
EN A+EN A1 3.90 2.81 0.91 2.92±1.29 Ant  1.45±0.69 Add  1.03±0.66 Add  0.78±0.64 Add  0.62±0.63 Add  
EN A+EN B 4.19 1.83 0.86 5.12±3.16 Ant  1.64±1.02 Add  1.04±0.95 Add  0.84±1.11 Add 0.81±1.50 Add  
EN A+EN B1 2.76 3.46 0.91 2.59±0.75 Ant 1.45±0.62 Add  1.15±0.60 Add  1.00±0.69 Add  0.92±0.78 Add  
EN B+EN A1 3.79 2.03 0.83 6.62±3.26 Ant 1.95±0.97 Add  1.01±0.75 Add  0.56±0.61 Add  0.33±0.53 Syn  
EN B1+EN A1 2.29 2.78 0.86 1.76±0.58 Ant 0.93±0.39 Add  0.66±0.37 Add  0.49±0.36 Syn   0.38±0.36 Syn  
EN B+EN B1 8.39 1.11 0.93 10.36±4.22 Ant 2.06±0.71 Ant 1.19±0.62 Add  1.25±0.97 Add  1.36±1.45 Add  
EN A+EN A1+EN B 2.18 2.94 0.90 6.28±2.34 Ant 1.61±0.62 Add 0.85±0.47 Add  0.52±0.40 Syn  0.37±0.37 Syn  
EN A+EN A1 +EN B1 2.06 2.90 0.87 2.05±0.88 Ant 1.23±0.55 Add 0.99±0.58 Add  0.85±0.63 Add  0.70± 
0.70 
Add  
EN A+EN B+EN B1 2.05 3.01 0.91 6.20±2.30 Ant 1.47±0.52 Add  0.96±0.46 Add  
0.76±0.48 
Add  
0.68±0.53 
Add 
EN A1+ EN B+ EN B1 2.05 3.00 0.90 5.17±2.02 Ant 1.71±0.62  Add 1.00±0.49 Add  0.69±0.44  Add  0.56±0.44 Add  
EN A+EN A1+EN B+EN B1 2.13 2.67 0.80 5.97±3.07 Ant 1.97±1.08 Add  1.30±0.96 Add  1.00±1.00 Add  0.88±1.15 Add  
The parameters m, Dm and r are the antilog of x-intercept, the slope and the linear correlation coefficient of the median-effect 
plot, which signifies the shape of the dose-effect curve, the potency (EC50), and conformity of the data to the mass-action law, 
respectively (Chou, 1976; Chou and Talalay, 1984; Chou, 2006). Dm and m values are used for calculating the CI values; CI <1, =1, 
and >1 indicate synergism (Syn), additive effect (Add), and antagonism (Ant), respectively. IC5, IC25, IC50, IC75 and IC90, are the doses 
required to inhibit proliferation 5, 25, 50, 75 and 90%, respectively. Computer software CompuSyn was used for automated 
calculation and simulation. 
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4. Discussion  
 The co-occurrence of several mycotoxins in the same sample is 
of great importance because their combination could lead to  possible 
adverse health effects which are riskier then the intake of one 
mycotoxin alone since, their possible interaction leads to antagonistic, 
additive or synergistic effects (Ruiz et al., 2011a,b). 
The four ENs selected naturally occur in food commodities. 
Contamination of food with ENs is a relatively widespread phenomenon: 
in several countries of Europe, levels of μg/kg up to mg/kg have been 
found in cereal grains as well as in processed food (Jestoi et al., 2004; 
Meca et al., 2010; Malachova et al., 2011). ENs A, A1, B and B1 were 
detected in 73% of cereal based products from Czech Market and the 
remainder samples were contaminated with at least three of them 
(Malachova et al., 2011). Moreover, ENs co-contamination has been 
demonstrated in 89% of Finnish grain samples, where ENs B and B1 were 
the most predominant mycotoxins in the commercially available 
samples, and in 82% in cereals of Spanish markets (Jestoi et al., 2004; 
Meca et al., 2010). The range of concentrations tested in this study was 
selected depending on the concentrations found in cereals, as reported 
in literature. Consecutively it has been explained the importance of the 
o-occurrence of ENs in the cereals in respect to the levels of combined 
toxicity. Although, ENs are still not legislated and no estimated daily 
intake (TDI) or provisional maximum tolerable daily intake (PMTDI) have 
been proposed by competent authorities, for other fusarotoxins, such as 
fumonisins (FBs) the maximum levels has been established in raw 
cereals as 2000 μg/Kg. Taking into consideration this value and 
considering that cereals consumption (excluding beer) in European 
Resultados 
 
 
111 
 
Union is 125.4 Kg/year (FAO, 2007), it could be possible to calculate 
that European people is approximately exposed to almost 680 μg/day of 
FBs. Applying this calculation to ENs, i.e. EN A1, the ingestion is 
approximately estimated to almost 1.01 μM, which is included in the 
range of concentrations tested. In addition, higher concentrations (up to 
5.0 μM) have been tested since ENs concentration in food depends on 
dietary food variety. 
 Literature data repeatedly report the substantial cytotoxicity 
associated with exposure of ENs to different types of cells up to 
micromolar concentration (Tedjiotsop Feudijo et al., 2010). ENs A1, B 
and B1 showed a moderate cytotoxicity (IC50 values of 10-25 μM by the 
MTT assay) in human hepatoma (HepG2) and rat glioma (C6) cells, but 
cytotoxicity was stronger (IC50 values of 1-2.5 μM) in H4IIE rat hepatoma 
cells where an increase in caspase 3/7 activity and nuclear 
fragmentation were also observed (Wätjen et al. 2009). Higher 
cytotoxicity was also reported for ENs A, A1, B, B1, B2 and B3 in MRC-5 
cells with  IC50-values that were 1.4 μM (EN A1), 1.4 μM (EN B1) and 3.6 
μM (EN B) as determined by BrdU assay. When the Alamar Blue assay 
was used, IC50-values were 6.9 μM (EN A1), 4.7 μM (EN B1) and 9.8 μM 
(EN B; Ivanova et al., 2006). 
 Moderate toxicity for ENs in HepG2 cells was found by Ivanova et 
al. (2006) with IC50-values that were 18.1 μM (EN A1), 36 μM (EN B1) and 
435 μM (EN B) as measured in the Alamar Blue assay. Similar results (IC50 
from 2.6 ± 0.6 to 26.2 ± 7.6 μM) in HepG2 cells were obtained by Meca 
et al. (2011). The results obtained in Caco-2 cells by Meca et al. (2011) 
were comparable with those obtained in this study. The highest toxicity 
was exerted by EN A1, that induced 50% cell death with 12.3 ± 4.3 μM 
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concentration. Higher toxicity was found in CHO-K1 by Lu et al. (2013). 
After 24, 48 and 72 h of exposure, the IC50 values ranged from > 7.5 to 
1.65 ± 0.7 μM. After 24 h of exposure EN B1 showed the highest toxicity 
(IC50=4.53 ± 1.23).   
 According to results obtained in this study and in the revised 
literature, the H4IIE, CHO-K1 and MRC-5 cells were more sensitive to 
ENs cytotoxicity, among all cells used. Moreover, depending on the cell 
lines tested, the ENs A1 and B1 showed higher toxic effects than the 
other ENs tested.  
 It is of high importance to check whether a combined intake of 
mycotoxins would lead to higher cytoxicity values, however, few studies 
reported the cytotoxicity of ENs mixture. Fornelli et al., (2004) 
evaluated the cytotoxicity of a mixture composed by four ENs (A, A1, B, 
B1) on the lepidopteran SF-9 cell line. After 48 h of incubation with 1-10 
µM concentration, the cytotoxicity obtained by MTT, expressed as IC50, 
was 6.6 µM. The same mixture was tested by Uhlig et al. (2005) on PK-
15 (porcine kidney) cells by the Alamar Blue assay and, after 24 h 
exposure, the IC50 obtained was 41 µM. Dornetshuber et al. (2007) and 
Gammelsrud et al. (2012) showed a reduction of cell viability through 
different endpoints which demonstrated a loss of mitochondrial 
membrane potential and an increasing of apoptotic cells at low 
micromolar ENs concentrations. That study, according to Tonshin et al. 
(2010), hypothesized that the mechanism of action of ENs is related to 
the strongly potassium-selective ionophoricity of ENs that causes 
predominantly mitochondrial damage. ENs induced a drop in the 
electric transmembrane potential of the mitochondrion, a K+ influx into 
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the mitochondrial matrix, a mitochondrial swelling and uncoupling of 
oxidative phosphorylation.  
 On the other hand, as determined by isobologram method, the 
nature of interactions produced by all the ENs combinations tested was 
not uniform along the fraction affected (from IC5 to IC90). In general, 
antagonism predominated at low fractions affected but at the highest 
ones, interactions became additive though all combinations tested or 
slight synergistic. This behavior cannot be explained by the 
isobolograms method since this one allows a quantitative determination 
of additive effects, synergism or antagonism, but not the elucidation of 
mechanisms by which these types of interaction are produced. 
However, tentatively, antagonism, that is the predominant interaction 
produced at the lowest fraction affected, could be due to the fact that 
ENs A, A1, B and B1, that possess similar structures, have been 
competing for same receptors at low doses producing a lower effect 
than the expected. Table 1 shows that antagonism was found in EN B 
+EN B1 combination effect at low and intermediate fractions affected. 
This could be due to the fact that ENs of B group may compete for the 
same receptor. They induced the lowest reduction of Caco-2 cells 
viability. EN B resulted to be the less cytotoxic among ENs tested in 
Caco-2 cells. The weakest activity of EN B has been reported also by 
Tonshin et al. (2010) on mitochondrial damage. Furthermore, EN B was  
less effectively pumped into cells from blood plasma by cell membrane 
potential than the other tested compounds with a possible explanation 
in the lower lipophilic properties  compared tothe other ENs. This 
weaker toxicity could explain the lower viability reduction obtained for 
EN B+EN B1. These findings could be interesting since EN B is one of the 
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most common minor Fusarium mycotoxins in several countries of Europe 
(Jestoi et al., 2004; Meca et a., 2010). 
On the contrary, the  interaction observed at intermediate and high 
fractions affected is additive and became slight synergistic for the 
binary EN A+EN A1 and EN A1+EN B1 combinations and the EN A+EN A1+EN 
B tertiary combinations. Normally, when two or more compounds with 
the same mechanism of toxicity displayed an additive or antagonistic 
effects. In this case, it could be hypothesized that ENs at low doses are 
competing for the same receptors, whereas at higher concentrations, 
after diffusing cell membranes by their lipophilic nature, binds their 
receptors and the resulting effect is the sum of their individual effects 
(additive). Regarding tertiary and quaternary mixtures, a general 
additive effect was produced  confirming the similar mode of action of 
ENs tested on Caco-2 cells cytotoxicity.  
 At high fractions affected a synergistic nature of interaction by 
EN A+EN A1, EN A1+EN B1 and EN A+EN A1+EN B mixtures is observed 
(Table 1). One could speculate that there is a potentiation of cytotxic 
effects due to their lipophilic structure (in the order EN A>EN A1>EN 
B1>EN B) which allows them to be easily incorporated in cell membranes 
and to exert cytotoxic action (Tedjiotsop Feudjio et al., 2010). 
Moreover EN A1 showed the higher inhibitory Caco-2 viability and it 
possesses a good pore forming activity with a pronounced potential 
dependency of the time constants for open times, as well as EN B1 
(Kamyar et al., 2004). EN A and EN A1 resulted to be the most cytotoxic 
ENs among ENs tested. The synergistic effects is produced when their 
co-occur with ENs of B group. It could be supposed that ENs of A group 
in combination with ENs of B group can induce a “facilitating action” 
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that means that secondary actions of one drug enhances the activity of 
other compound in the mixture or “complementary actions  when 
compounds act at the same target at different sites, at overlapping sites 
or at different targets of the same pathways (Jia et al., 2009).  
 Other co-occurring mycotoxins structurally related to ENs, like 
beauvericin (BEA), interact leading to synergistic or additive or 
antagonistic effects. In this way, additive effects have been reported by 
Klaric et al. (2008) after exposure to fumonisin B1 (FB1), ochratoxin 
(OTA) and beauvericin (BEA) at lower concentrations on porcine kidney 
epithelial (PK15) cells, whereas antagonistic effects were observed at 
higher concentrations. BEA, deoxynovalenol (DON) and thricotecene T-2 
mycotoxins combinations interact to produce antagonism in Vero cells 
and CHO-K1 cells (DON+BEA, DON+T-2), whereas synergism was 
produced in BEA+T2 and BEA+DON+T-2 in CHO-K1 cells, which showed 
antagonism in Vero cells (Ruiz et al., 2011a,b).  
 Results obtained in the present study suggest that the binary, 
tertiary and quaternary mixtures of A, A1, B and B1, could interact and 
produce a general additive effect on Caco-2 viability when exposed to 
ENs combination as compared to their individual effect, with the 
exception of EN B+B1 mixture that produced antagonism. These findings 
should be taken into account since toxic effects are enhanced by ENs 
combinations whose co-occurrence is in fact naturally encountered. 
Further research needs to be completed to enable an appropriate 
assessment of health risk effects in foodstuff.  
Conflict of interest 
The authors declare that there are no conflicts of interest.  
Resultados 
 
 
116 
 
Acknowledgements 
This research was supported by the Ministry of Science and Innovation 
(AGL2010-17024) and by the pre PhD program of University of Valencia 
“Santiago Grisolia”. 
References 
Bernhoft, A., Keblys, M., Morrison, E., Larsen, H. J. S., Flåøyen, A. 
(2004). Combined effects of selected Penicillium mycotoxins on in 
vitro proliferation of porcine lymphocytes. Mycopathologia, 158, 
441-450. 
Chou, T.-Ch., 2006. Theoretical basis, experimental design, and 
computerized simulation of synergism and antagonism in drug 
combination studies. Pharmacol. Rev. 58, 621-681. 
Chou, T.-Ch., Talalay, P., 1984. Quantitative analysis of dose-effect 
relationships: the combined effects of multiple drugs or enzyme 
inhibitors. Adv. Enzyme Regul. 22, 27-55. 
Dornetshuber, R., Heffeter, P., Kamyar, M. R., Peterbauer, T., Berger, 
W., Lemmens-Gruber, R., 2007. Enniatin exerts p53-dependent 
cytostatic and p53-independent cytotoxic activities against human 
cancer cells. Chem. Res. Toxicol. 20, 465-473. 
Dornetshuber, R., Heffeter, P., Lemmens-Gruber, R., Elbling, L., Marko, 
D., Micksche, M., & Berger, W., 2009. Oxidative stress and DNA 
interactions are not involved in enniatin- and beauvericin-mediated 
apoptosis induction. Mol. Nutr. Food Res. 53, 1112 – 1122.  
EC (2006) COMMISSION REGULATION (EC) No 1881/2006 of 19 December 
2006 setting maximum levels for certain contaminants in foodstuffs. 
(2006). 
FAO (2007). http://faostat.fao.org: Food Balance Sheet. 
Föllmann, W., Behm, C., Degen, G. H., 2009. The emerging Fusarium 
toxin enniatin B: in-vitro studies on its genotoxic potential and 
Resultados 
 
 
117 
 
cytotoxicity in V79 cells in relation to other mycotoxins. Mycotoxin 
Res. 25, 11-19.  
Fornelli, F., Minervini, F., Logrieco, A., 2004. Cytotoxicity of fungal 
metabolites to lepidopteran (Spodoptera frugiperda) cell line (SF-9). 
J. Invertebr. Pathol. 85, 74-79. 
Gammelsrud, A., Solhaug, A., Dendelé, B., Sandberg, W. J., Ivanova, L., 
Kocbach Bølling, A., Lagadic-Gossmann, D., Refsnes, M., Becher, R., 
Eriksen, G., Holme, J. A., 2012. Enniatin B-induced cell death and 
inflammatory responses in RAW 267.4 murine macrophages. Toxicol. 
Appl. Pharm. 261, 74–87.  
Heussner, A. H., Dietrich, D. R., O'Brien, E., 2006. In vitro investigation 
of individual and combined cytotoxic effects of ochratoxin A and 
other selected mycotoxins on renal cells. Toxicol. In Vitro, 20, 332-
341. 
Ivanova, L., Egge-Jacobsen, W. M., Solhaug, A., Thoen, E., Fæste, C. 
K., 2012. Lysosomes as a possible target of enniatin B-induced 
toxicity in Caco-2 cells. Chem. Res. Toxicol. 25, 1662–1674. 
Ivanova, L., Skjerve, E., Eriksen, G. S., Uhlig, S., 2006. Cytotoxicity of 
enniatins A, A1, B, B1, B2 and B3 from Fusarium avenaceum, Toxicon, 
47, 868 –876. 
Jia, J., Zhu, F., Ma, X., Cao, Z W., Li, Y. X., Chen, Y. Z., 2009. 
Mechanisms of drug combinations: interaction and network 
perspectives. Nat. Rev. Drug Discov. 8, 111-128. 
Jestoi, M., Rokka, M., Yli-Mattila, T., Parikka, P., Rizzo, A., Peltonen, 
K. 2004. Presence and concentration of the Fusarium-related 
mycotoxins beauvericin, enniatins and moniliformin in Finnish grain 
samples. Food Addit. Contam. 21, 794–802. 
Kamyar M., Rawnduzi, P., Studenik, C., Kouri, K., Lemmens-Gruber, R., 
2004. Investigation of the electrophysiological properties of 
enniatins. Arch. Biochem. Biophys. 429, 215-223.   
Klarić, M. Š., Rumora, L., Ljubanović, D., Pepeljnjak, S., 2008. 
Cytotoxicity and apoptosis induced by fumonisin B1, beauvericin and 
ochratoxin a in porcine kidney PK15 cells: Effects of individual and 
combined treatment. Arch. Toxicol. 82, 247-255. 
Resultados 
 
 
118 
 
Kouadio, J. H., Dano, S. D., Moukha, S., Mobio, T. A., Creppy, E. E., 
2007. Effects of combinations of Fusarium mycotoxins on the 
inhibition of macromolecular synthesis, malondialdehyde levels, DNA 
methylation and fragmentation, and viability in Caco-2 cells. Toxicon 
49, 306-317. 
Lu, H., Fernández Franzón, M., Font, G., Ruiz, M.J. (2013). Toxicity 
evaluation of individual and mixed enniatins using an in vitro method 
with CHO-K1 cells. Toxicol. In Vitro, 27, 672-680.   
Luongo, D., De Luna, R., Russo, R., Severino, L., 2008. Effects of four 
Fusarium toxins (fumonisin B1, α-zearalenol, nivalenol and 
deoxynivalenol) on porcine whole-blood cellular proliferation. 
Toxicon 52, 156-162. 
Malachova, A., Dzuman, Z., Veprikova, Z., Vaclavikova, M., 
Zachariasova, M., Hajslova, J., 2011. Deoxynivalenol, 
deoxynivalenol-3-glucoside, and enniatins: the major mycotoxins 
found in cereal-based products on the Czech market. J. Agric. and 
Food Chem. 59, 12990–12997.  
Meca, G., Zinedine, A., Blesa J., Font, G., Mañes, J., 2010. Further data 
on the presence of Fusarium emerging mycotoxins enniatins, 
fusaproliferin and beauvericin in cereals available on the Spanish 
markets. Food Chem. Toxicol. 48, 1412–1416. 
Meca G., Font, G., Ruiz, M. J., 2011. Comparative cytotoxicity study of 
enniatins A, A1, A2, B, B1, B4 and J3 on Caco-2 cells, HepG2 and HT-
29. Food Chem. Toxicol. 49, 2464-2469.  
Ruiz, M. J., Macáková, P., Juan García, A., Font, G., 2011a. Cytotoxic 
effects of mycotoxin combinations in mammalian kidney cells. Food 
Chem. Toxicol. 49, 2718-2724. 
Ruiz, M. J., Franzova, P., Juan García, A., Font, G. 2011b. Toxicological 
interactions between the mycotoxins beauvericin, deoxynivalenol 
and T-2 toxin in CHO-K1 cells in vitro. Toxicon 58, 315-326. 
Ruiz, M. J., Festila, L. E., Fernández, M., 2006. Comparison of basal 
cytotoxicity of seven carbamates in CHO-K1 cells. Environ. Toxicol. 
Chem. 88, 345-354.  
Resultados 
 
 
119 
 
Speijers, G. J. A., Speijers, M. H. M., 2004. Combined toxic effects of 
mycotoxins. Toxicol. Lett. 153, 91-98. 
Tajima, O., Schoen, E. D., Feron, V. J., Groten, J. P., 2002. Statistically 
designed experiments in a tiered approach to screen mixtures of 
Fusarium mycotoxins for possible interactions. Food Chem. Toxicol. 
40, 685-695. 
Tedjiotsop Feudjio, F., Dornetshuber, R., Lemmens, M., Hoffmann, O., 
Lemmens-Gruber, L., Berger, W., 2010. Beauvericin and enniatins: 
emerging toxins and/or remedies? World Mycotoxin J. 3, 415-430. 
Tonshin, A. A., Teplova, V. V., Andersson M. A., Mirja S. Salkinoja-
Salonen, M. S., 2010. The Fusarium mycotoxins enniatins and 
beauvericin cause mitochondrial dysfunction by affecting the 
mitochondrial volume regulation, oxidative phosphorylation and ion 
homeostasis. Toxicology 276, 49–57.  
Uhlig, S., Gutleb, A. C., Thrane, U., Flåøyen, A., 2005. Identification of 
cytotoxic principles from Fusarium avanaceum using bioassay-guided 
fractionation. Toxicon 46, 150–159. 
Wätjen, W., Debbab, A., Hohlfeld, A., Chovolou, Y., Kampkötter, A., 
Edrada, R. A., Ebel, R., Hakiki, A., Mosaddak, M., Totzke, F., 
Kubbutat, M. H. G., Proksch, P., 2009. Enniatins A1, B and B1 from an 
endophytic strain of Fusarium tricinctum induce apoptotic cell death 
in H4IIE hepatoma cells accompanied by inhibition of ERK 
phosphorylation. Mol. Nutr. Food Res. 53, 431-440.  
 
  
Resultados 
 
 
120 
 
 
  
 
 
 
Resultados 
 
 
121 
 
Toxicology Letters (under review) 
BEAUVERICIN-INDUCED CYTOTOXICITY VIA ROS PRODUCTION AND 
MITOCHONDRIAL DAMAGE IN CACO-2 CELLS. 
Prosperini, A., Juan-García, A., Font, G., Ruiz, M.J. 
Laboratory of Toxicology, Faculty of Pharmacy,  
University of Valencia Av. Vicent Andrés Estellés s/n 46100 Burjassot, 
València, Spain 
 
  
                                                          
 Corresponding author, tel: +34963544958. Fax: +34963544954 
E-mail: alessandra.prosperini@uv.es. 
Resultados 
 
 
122 
 
  
 
 
Resultados 
 
 
123 
 
ABSTRACT 
The cytotoxicity of beauvericin (BEA) on human colon adenocarcinoma 
(Caco-2) cells was studied as a function of time. Moreover, the oxidative 
damage and cell death endpoints  were monitored after 24, 48 and 72 
h. After BEA exposure, the IC50 values ranged from 1.9 ± 0.7 to 20.6 ± 
6.9 µM. A decrease in reduced glutathione (GSH; 31%) levels, as well as 
an increase in oxidized glutathione (GSSG, 20%) was observed. In the 
presence of BEA, reactive oxygen species (ROS) level was increased at 
an early stage with the highest production of 2.0-fold than the control 
at 120 min. BEA induced cell death by apoptotic process with a loss of 
the mitochondrial membrane potential (ΔΨm; from 2% to 95%, as 
compared to the control), increased LPO level (from 120% to 207%, in 
respect to the control) and reduced G0/G1 phase, with an arrest in 
G2/M, in a dose and time-dependent manner. Cell death, apoptosis and 
reduction of ΔΨm, were in a dose- time- dependent manner. Moreover, 
DNA damage was observed after 12.0 μM concentration. This study 
demonstrated that oxidative stress is one of the mechanism involved in 
BEA toxicity, moreover apoptosis induction, DNA damage and loss of 
ΔΨm contribute to its cytotoxicity in Caco-2 cells.  
Keywords: beauvericin, oxidative stress, cell cycle, apoptosis, 
mitochondrial membrane potential, DNA damage, Caco-2 cells. 
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1. Introduction  
 Mycotoxins are toxic metabolites produced by fungi. They occur 
naturally and are the most prevalent source of food-related health risk 
in field crops. Consumption of high mycotoxins level can cause several 
diseases, since they can be acutely and/or chronically toxic, depending 
on the type of mycotoxin, the dose and the time of exposure 
(http://www.fao.org). Beauvericin (BEA), a cyclic hexadepsipeptide of 
alternating l-N-methylphenylalanyl and d-α-hydroxyisovaleryl residues, 
is synthesized by various toxigenic fungi, including Beauveria bassiana 
and several Fusarium species, parasitic to maize, wheat, rice and other 
important commodities (Santini et al., 2012). Levels up to 4 mg/Kg have 
been detected in wheat samples of the Mediterranean Area (Meca et 
al., 2010; Zinedine et al., 2011). BEA, as ionophore compound, 
increases ion permeability in biological membranes by forming a 
complex with essential cations (Ca2+, Na+, K+) consequently affecting the 
ionic homeostasis (Kouri et al., 2003) and uncoupling the oxidative 
phosphorylation (Tonshin et al., 2010). So, one of the potential target 
sites for BEA-mediated cytotoxicity is the mitochondria. A loss of 
mitochondrial membrane integrity by toxic substances increases their 
permeability due to the formation of high conductance channel in their 
membrane and the opening of their channel leads to necrosis (Kroemer 
et al., 1998). Mitochondria also sequester several proteins between 
their outer and inner membranes that are capable of activating 
apoptotic pathways (Orrenius, 2004). Apoptosis has a pivotal role in 
maintaining homeostasis in cells. In response to apoptotic stimuli, DNA 
damage and oxidative stress, the mitochondrial pathway is triggered. 
Due to that, understanding the mode of action of BEA is essential to 
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predict the harmful effects on human health when BEA contaminates 
food commodities. The aims of this work were to study the implication 
of intracellular ROS generation, LPO production, alteration of 
intracellular GSH levels, the disturbance of the cell cycle progression, 
DNA damage, apoptosis and changes in the mitochondrial membrane 
potential (ΔΨm) in the cytotoxic effect induced by BEA. the study was 
carried out with human intestinal Caco-2 cells.  
2. Materials and methods 
2.1 Reagents  
 Sigma Chemical Co. (St Louis, MO, USA) provided the reagent 
grade chemicals, cell culture components used and BEA (783.95 g/mol, 
≥97% purity). Fetal calf serum (FCS) was from Cambrex Company 
(Belgium). Human recombinant Annexin V-FITC coniugate, tetramethyl 
rhodamine methyl ester (TMRM), To-Pro®-3 iodide were from Invitrogen, 
(USA).  
 Stock solution of BEA was prepared in methanol (MeOH) and 
maintained at -20°C.  
  
2.2 Cell culture and treatment  
 Caco-2 cells (ATCC HTB-37) were maintained in DMEM medium 
supplemented with 25 mM HEPES buffer, 1% (v/v) of Non Essential 
Amino Acids (NEAA), 100U/mL penicillin, 100mg/mL streptomycin and 
10% (v/v) Fetal Calf Serum (FCS) inactivated. Incubation conditions 
were pH 7.4, 37°C under 5% CO2 and 95% air atmosphere at constant 
humidity. Absence of mycoplasma was checked routinely using the 
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Mycoplasma Stain Kit (Sigma-Aldrich, St Louis Mo. USA). The final BEA 
concentrations tested were achieved by adding BEA solutions to the 
culture medium with a final MeOH concentration of 1% (v/v). 
Appropriate controls containing the same amount of solvent were 
included in each experiment. Total protein content (µg/mL) was 
determined by Bradford method (Bio-Rad DC Protein Assay (catalogue 
number 500-0116) http://www.bio-
rad.com/LifeScience/pdf/Bulletin_9005.pdf). 
2.3 In vitro cytotoxicity  
 Caco-2 cells were cultured in 96-well tissue culture plates at the 
density of 3x104 cells/well. After cells reached confluence, the culture 
medium was replaced with fresh medium containing the serial dilution 
(n=2) of BEA ranging from 3.125 to 25 µM. The basal cytotoxicity 
endpoints assayed were tetrazolium salt reduction (MTT) and Neutral 
Red (NR) assays as described by Ruiz et al. (2006). The IC50 values 
obtained from both cytotoxicity assays were calculated from full dose-
response curves.  
2.4 Intracellular ROS generation 
 Early intracellular ROS production was monitored in Caco-2 cells 
according to Ruiz-Leal and George (2004) by using the H2-DCFDA probe. 
DCFH-DA is taken up by the cells, then deacetylated by intracellular 
esterases and the resulting H2-DCFDA is oxidized by ROS and forms the 
highly fluorescent DCF. Briefly, 3x104 cells/well were seeded in a 96-
well black culture microplate. After reaching confluence, cells were 
loaded with 20 µM H2-DCFDA in fresh medium for 20 min. Subsequently 
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H2-DCFDA was removed and cells were washed with PBS and exposed to 
1.5 and 3.0 μM of BEA. Increases in fluorescence were measured on a 
Wallace Victor2, model 1420 multi-label counter (Perkin Elmer, Turku, 
Finland), at intervals up to 2 h at excitation/emission wavelengths of 
485/535 nm. Results are expressed as increase in fluorescence in 
respect to control. 
2.5 Lipid peroxidation assay 
 LPO assay was carried out by determining the formation of 
reactive thiobarbituric acid reactive substances (TBARS), according to 
Buege and Aust (1978). Briefly, 4.8x105 cells/well were seeded in 6-well 
plates. After achieving confluence, cells were treated with BEA at 1.5 
and 3.0 µM for 24 h. After washing with PBS and homogenized in 20 mM 
Tris 0.1% Triton, cells were boiled (100 °C for 30 min) in presence of 
0.5% TBA, 1.5 mM DFA and 3.75% BHT. Subsequently cells were cooled 
and centrifugated (1287 g, 15 min) and TBARS formed were measured at 
532 nm. Results are expressed as ng of MDA/mg of protein measured by 
the Bradford method.  
2.6 Intracellular glutathione 
 Determination of reduced and oxidized glutathione (GSH; GSSG) 
was assayed according to Maran et al. (2009). 4.8x105 cells/well were 
seeded in 6-well plates and treated with BEA at 1.5 and 3.0 µM for 24. 
Measurement of GSH and GSSG was carried out at the 
excitation/emission wavelengths of 345/425 nm.  
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2.7 Cell cycle analysis 
 Cell cycle analysis was performed by staining the DNA with PI as 
described previously (Juan-García et al., 2013). PI is a popular 
fluorescent nucleic acid dye which is capable of binding and labeling 
double-stranded nucleic acids. 4.8x105 cells/well were seeded in 6-well 
plates and treated with BEA at 1.5 and 3.0 µM for 24, 48 and 72h. Four 
independent experiments were performed for each BEA treatment and 
at least 10,000 cells were analyzed for each sample. 
2.8 Flow cytometry analysis of apoptosis (and necrosis) 
 Cell death generally proceeds through two molecular 
mechanisms: necrosis and apoptosis. One of the characteristics of 
apoptosis is the externalization of phosphatidylserine (PS) to the outer 
leaflet of the plasma membrane. The differential of population of 
apoptotic cells (early or late), necrotic and dead cells was identified by 
Annexin V-FITC/PI double staining (Vermes et al., 1995). 4.8 x 105 
cells/well were seeded in 6-well plates. After 24, 48 and 72h of 
exposure at 1.5 and 3.0 µM of BEA, the assay was carried out as 
described by (Juan-García et al., 2013) 10,000 cells were acquired and 
analyzed on a BD FACSCanto flow cytometer with FACSDiva software v 
6.1.3 (BD Biosciences). Green (FL-1, 530 nm) and orange-red 
fluorescence (FL-2, 585 nm) were detected, emitted by FITC and PI, 
respectively. Quadrant statistics were performed to determine viable 
cells, early apoptotic, late apoptotic and dead cells from the total 
population of cells. Caco-2 cells treated with 1% MeOH in the media 
were considered as control.  
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2.9 Detection of mitochondrial membrane potential (ΔΨm) by 
tetramethyl rhodamine methyl ester [TMRM] method.   
 Induction of apoptosis leads to the loss of ΔΨm (Orrenius, 2004). 
Changes in ΔΨm, after BEA exposure (1.5 and 3.0 μM) were evaluated 
using TMRM and To-Pro®-3 double labeling as described by Tsiper et al. 
(2012). TMRM was used to detect ΔΨm changes. To-Pro®-3, a 
membrane-impermeable nuclear marker was used to characterize 
plasma membrane integrity. 4.8 x 105 cells/well were exposed to BEA at 
1.5 and 3.0 μM, trypsinized, resuspended in growth medium with a mix 
of the two markers (140 nM and 160 nM for TMRM and To-Pro®-3, 
respectively). After 30 min of incubation at 37°C in the dark, 
fluorescent intensities of TMRM (λex= 548 nm and λem= 573 nm) and of 
To-Pro®-3 (λex= 642 nm and λem= 661 nm) were measured by using a flow 
cytometer FACSCanto (Beckton-Dickinson, Italy). Data from fluorescent 
histograms were analyzed using the FACSDiva software v 6.1.3 (BD 
Biosciences). The percentage of TMRM and ToPro-3 stained cells was 
calculated from the total 10,000 cells in comparison to the control.  
2.10 Alkaline comet assay (pH>13) 
 The DNA strand breaks induction was determined using the 
alkaline comet assay (pH>13), according to the method described 
previously (Singh et al., 1988; Marabini et al., 2011), with some 
modifications. Caco-2 cells were treated with BEA (1.5, 3.0 and 12.0 
µM), for 24 h. Subsequently, 2x104 cells/mL were suspended in pre-
warmed LMA (0.5% PBS; 37°C) and 80 μL of the suspension were rapidly 
transferred to agarose precoated slides (1% PBS) and covered with a 
coverslip. After gelling for 10 min at 0°C, the coverslip was gently 
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removed and a third layer of 80 μL LMA was added. After gelling once 
again for 10 min at 0°C, the coverslip was gently removed and slides 
were put on a tank filled with lysis solution (2.5 M NaCl, 100 mM Na-
EDTA, 10 mM Tris, 250 mM NaOH, 10% DMSO and 1% Triton X-100, freshly 
added) for 30 min at 0°C. Slides were then removed from lysis solution, 
washed with neutralization buffer (0.4 M Tris, pH 7.5) and  incubated 
for 20 min in fresh electrophoresis buffer (300 mM NaOH, 1 mM Na-
EDTA) to allow DNA to unwind. Electrophoresis was carried out at 25 V, 
300 mA, during 40 min. Slides were washed for 5 min with 
neutralization buffer and left to dry overnight at 4 °C. After staining 
with 500 μL of PI (20 μg/mL), cells were visualized by a fluorescence 
microscope (NIKON Eclipse E800), equipped with camera (NIKON 
DXM1200F) to capture imagines. Images of ≥100  randomly selected cells 
were analyzed by using the Automatic Comet Assay by TriTek 
CometScoreTM freeware 
(http://autocomet.com/index.php?id=cometscorepro). Results are 
expressed as the median tail moment (TM) calculated according to the 
equation: TM = TL x Tail DNA% where TL is the tail length, i.e. the 
distance (μm) between the center of the comet head and the end of the 
comet tail. 
2.11 Statistical analysis of data 
 Statistical analysis of data was carried out using SPSS Statistic 
19.0 (SPSS, Chicago, IL, USA) statistical software package. Data were 
expressed as mean ± SD of three independent experiments. The 
statistical analysis of the results was performed by Student’s t-test for 
paired samples. Differences between concentrations were analyzed 
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statistically with ANOVA followed by the Tukey HDS post hoc test for 
multiple comparisons. The level of p ≤ 0.05 was considered statistically 
significant.  
3. Results  
3.1 In vitro cytotoxicity 
 Results indicate that BEA induced a marked decrease in Caco-2 
cell viability in a dose and time-dependent manner (data not shown). 
The IC50 values obtained in Caco-2 cells after BEA exposure ranged from 
3.2 ± 1.1 to 20.6 ± 6.9 by the MTT assay and from 1.9 ± 0.7 to 8.8 ± 0.9 
μM by the NR assay (Table 1).  
 
Table 1. Medium inhibitory concentration (IC50) values of BEA on Caco-2 
cells, after 24, 48 and 72 h of exposure by the MTT and NR assays. IC50 
values were calculated from full-dose response curve. Results are mean 
± SD of three experiments.  
Assays IC50 (µM) ± SD 
 24 h 48 h 72 h 
MTT 20.6 ± 6.9 12.8 ± 4.8 3.2 ± 1.1 
NR 8.8 ± 0.9 3.4 ± 0.9 1.9 ± 0.7 
 
3.2 Intracellular ROS generation 
 To determine changes in the redox status of Caco-2 cells in 
response to BEA exposure, cells were exposed to BEA at 1.5 and 3.0 µM 
from 0 to 120 min. The production of ROS was determined by DCFH-DA 
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assay (Fig. 1). Results obtained demonstrated that Caco-2 cells showed 
a high production of oxidizing species depending on the time and 
concentrations of BEA exposure when compared to the basal rate. 
Significant production of ROS (1.4-fold higher than the control) was 
observed immediately after BEA exposure (Fig. 1). However, the highest 
relative intensity of fluorescence (2.0-fold higher than the control) in 
Caco-2 cells was observed at the highest time of exposure (Fig. 1). 
Moreover, the ROS-production between the two BEA concentrations 
tested were significantly different (p ≤ 0.05), between 5 and 60 min 
intervals (Fig. 1). 
 
 
Figure 1. Time dependence of ROS-induced fluorescence in Caco-2 cells 
exposed to BEA at 1.5 and 3.0 µM. H2-DCFDA was added to Caco-2 cells 
and left for 20 min previously to BEA addition. Results are expressed as 
mean ± SD, (n=3). p ≤ 0.05 (*), p ≤ 0.001 (**), p ≤ 0.000 (***), 
significantly different from the control. p ≤ 0.05 (#), p ≤ 0.000 (###), 
significantly differences between the two concentrations tested (1.5 
and 3.0 μM).  
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3.3 Lipid peroxidation assay 
 The LPO production on Caco-2 cell in the presence of BEA at 1.5 
and 3.0 µM can be observed in Figure 2. Results obtained demonstrated 
that after 24 h of BEA exposure MDA production increased in a dose 
dependent manner by 120% (1.5 µM) and 207% (3.0 µM) with respect to 
the control cells (p ≤ 0.000).  
 
 
Figure 2. Lipid peroxidation as measured by MDA production in Caco-2 
cells incubated for 24 h with 1.5 and 3.0 µM of BEA. Results are 
expressed as mean ± SD in ng of MDA/mg of protein measured by 
Bradford method. p≤0.000 (***): significantly different from control. 
p≤0.000 (###) significant differences between the two concentrations 
tested (1.5 and 3.0 μM). 
 
3.4 Intracellular glutathione 
 BEA decreased intracellular GSH levels in Caco-2 cells in a dose 
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BEA reduced GSH levels by 23% and 31%, as compared to the control (p ≤ 
0.05), respectively. However, BEA exposure increased GSSG levels in 
Caco-2 cells only after 3.0 µM concentration (20% as compared to the 
control; Fig. 3).  
 
 
 
Figure 3. Reduced (GSH) and oxidize (GSSG) glutathione levels in Caco-
2 cells after exposure to BEA at 1.5 and 3.0 μM for 24 h. p ≤ 0.05 (*), p ≤ 
0.001 (**) significantly different from the control, p ≤ 0.05 (#) 
significantly different between the two concentration of BEA tested. 
Results are expressed as percentage of control cells. Values are 
expressed as mean ± SD (n = 4).   
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3.5 Cell cycle analysis 
 Flow cytometry was used to determine cell proliferation by cell 
cycle analysis with PI staining. As shown in Figure 4, after 24, 48 and 72 
h of exposure to 1.5 and 3.0 μM of BEA, a significant (p≤0.05) 
percentage of cell reduction in G0/G1 phase accompanied by an 
increase of G2/M phase, was observed, as compared to the control. 
After 24 h of exposure, the percentage of Caco-2 cells in the G0/G1 
phase was 54.4 ± 0.5 and 45.3 ± 0.6% respectively after 1.5 and 3.0 μM 
of BEA, as compared to the control (58.7 ± 1.5%; Fig. 4A). Conversely, 
an increase in the number of cells in the G2/M phase was observed after 
exposure to 3.0 μM of 29.9 ± 1.0%, as compared to the control (23.9 ± 
3.6%), with no changes in cells in S phase. After 48 h of exposure to 3.0 
μM BEA, a reduction of G0/G1 phase (58.2 ± 1.8%) compared with the 
control (62.3 ± 1.2%; Fig. 4B) was observed. The increase in G2/M phase 
with a cell percentage of 20.6 ± 1.1%, in respect to control (16.7 ± 1.5%) 
was obtained. The percentage in S phase remained unchanged. After 72 
h of exposure, Caco-2 cells in the G0/G1 phase decreased (Fig. 4C). The 
percentages were 55.7 ± 1.0 and 43.4 ± 0.9% after 1.5 μM and 3.0 μM of 
BEA, respectively, as compared to the control (65.9 ± 3.7%). Cell 
percentage in G2/M phase increased, with a value of 17.7 ± 1.8 and 20.3 
± 1.1 after 1.5 μM and 3.0 μM, respectively, as compared to the control 
(14.0 ± 0.9%). The proportion of cells in S phase increased with a value 
of 20.2 ± 0.41% (after 3.0 μM of BEA), compared to the control (14.5 ± 
4.0%). A marked increase in SubG1 population was only observed after 
72 h of exposure. The percentage was 6.3 ± 0.6 and 9.5 ± 0.5% at 1.5 
and 3.0 μM, respectively, in respect to control (2.5 ± 0.6%; data not 
shown). The maximum reduction of cells in G0/G1 phase (about 35%) 
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and  the highest percentage of cells in G2/M phase (43% respect to the 
control) were observed  after 72 h of exposure. 
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Figure 4. Analysis of cell cycle distribution of Caco-2 cells treated with 
BEA at 1.5 μM and 3.0 μM for 24 (A), 48 (B) and 72 h (C). Data are 
expressed as mean values ± SD (n = 3). (*) p ≤ 0.05 and (**) p ≤ 0.001 
indicate a significant difference with the control, (#) p ≤ 0.05 and (###) 
p ≤ 0.000 indicate significant differences between the two 
concentrations tested (1.5 and 3.0 μM).  
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3.6 Flow cytometry analysis of apoptosis (and necrosis) 
 As shown in Figure 5, the population of early apoptotic cells was 
increased after 24 and 48 h in a dose dependent manner. After 24 h 
(Fig. 5A), apoptotic cells percentages  were 25.1 ± 0.9 and 33.7 ± 2.6%, 
as compared to the control (11.7 ± 1.3%) after 1.5 and 3.0 μM of BEA 
exposure, respectively. After 48 h (Fig. 5B), apoptotic cells percentages 
were 14.0 ± 4.0 and 25.6 ± 3.9%, after 1.5 and 3.0 μM of BEA exposure, 
respectively, as compared to the control (6.5 ± 1.3%). Results obtained 
in Figure 5 showed that the population of early apoptotic cells was 
increasing in a dose-dependent manner after 24 (from 100 to 183%, in 
respect to control) and 48 h (from 143 to 286%, in respect to control) of 
exposure. Nevertheless, no significant increase after 72 h of exposure 
was observed (Fig. 5C). On the other hand, a significant increase of 
apoptotic/necrotic cells was observed after 24 h of exposure, with cells 
percentages of 27.4 ± 6.8 and 30.8 ± 2.2% after BEA exposure at 1.5 and 
3.0 μM concentrations, respectively (as compared to the control: 12.0 ± 
0.8%). Apoptotic/necrotic cells were observed after 72 h of exposure to 
3.0 μM of BEA, with a percentage of 15.8 ± 0.7%, as compared to the 
control (10.7 ± 1.4%; Fig. 5).  
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Figure 5. Analysis of apoptosis induction in Caco-2 cells treated with 
BEA at 1.5 μM and 3.0 μM for 24 (A), 48 (B) and 72 h (C). Cells were 
stained with Annexin-FITC and PI to distinguish early apoptotic from 
apoptotic/necrotic cells. Data are expressed as mean values ± SD (n = 
3). p ≤ 0.05 (*) and  p ≤ 0.000 (***) indicate a significant difference with 
the control, p ≤ 0.05 (#) and p ≤ 0.000 (###) indicate a significant 
difference with the two concentrations tested (1.5 and 3.0 μM). 
APO=apoptosis; APO/NECRO=apoptosis/necrosis. 
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3.7 Detection of mitochondrial membrane potential (ΔΨm) by 
tetramethyl rhodamine methyl ester [TMRM] method.   
 To better characterize the apoptotic cell death triggered by BEA, 
the role of mitochondria was investigated. The evaluation of ΔΨm 
changes in Caco-2 cells were determined by flow cytometry with the 
TMRM and To-Pro®-3 double staining. Cells showed a significant (p≤0.05) 
decrease in TMRM fluorescence intensity (%) after all concentration and 
times of exposure (Fig. 6). The drop in TMRM intensity was drastically 
produced after 72 h of exposure (Fig. 6).  Reduction of ΔΨm was from 
2% to 95% after 1.5 μM of BEA and from 10% to 80% after 3.0 μM of BEA 
in respect to control (Fig. 6).   
 
 
 
Figure 6. Loss of mitochondrial membrane potential (ΔΨm) in Caco-2 
cells as detected by flow cytometry after TMRM/ To-Pro-3 double 
staining. Caco-2 were treated with 1.5 and 3.0 μM of BEA, for 24, 48 
and 72 h. p ≤ 0.05 (*), p ≤ 0.001 (**), p ≤ 0.000 (***), significantly 
different from the control. p ≤ 0.000 (###) significant differences 
between the two concentrations tested. 
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3.8 Alkaline comet assay  
 Figure 7 presents the alkaline comet assay data in Caco-2 cells 
exposed to BEA for 24 h. B(α)P 20 μM was used as positive control. After 
24 h of exposure the lowest concentrations tested (1.5 and 3.0 μM) did 
not produce any significant increase in the TM parameter in respect to 
the control. However, a significant increase (p≤0.000) in the TM was 
obtained after 12.0 μM of BEA exposure (Fig. 7).  
 
 
Figure 7. Alkaline comet assay (pH > 13) on Caco-2 cells after 24 h 
exposure to 1.5, 3.0 and 12.0 μM BEA. Migration of DNA is reported as 
median TM. B(α)P (20 μM) was the positive control. The box plots show 
the medians (middle bar), standard deviations, 25% and 75% percentiles. 
p ≤ 0.000 (***) significantly different from the control.  p ≤ 0.000 (###)  
significantly different from 1.5 and 3.0 μM concentrations. Extreme 
cases and (  ) atypical values (○).  
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4. Discussion 
 The IC50 values obtained in this study, demonstrated that BEA 
induces cytotoxicity in Caco-2 cells by increasing lysosomal damage and 
decreasing cellular metabolism as assessed by the NR and MTT assays, 
respectively. Lysosomal functionality was more affected compared to 
the mitochondrial one. However, the findings obtained by the NR assay 
cannot be interpreted as deleterious effects in this sub-cellular 
compartment since NR dye penetrates cell membranes by nonionic 
passive diffusion and concentrates only in the lysosomes of viable cells 
(Repetto et al., 2008), on the contrary MTT assay reported BEA 
cytotoxicity in the form of reduced cell viability through the reduction 
of  mitochondrial dehydrogenase activity. So, MTT conversion could 
provide an indirect measure of cell metabolism, since  the reduction of 
formazan in viable cells take place via mitochondrial dehydrogenases 
reaction coupled to oxidative phosphorilation. In addition, this 
difference could be due to the fact that the plasma membrane of the 
lysosomes, which is the first site exposed to the mycotoxin, is attacked 
more easily as compared to the mitochondrial one. Besides this, the 
mitochondrial toxicity do not exclude the involvement of lysosomal 
system,  which has been recently connected to apoptotic cell death 
process triggered by the mitochondria (Boya and Kroemer, 2008).  
 Results obtained show that BEA is cytotoxic to Caco-2 cells at 
low micromolar concentrations, similar to ones obtained in Vero, CHO-
K1, HepG2 and MRC-5 cells (Ruiz et al., 2011a,b; Ferrer et al., 2009; 
Ivanova et al., 2006). However, lower  IC50 values were obtained by 
Dornetshuber et al. (2009a) in several human cell lines and their 
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chemoresistant sublines. Results obtained showed that GLC-4 (small cell 
lung carcinoma) cell line was the most sensitive (IC50=1.88 µM) and SW-
1573 (alveolar epithelial cell carcinoma) the most resistant (IC50=3.17 
µM) cell line to BEA. These results agree with Jow et al. (2004) and Lin 
et al. (2005), that obtained IC50 values of 2.6 and 4.5 μM in CCRF-CEM 
(human leukemia) and in NSCLC A549 (non small cell lung cancer), 
respectively. Although Caco-2 cell line was not the most sensitive to 
BEA cytotoxicity, results obtained show that Caco-2 cells are sensitive 
to BEA cytotoxicity in a dose and time dependent manner (data not 
shown).    
 In order to assess the mechanism of cytotoxicity produced by 
BEA on Caco-2 cells, this study investigated the role of oxidative stress 
in terms of early ROS generation, LPO production and GSH levels 
depletion. The effect of BEA on oxidative stress was analyzed in Caco-2 
cells treated with BEA sub-cytotoxic concentrations of 1.5 and 3.0 μM at 
different time of incubation. The selection of this two concentration 
was based on the fact that they are in the range of concentrations 
found previously in food. In fact, according to Zinedine et al. (2011), 
levels up to 4 mg/Kg have been detected in wheat samples from 
Morocco. Considering the consumption of wheat in Morocco (175.4 
Kg/year; FAOSTAT, 2009), the estimated total intake of BEA is about 
2.45 μmol/day, a value that is included in the range of concentration 
tested in this study. Moreover, the selection of 1.5 and 3.0 μM was due 
to the fact that they were not cytotoxic to Caco-2 cells, since they were 
the inhibitory concentration 90 (IC90; obtained by the MTT assay). The 
time-dependent increase in ROS formation observed in Figure 1 suggests 
that generation of ROS is an important mechanism of action which 
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might contribute to the cytotoxicity of BEA in Caco-2 cells. High ROS 
spikes were found inside Caco-2 cells after BEA exposure, which 
continued up to 2 h and increased up to 2.2 folds as compared to the 
control (Fig. 1). The present study confirmed that ROS generation are 
produced by BEA after early exposure to non toxic concentration as 
reported for CHO-K1 (Ferrer et al., 2009). Results are comparable to 
other mycotoxins that are well-known inducer of oxidative stress and 
oxidative damage in cell culture. Bouaziz et al. (2008) reported that 
zearalenone (ZEA) and T-2 toxin induced a higher increase in ROS 
generation with respect to BEA, of about 5- and about 4- folds when 
compared to the control. However higher time of exposure (24 h) were 
taken into account. Similar to BEA, OTA induced ROS generation 1.6- 
folds higher than the control (Arbillaga et al., 2007). It would be logical 
to assume that multiple ROS spike events might damage or destroy the 
antioxidant GSH and can induce oxidative damage to cellular 
components such as lipids by means of LPO. Earlier in vitro studies 
demonstrated that BEA induced LPO and GSH depletion in other cell 
lines (Klarić et al., 2007; Ferrer et al., 2009). These study have now 
been confirmed by our results obtained in Caco-2 cells. Similarly, Ferrer 
et al. (2009) observed that the increase of ROS production was higher 
than the control at the early stage of BEA exposure (about 4-folds 
higher than control), whereas from 5 to 120 min, less production of ROS 
was obtained, but also 2-folds higher than the control. Moreover, these 
authors also found a relationship between ROS generation and LPO 
produced. The increase in the MDA levels ranged from 45% to 182% of 
the control after BEA exposure. In Caco-2 cells the increase was higher 
(up to 207%). This could be due to the higher susceptibility of Caco-2 
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cells to LPO induced by mycotoxins (Kouadio et al., 2005). Similarly, 
Klarić et al. (2007) demonstrated that 5 µg/mL (6.4 μM) of BEA caused a 
significant increase in MDA production (80%) in kidney PK15 cells, after 
48 h of exposure. These authors also found that treatment with 
concentrations ranging from 0.5 to 5 μg/mL of BEA decreased GSH levels 
in PK15 cells after 24 h of exposure, from 13% to 28%, as compared to 
the control, respectively. Results obtained by us and other authors 
confirm that ROS generation plays an important role in the molecular 
events leading to cell damage particularly by the induction of LPO and 
GSH depletion.  
 LPO is one of the cellular pathway involved in oxidative damage, 
that lead cells to apoptotic cell death, as well as GSH depletion with 
apoptosis have been demonstrated to occur in response to apoptotic 
stimuli in Caco-2 cells (Wang et al., 2000). Besides this, it have been 
reported that the alteration of cellular redox status resulted in an 
inhibition of cell proliferation (Noda et al., 2001; Gotoh et al., 2002). 
Generally, mycotoxins that perturb the cell cycle progression start their 
activity with anti-proliferative effect followed by accumulation of cells 
in one or more phases of the cell cycle. Caco-2 cells, treated with BEA 
resulted significantly in the following: reduction of cells percentage in 
G0/G1 phase and arrest in G2/M and S phase. After treatment with 3.0 
μM concentration, BEA is capable to produce impairment of mitosis 
since an arrest in G2/M phase was produced after all time of exposure 
tested (Fig. 4). The same was observed after 72 h of exposure to BEA at 
1.5 μM concentration. According to Noda et al. (2001), this type of 
arrest could be a consequence of cellular redox imbalance induced by 
BEA in Caco-2 cells, as determined by LPO production and GSH 
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depletion. The decrease of GSH and the increase of GSSG have been 
related to a redox-induced suppression of Caco-2 cells proliferation in 
G2/M phase of the cell cycle (Noda et al., 2001). Moreover, the 
reduction in G0/G1 phase cell number, that has been  induced by BEA, 
suggests its apoptotic effect, as reported before for other compound in 
Caco-2 cells (Lazzè et al., 2004). After 72 h, exposure to 3.0 μM BEA 
caused a significant accumulation of the cells in S phase, along with a 
decrease in the corresponding G0/G1 population in a concentration-
dependent manner, whereas in general the proportion of cells in the 
G2/M phase was also increased (Fig. 4). The reduction of cell 
distribution in G0/G1 phase observed at all time of exposure 
corroborates the induction of apoptosis and necrosis in Caco-2 cells. 
However, after 72 h of exposure, the damage persists, and it is 
confirmed by the S and G2/M phase arrest in cell cycle, and by the 
uncontrolled cell death (necrosis). The cell cycle perturbation could be 
explained as due to a checkpoint response to DNA damage or may be an 
adaptive process in which a surveillance mechanism delays or arrests 
the cell cycle when DNA lesions occur in order to make repair take place 
(Abid Essefi et al. 2003). However, this study showed unambiguously 
that no DNA damage is responsible for the cell cycle arrest. Other 
mechanisms, that have not been investigated here, need to be further 
studied.  
 Even if there are no reports about cell cycle effects after 
exposure to BEA, similar behavior have been reported by the 
structurally related enniatin B (EN B) on Caco-2 cells (Ivanova et al., 
2012). They found that 25 μM of EN B increased cell population in G2/M 
phase (31 ± 1.3%, compared to the control (23 ± 1.0%) demonstrating 
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apoptotic effect of EN B. Ivanova et al. (2012) described this type of 
arrest as a possible consequence of external stimuli leading to apoptosis 
via caspase pathway or to non-apoptotic mitotic death (Ivanova et al., 
2012). Similar behavior was observed in Caco-2 cells (Abid-Essefi et al. 
2003) and HepG2 (Gazzah Chatti et al. 2010) exposed to ZEA.  
 On one hand, genotoxic potential of BEA could be implicated in 
its cytotoxicity, independently of ROS generation. Dornetshuber et al 
(2009b) demonstrated that BEA provides at least another possible 
pathway for the cytotoxicity of BEA which is a ROS-independent 
pathway that is directly not related to ROS-induced DNA strand breaks. 
This is in accordance with results obtained by this study, since no DNA-
damage was observed after exposure to ROS inducing concentration of 
BEA in Caco-2 cells. However, the concentration of 12.0 μM produced a 
significant increase in the % of DNA in the tail (expressed as TM) which 
could be indicative of the activation of BEA-induced apoptotic pathways 
in Caco-2 cells, and cannot completely  exclude the genotoxic potential 
of BEA, even though not related with ROS generation and oxidative 
stress in Caco-2 cells. Results are in accordance with Klarić et al. (2010) 
and Çelik et al. (2010) which tested the genotoxic potential of BEA on 
PK15 cells and lymphocytes by the comet and micronucleus assays, 
respectively. They reported the genotoxic potential of BEA even if 
produced by concentrations much more lower than ones tested in this 
study.  
 On the other hand, the generation of intracellular ROS that 
induces cytotoxicity and the decrease in GSH levels upon oxidation were 
also linked with their diffusion into mitochondrial matrix, with 
subsequent loss of integrity and finally cell death mediated by 
Resultados 
 
 
148 
 
mitochondrial dysfunction and the induction of apoptosis. As obtained in 
this study, BEA induced apoptosis in Caco-2 cells, after 24 h of exposure 
in a dose-dependent manner and underwent necrosis. This could be due 
to the fact that under the same stimulus, features of both apoptosis and 
necrosis may coexist in the same cell. However, necrosis was not 
observed after 48 h of exposure and this could be explained by the fact 
that Caco-2 cells maybe have entered in a non-apoptotic cell death 
pathway, showing “pseudo-necrotic” morphological features only after 
24 h of exposure (Zong and Thompson, 2006). At this time of exposure, 
apoptosis was also observed, confirming the prevalence of apoptotic 
activity of BEA, at sub-toxic concentrations. After 72 h of exposure, only 
necrosis was induced by BEA in response to the same stimulus, but with 
higher doses or intensity (Kroemer et al., 1998).  
 BEA induced significant cell death in several cell lines derived 
from healthy and malignant tissues of different origin (Dornetshuber et 
al, 2009a,b; Jow et al., 2004). Apoptosis induction (8 μM and 72 h), but 
not necrosis, was evidenced by nuclear DNA fragmentation and light 
microscopy in turkey peripheral blood lymphocytes (Dombrink-
Kurtzman, 2003) and human NSCLC A549 cells (3 and 10 μM treatment 
during 24 h; Lin et al., 2005). In contrast to results obtained in this 
study and by the other above-mentioned authors, Dornetshuber et al. 
(2009b) did not detect oxidative cell damage induced by 10 µM of BEA in 
the human lung cancer cell lines (A549 and GLC-4), in the epidermal 
carcinoma-derived cell line (KB-3-1) and in the promyelocytic leukemia 
cell line (HL-60) during 15 min of exposure in respect to control. 
However, ROS production was always observed at higher times of 
exposure. The results of Dornetshuber et al (2009b) and those obtained 
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in this study could be explained by the different in vitro method, time 
of exposure, cell lines used and  by the sensitivity of the applied test 
which could condition their response.   
 From results obtained in our study, it could be assumed that the 
BEA-induced (apoptotic) cell death was likely to be mediated by the 
generation of intracellular ROS and oxidative stress. As assessed by MTT 
and flow cytometry determination of ΔΨm (Fig. 6), the mitochondrial 
dysfunction is also involved in BEA cytotoxicity. It has been proposed 
that BEA interacts with cell membranes (ionophoric activity) which 
cause an increase in the intracellular Ca2+ concentration. According to 
Jow et al. (2004)  cell death caused by BEA involves a Ca2+-dependent 
pathway, in which BEA induced a significant increase in intracellular 
[Ca2+] that leads to a combination of cellular apoptosis and necrosis 
responses. Moreover, in isolated mitochondria BEA induced ΔΨm drop, 
K+ influx into the mitochondrial matrix, mitochondrial swelling and 
uncoupling of oxidative phosphorylation, followed by induction of 
apoptosis (Tonshin et al., 2010). The loss of ΔΨm could trigger the 
release of the cytosolic cyt c mitochondria to the cytosol under the 
regulation of the Bcl-2 family and caspase 3 which finally lead to cell 
death (Dornetshuber et al., 2009b). Moreover, the expression of Bcl-2 
family proteins can be differently regulated by BEA, suggesting that the 
BEA-induced apoptosis is controlled by a balanced expression between 
those apoptosis-inducing and apoptosis- suppressing molecules (Jow et 
al., 2004; Lin et al., 2005; Klarić et al., 2008). Taken together, these 
observations provide a hypothesis that ROS generation could be a direct 
pathway to BEA produced cytotoxicity in Caco-2 cells.  
Resultados 
 
 
150 
 
 Based on the data obtained, it might be hypothesized that BEA 
can exert toxicological effects by means of a ROS-dependent pathway 
rather than DNA damage. Cells exhibit mitochondrial dysfunction that 
can lead to the stable depolarized state of ΔΨm and cell death. 
Moreover, ROS generation with alteration of GSH content and LPO 
production lead to the increase of oxidative stress which causes 
apoptosis in Caco-2 cells and changes in the normal cell cycle.  
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ABSTRACT 
The cytotoxic effects, the generation of reactive oxygen species (ROS) 
and lipid peroxidation (LPO) as well as the cell cycle disruption, the 
induction of apoptosis and necrosis, changes in mitochondrial membrane 
potential (ΔΨm) and DNA damage have been determined in human 
colorectal adenocarcinoma (Caco-2) cells after exposure to enniatins 
(ENs) A, A1, B and B1. IC50 values obtained by the MTT and Neutral Red 
assay, after 24, 48 and 72 h of exposure ranged from 0.5 ± 0.1 to > 15 
µM. A significant increase (p ≤ 0.05) in ROS generation and LPO 
production, as determined by the fluorescent probe H2-DCFDA and 
TBARS method respectively, was observed for all mycotoxins tested at 
3.0 µM concentration. The highest increase in ROS generation (2.6 fold 
higher than control) and LPO production (111%, as compared to control) 
was observed with EN A. Cell cycle was significantly arrested at G2/M 
phase after 24 h of exposure to EN A, A1, B1, whereas after 72 h of 
exposure an arrest in S phase was observed almost for all mycotoxins 
tested. Moreover, after 24 and 48 h of exposure, ENs increased the 
early apoptotic cells, whereas after 72 h of exposure necrosis was 
observed. In addition the loss of ΔΨm was produced on Caco-2 cells 
after ENs exposure. ENs A, A1, B and B1 cytotoxicity involved early ROS 
generation that induced LPO oxidative damage, apoptosis and necrosis 
via the mitochondrial pathway. ENs A, A1 and B1 induced DNA damage. 
However the same effects cannot be proposed for and EN B. Further 
studies on the toxicological effects induced by ENs A, A1, B and B1 are 
needed.  
Resultados 
 
 
160 
 
Keywords: enniatins, cytotoxicity, oxidative stress, cell cycle, 
apoptosis, mitochondrial membrane potential, DNA damage, Caco-2 
cells. 
  
Resultados 
 
 
161 
 
1. Introduction 
 The enniatins (ENs) are cyclic hexadepsipeptidic mycotoxins 
produced by several species of Fusarium, that naturally occur in cereal 
grains, bread, malt and silage (Prosperini et al., 2013). They have 
become an issue of high concern for human and animal health during 
the last decade, because of their potential toxicity, probably linked to 
their ionophoric activities (Tedjiotsop Feudjio et al., 2010; Jestoi, 
2008). Their hydrophobic nature allows them to incorporate easily in 
biological membranes by forming dimeric structure that transports 
monovalent ions across the cellular membranes, in particular the 
mitochondrial membrane, affecting ionic homeostasis (Tonshin et al., 
2010). On the other hand, excessive reactive oxygen species (ROS) 
generation leads to oxidative stress status, which can lead to oxidized 
macromolecular structures, including membrane lipids, proteins and 
DNA, and causes cell cycle arrest and cell apoptosis. The induction of 
ROS, lipid peroxidation (LPO) and gluthation (GSH) decrease have been 
reported for the structurally related Fusarium mycotoxin beauvericin 
(BEA; Ferrer et el., 2009; Klarić et al., 2007). However, current studies 
reported that ROS generation induced by ENs is not a cause but a result 
of ENs toxicity in mitochondria (Ivanova et al., 2012). In our laboratory, 
a special interest has been given to the study of ENs toxicity pathways. 
We have demonstrated that ENs are cytotoxic by a further set of 
endpoints; they inhibit cell proliferation in different cell line (Meca et 
al., 2011; Lu et al., 2013) and their binary and tertiary combinations 
produce higher cytotoxic effects (Lu et al., 2013). We have already 
demonstrated the bioaccessibility of ENs from different food 
commodities (Prosperini et al., 2013) and bioavailability by applying an 
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in vitro method which allowed the simulation of the small and large 
intestine (Meca et al., 2012). Moreover, prevention of ENs-induced 
cytotoxic effect in mammalian cells has been previously evaluated by 
addition of polyphenols in cell culture (Lombardi et al., 2012). 
However, very few data about cellular targets and resulting 
toxicological consequences in in vitro cell cultures are available about 
ENs A, A1, B and B1. In this context, the aims of the this study were to 
determine if the cytotoxic effects of ENs A, A1, B and B1 could be 
related to the generation of ROS and cell damage, such as LPO, cell 
cycle disruption and apoptosis induction through changes in 
mitochondrial membrane potential (ΔΨm) in human colon 
adenocarcinoma cells (Caco-2). Caco-2 cells was chosen as a model 
because all previous studies in our laboratory have been developed in 
this type of cells.   
2. Materials and methods 
2.1 Reagents   
 EN A (purity: ≥ 97%, molecular weight: 681.9 g/mol), EN A1 
(purity: ≥ 97%, molecular weight: 667.9 g/mol), EN B (purity: ≥ 90%, 
molecular weight: 639.4 g/mol) and EN B1 (purity: ≥ 97%, molecular 
weight: 654.9 g/mol) were from Enzo Life Sciences, Switzerland. The 
reagent grade chemicals and cell culture components used, Dulbecco’s 
modified Eagle’s medium (DMEM), penicillin, streptomycin, HEPES, 
tetrazolium Bromide (MTT), Neutral Red (NR), non essential aminoacids 
(NEAA), phosphate buffer saline (PBS), Trizma base, Triton X-100, 
glucose, dimethyl sulfoxide (DMSO), thiobarbituric acid (TBA), 
deferoxamine mesylate salt (DFA), di-ter-butyl-methylphenol (BHT), 
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1,1,3,3 tetramethoxipropan, 2´,7´-dichlorodihydrofluorescein diacetate 
(H2-DCFDA), propidium iodide (PI), RNase A, Na-EDTA, agarose, agarose 
low melting temperature (LMA) and benzo(α)pyrene (B(α)P) were from 
Sigma Chemical Co. (St Louis, MO, USA). Fetal calf serum (FCS) was 
from Cambrex Company (Belgium). NaOH was from Guinama (Spain). 
Deionised water (resistivity <18 MΩ cm) was obtained using a Milli-Q 
water purification system (Millipore, Bedford, MA, USA). NaCl and 
ethanol were from Merck KGaA (Germany). CaCl2 and formaldehyde 
were from Scharlau Chemie S.A. (Barcelona, Spain). Methanol (MeOH) 
and Glacial acetic acid were from VWR International (LLC, Pennsylvania, 
USA). Human recombinant annexin V-FITC coniugate, tetramethyl 
rhodamine methyl ester (TMRM), To-Pro®-3 iodide and the protonophore 
carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) were from 
Invitrogen, (USA). All other reagents were of standard laboratory grade.  
Stock  solutions of ENs (1 mM) were prepared in methanol and 
maintained at -20°C.  Final concentrations tested were achieved by 
adding ENs in the culture medium with the final methanol concentration 
of 1% (v/v). Total protein content (µg/mL) was determined by Bradford 
method (Bio-Rad DC Protein Assay, catalogue number 500-0116, 
http://www.bio-rad.com/LifeScience/pdf/Bulletin_9005.pdf).  
 
2.2 Cell culture  
 Caco-2 cells (ATCC HTB-37) were maintained in DMEM medium 
supplemented with 25 mM HEPES buffer, 1% (v/v) of NEAA, 100U/mL 
penicillin, 100mg/mL streptomycin and 10% (v/v) FCS inactivated. 
Incubation conditions were pH 7.4, 37°C under 5% CO2 and 95% air 
atmosphere at constant humidity. Culture medium was changed every 
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two days. Absence of mycoplasma was checked routinely using the 
Mycoplasma Stain Kit (Sigma-Aldrich, St Louis Mo. USA). 
2.3 Cell viability assays 
 The MTT and NR assays were performed as described by Ruiz et 
al. (2006) with some modifications. Caco-2 cells were cultured in 96-
well tissue culture plates by adding 200 µL/well of a suspension of 3 x 
104 cells/well. After cells reached 80% confluence the culture medium 
was replaced with fresh medium containing the serial dilution of each 
mycotoxins ranging from 0.9 to 15 µM for ENs A1, B and B1 and from 0.45 
to 7.5 µM for EN A.  
For NR assay, after 24, 48 and 72 h of incubation with different ENs 
concentrations (serial dilution=2), medium containing each ENs was 
removed and 200 μL of freshly prepared NR solution (50 μg/mL) pre-
warmed at 37°C, was added to each well and all plates returned to the 
incubator at 37°C for 3 h. The cells were washed once with PBS and 
fixed with formaldehyde– CaCl2 solution, and then extracted by adding 
acetic acid–ethanol solution. Plates were gently shaken for 5 min so that 
complete dissolution was achieved before measuring absorbance at 540 
nm with an automatic ELISA plate reader Multiscan EX (Thermo 
Scientific, MA, USA). Cell viability was expressed in percent relative to 
control cells (1% MeOH). Three independent experiments were 
conducted and mean inhibition concentration (IC50) values were 
calculated from full-dose response curve.  
For MTT assay, after 24, 48 and 72 h of exposure with serial 
concentrations of ENs, each well received 200 μL of fresh medium 
containing 50 µL of MTT. After 4 h of incubation (37°C in darkness), the 
Resultados 
 
 
165 
 
resulting formazan was solubilised in DMSO. The absorbance was 
measured at 570 nm using the ELISA plate reader Multiscan Ex (Thermo 
Scientific, MA, USA). Cell viability was expressed in percent relative to 
the solvent control (1% MeOH). Three independent experiments were 
performed and the IC50 values were calculated from full dose-response 
curves.   
2.4 ROS generation assay 
 Intracellular ROS production was monitored in Caco-2 cells by 
adding the H2-DCFDA according to Ruiz-Leal and George (2004). Briefly, 
3 x 104 cells/well were seeded in a 96-well black culture microplate. 
Once cells exhibited 80% confluence, the culture medium was replaced 
and cells were loaded with 20 µM H2-DCFDA for 20 min and then, the 
medium with H2-DCFDA was removed and washed twice with PBS before 
the addition of medium/1% MeOH (control) or medium with ENs. The 
selection of the two different concentration, 1.5 and 3.0 µM, for each 
ENs was made according to previous outcomes that confirm that they 
resulted to be non toxic and both of them are below the IC50 values 
obtained in Caco-2 cells. This method is exceptionally sensitive and it 
provides a direct measure of overall oxidative stress, which detects 
intracellular oxidants. DCFH-DA is taken up by the cells, then 
deacetylated by intracellular esterases and the resulting H2-DCFDA 
becomes trapped inside the cell. The oxidation of the non fluorescent 
2’,7’– dichlorodihydrofluorescein moiety H2-DCFDA by ROS to the DCF 
that is highly fluorescent is possible. Increases in fluorescence were 
measured at intervals up to 2 h at excitation and emission wavelengths 
of 485 and 535 nm, respectively. Twenty-four replicates were 
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developed. Results are expressed as increase in fluorescence in respect 
to control.  
2.5 Lipid peroxidation assay 
 LPO was measured according to Buege and Aust (1978) based on 
the formation of thiobarbituric acid reactive substances (TBARS). This 
assay is based on the formation of a red adduct (absorption maximum 
532 nm) between TBA and MDA, a final product of the peroxidation 
process. Briefly, 4.8 x 105 cells/well were seeded in 6-well plates. After 
achieving the 80% confluence, cells were treated with each mycotoxin 
individually, at the two concentrations, 1.5 and 3.0 µM selected, for 24 
h. Later the medium was removed and cells were washed with PBS and 
then homogenized in 20 mM Tris 0.1% Triton. Lysated and homogenized 
cells were boiled (100 °C water bath for 30 min) under acid conditions 
in the presence of 0.5% TBA, 1.5 mM DFA and 3.75% BHT. Samples were 
cooled, centrifuged (1287 g, 15 min) and the formation of TBARS was 
measured at 532 nm. Three independent experiments were conducted 
and results are expressed as ng of MDA/mg of protein measured by the 
Bradford method.   
2.6 Cell cycle analysis by flow cytometry 
 Cell cycle analysis was performed by staining the DNA with PI as 
described previously (Juan-García et al., 2013) with some modifications. 
The PI fluorescent nucleic acid dye is capable of binding and labeling 
double-stranded nucleic acids, making possible to obtain a rapid and 
precise evaluation of cellular DNA content by flow cytometric analysis, 
and subsequent identification of hypodiploid cells. A number of 4.8 x 
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105 cells/well were seeded in 6-well plates. After 24, 48 and 72h of 
exposure at 1.5 and 3.0 µM, Caco-2 cells were trypsinized and placed on 
ice for 30 min with 860 µL of fresh medium containing 29 ng/mL of 
Vindelov’s PI staining solution prepared as follows: 10 mg (700 U/L) 
RNase A, 0.1 ml of Nonidet P-40, 0.1% Triton X-100, 10 mM Tris, 10 mM 
NaCl and 50 μg/mL of PI in PBS. Ten thousand cells were analyzed by 
using EPICS XL MCL 4 CLR (Coulter Corporation) at the excitation 
wavelength of 488 nm and the emission wavelength of 620 nm. Data 
from the raw histograms were extracted by rectangular fitting 
(CYLCHRED or MODIFIT software, Beckton Dickinson, Milan, Italy). Cell 
cycle analysis was  calculated by rectangular curve fitting (MODIFIT, 
Beckton Dickinson, Milan, Italy) using 1024 channels which produced 
histograms with a single G0/G1 peak at channel 200 when DNA is 
diploid, an S peak between channels 200 and 400 when DNA is 
replicating, a G2/M peak at channel 400 when DNA is tetraploid and a 
debris peak between channels 100 and 200 when DNA is hypodiploid or 
damaged (Minervini et al., 2004). The small coefficient of variation (CV) 
obtained in this study was the result of the high resolution achieved by 
proper alignment. Three independent experiments were performed for 
each EN treatment.   
2.7 Flow cytometry analysis of apoptosis (and necrosis) 
 Cell death constitutes one of the key events in biology. At least 
two modes of cell death can be distinguished: apoptosis and necrosis. It 
is now generally assumed that both forms of cell death constitute two 
extremes of a continuum (Kroemer et al., 1998). As a matter of fact, 
the same toxin can induce apoptosis or necrosis at a low or high dose, 
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respectively. Apoptosis is a strictly genetically regulated cell death, 
whereas necrosis is an accidentally unregulated cell death, 
characterized by membrane lysis and release of cellular content. During 
apoptosis, the externalization of phosphatidylserine (PS) to the outer 
leaflet of the plasma membrane occurs. The differential of population 
of apoptotic cells (early or late), necrosis and dead cells can be 
identified by Annexin V-FITC/PI double staining (Vermes et al., 1995). 
Annexin V is a Ca2+- dependent phospholipid-binding protein with high 
affinity for PS, and binds to cells exposing PS to the extracellular side of 
the plasma membrane, whereas PI binds to the DNA of necrotic/dead 
cells. Viable cells with intact membranes exclude PI, whereas the 
membranes of dead and damaged cells are permeable to PI. Cells 
considered as viable are both Annexin V-FITC-/PI-; cells in early 
apoptosis (pro-apototic/apoptotic) cells are Annexin V-FITC+/PI-; cells in 
late apoptosis, that have completed the apoptotic and start the 
necrotic process (apoptotic/necrotic), are both annexin V-FITC+/PI+. For 
the annexin V-FITC assay, a number of 4.8 x 105 cells/well were seeded 
in 6-well plates. After 24, 48 and 72h of exposure at 1.5 and 3 µM of 
each ENs, cells were trypsinized and resuspended in 360 μL of HepesCa2+ 
buffer  prepared as follows: 10 mM HEPES-NaOH (pH 7.4), 135 mM NaCl 
and 2.5 mM CaCl2. After incubation at 4°C for 30 min in the dark, 
10,000 cells were acquired and analyzed on a BD FACSCanto (FACS-
Canto II, Deckton Dickinson, Italy) flow cytometer with FACSDiva 
software v 6.1.3 (BD Biosciences). Green (FL-1, 530 nm) and orange-red 
fluorescence (FL-2, 585 nm) were detected, emitted by FITC and PI, 
respectively. Quadrant statistics were performed to determine viable 
cells, early apoptotic, late apoptotic and dead cells from the total 
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population of cells. Caco-2 cells treated with 1% MeOH in the media 
were considered as control. Three independent experiments were 
performed for each EN treatment.     
2.8 Detection of mitochondrial membrane potential (ΔΨm) by 
tetramethyl rhodamine methyl ester [TMRM] method.   
 Induction of apoptosis leads to the loss of ΔΨm (Zamzami et al., 
1995). The ΔΨm can be monitored in living cells using the cationic 
lipophilic dye TMRM whose structure allows it to be distributed freely 
through membranes into the mitochondrial matrix, as a function of the 
Nerst equation, correlated to the ΔΨm (Juan García et al., 2013). In this 
study a double labeling with TMRM and To-Pro®-3 has been carried out 
as described by Tsiper et al. (2012). To-Pro®-3, a membrane-
impermeable nuclear marker was used to characterize plasma 
membrane integrity and, as consequence, cell viability. The ionophore 
FCCP was used to optimize the MMP change analysis (by TMRM signal 
decrease) and cell viability by To-Pro®-3 signal increase. Briefly, Caco-2 
cells were seeded in 6 well plates at a density of 4.8 x 105 cells/well. 
After ENs exposure (1.5 and 3.0 μM for each EN), cells were trypsinized 
and resuspended in growth medium (500 μL) where a cocktail of the two 
markers was included with a final concentration of 140 nM and 160 nM 
for TMRM and To-Pro®-3, respectively. After 30 min of incubation at 
37°C in the dark, fluorescent intensities of TMRM (λex= 548 nm and λem= 
573 nm) and of To-Pro®-3 (λex= 642 nm and λem= 661 nm) were measured 
by using a FACSCanto flow cytometer (FACS-Canto II, Deckton Dickinson, 
Italy). Data from fluorescent histograms were analyzed using the 
FACSDiva software v 6.1.3 (BD Biosciences). The percentage of TMRM 
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and ToPro-3 stained cells was calculated from the total 10,000 cells in 
comparison to the control (Caco-2 cells treated with 1% MeOH in the 
culture media). Three independent experiments were performed. 
2.9 Alkaline comet assay (pH>13) 
 The induction of DNA strand breaks was determined using the 
alkaline comet assay (pH>13), according to the method described 
previously (Singh et al., 1988; Marabini et al., 2011), with some 
modifications. Caco-2 cells (4.8 x 105 cells/well) were seeded in 6-well 
plates. After achieving the 60% confluence, cells were treated with ENs, 
at the concentrations of 1.5, 3.0 and 12.0 µM), for 24 h before 
preparation for analysis of DNA damage at pH>13. Subsequently, 2 x 104 
cells/mL were suspended in pre-warmed LMA (0.5% PBS; 37°C) and 80 
μL of the suspension were rapidly transferred to agarose precoated 
slides (1% PBS) and covered with a coverslip (24x36 mm). After gelling 
for 10 min at 0°C, the coverslip was gently removed and a third layer of 
80 μL LMA was added. After gelling for 10 min at 0°C, the coverslip was 
gently removed and slides were put on a tank filled with lysis solution 
(2.5 M NaCl, 100 mM Na-EDTA, 10 mM Tris, 250 mM NaOH, 10% DMSO 
and 1% Triton X-100, freshly added) for 30 min at 0°C. The slides were 
removed from lysis solution, washed with neutralization buffer (0.4 M 
Tris, pH 7.5) and incubated in fresh electrophoresis buffer (300 mM 
NaOH, 1 mM Na-EDTA) for 20 min at room temperature to allow DNA to 
unwind. Electrophoresis was then carried out at room temperature in 
fresh electrophoresis buffer for 40 min (25 V, 300 mA). After 
electrophoresis, slides were gently washed once for 5 min in fresh 
neutralization buffer. Slides were dried overnight at 4 °C, stained with 
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500 μL of PI (20 μg/mL) and covered with coverslip. Slides were 
visualized under a fluorescence microscope (NIKON Eclipse E800), 
equipped with camera (NIKON DXM1200F) to capture images. A 
minimum of 50 randomly selected individual cells were selected and 
analyzed by using the Automatic Comet Assay by TriTek CometScoreTM 
freeware (http://autocomet.com/index.php?id=cometscorepro). The 
DNA damage in Caco-2 cells was expressed as the median tail moment 
(TM). The TM was chosen as the effect parameter, calculated according 
to the equation: TM = TL x Tail DNA% where TL is the tail length, i.e. 
the distance (μm) between the center of the comet head and the end of 
the comet tail. All parameters are provided by TriTek CometScoreTM. 
The Tail DNA is expressed as a percentage of the total DNA content 
based on the total fluorescence intensity. 
2.10 Statistical analysis of data 
 Statistical analysis of data were carried out using SPSS Statistic 
19.0 (SPSS, Chicago, IL, USA) statistical software package. Data were 
expressed as mean ± SD of independent experiments. The statistical 
analysis of the results was performed by Student’s t-test for paired 
samples. Differences between concentrations were analyzed 
statistically with ANOVA followed by the Tukey HDS post hoc test for 
multiple comparisons. The level of p ≤ 0.05 was considered statistically 
significant.  
3. Results  
3.1 Cell viability 
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 Table 1 summarizes the IC50 value obtained by MTT and NR assay 
after exposure to each EN at the three different times of exposure. As 
determined by MTT assay, after 24 h of exposure, ENs A, B and B1 did 
not show IC50 value at the range of concentration tested. After 48 h of 
exposure, all ENs tested showed IC50, with exception of EN B. At 72 h of 
exposure all mycotoxins showed IC50 values. EN B showed the less 
cytotoxic effect on Caco-2 cells at the three times of exposure, 
following by ENs B1 = A = A1 (Table 1). As regards to NR uptake assay, 
after 24 h of exposure only ENs A and A1 showed a significant IC50 values 
on Caco-2 cells. After 48 h of exposure, the IC50 values of EN A and A1 
resulted to be similar, and lower than those obtained for ENs B and B1 
(Table 1). After 72 h of exposure, the IC50 values were ranging from 0.46 
± 0.1 (ENs A and A1) to 1.4 ± 0.2 μM (EN B). NR assay was the most 
sensitive methods for all ENs tested. ENs A and A1 showed lower IC50, as 
obtained by MTT and NR assays in Caco-2 cells. 
3.2 ROS generation  
 Changes in the redox status of Caco-2 cells in response to ENs A, 
A1, B and B1 was determined. Cells were exposed to different 
concentrations (1.5 and 3.0 µM) of these ENs from 0 to 120 min. The 
production of ROS was determined by DCFH-DA assay (Fig. 1). The 
results obtained demonstrated that high production of oxidizing species 
was produced depending on concentration of EN and time of exposure 
when compared to the basal rate. The highest relative intensity of 
fluorescence in Caco-2 cells was observed at the highest time of 
exposure after  testing all ENs (Fig. 1). EN A (Fig. 1a) showed a 
significant increase in ROS production up to 45 min of incubation at 1.5 
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and 3.0 µM of 1.8- and 2.6-fold higher than the control, respectively. 
ROS production in Caco-2 cells was observed at the early stage of ENs 
A1, B and B1 exposure (Fig. 1b, 1c and 1d). At 10 min, the EN A1 
concentration of 3.0 µM generated a ROS production of 1.9-fold higher 
than control, which continued growing up until it reached an increase of 
2.6- fold higher than control at 120 min of exposure. However, 1.5 µM 
of EN A1 increases 1.8-fold ROS production compared to the control 
from 10 to 120 min of exposure. As can be observed in Figure 1c, only 
3.0 µM of EN B increased ROS production in Caco-2 cells from 10 up to 
120 min. Higher fluorescence intensity (1.7-fold) was observed at 45 
min of exposure. Referring to EN B1, Figure 1d shows that the 
concentration of 1.5 µM produced a significant ROS generation from 10 
min (1.6-fold higher respect to the control), to 120 min of exposure 
(1.8-fold). Higher ROS generation was observed after 3.0 µM of EN B1 
exposure from 5 up to 120 min (2.1-times to control).  
 
Table 1. The medium inhibitory concentration (IC50) of ENs A, A1, B and 
B1 in Caco-2 cells after 24, 48 and 72 h of exposure by the MTT and NR 
assays. IC50 values are given as percent of control cells (1% MeOH). 
Results are mean ± SD of three experiments.  
 IC50 (µM) ± SD 
 NR MTT 
 24 h 48 h 72 h 24 h 48 h 72 h 
EN A 4.3±0.2 2.6±0.4 0.46±0.1 >7.5 6.8±1.6 1.6±0.8 
EN A1 7.7±0.2 2.9±0.6 0.46±0.1 14.8±2.7 7.7±1.2 1.3±0.6 
EN B >15 10.7±3.4 1.4±0.2 >15 >15 11.7±2.4 
EN B1 >15 10.8±3.8 0.8±0.3 >15 11.3±2.3 2.8±1.1 
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Figure 1. Time dependence of ROS-induced fluorescence in Caco-2 cells 
exposed to ENs (a) A, (b) A1, (c) B and (d) B1, at 1.5 and 3.0 µM. H2-
DCFDA was added to Caco-2 cells and left for 20 min and then exposed 
to ENs. Fluorescence of oxidized DCF was followed by emission at 535 
nm and the excitation at 485 nm. Mean ± SD, 24 replicates. p ≤ 0.05 (*), 
p ≤ 0.001 (**), p ≤ 0.000 (***), significantly different from the control. 
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3.3 Lipid peroxidation   
 The LPO on Caco-2 cell was determined by the TBARS method in 
the presence of individual ENs. The results obtained demonstrated that 
after 24 h exposure all ENs increased MDA production in Caco-2 cells. In 
Figure 2, at the highest concentration tested (3.0 µM), significant 
increases of 111% and 58% for EN A and A1, respectively, can be 
observed. EN B at 3.0 µM increased significantly MDA production up to 
48%. EN B1 at 1.5 and 3.0 µM increased MDA production up to 46% and 
59% in respect to the control. ENs A, A1 and B at 1.5 µM concentration 
didn’t produce any increase in MDA levels.   
 
 
Figure 2. Lipid peroxidation as measured by MDA production in Caco-2 
cells incubated for 24 h with 1.5 and 3.0 µM of EN A, A1, B and B1. 
Results are expressed as mean ± SD in ng of MDA/mg of protein 
measured by Bradford method. Significantly different from control, p 
≤0.05 (*), p ≤ 0.001 (**), p ≤ 0.000 (***). 
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3.4 Cell cycle analysis 
 Flow cytometry analysis performed by PI-staining on Caco-2 cells 
after 24, 48 and 72 h of incubation with ENs A, A1, B and B1 indicated a 
modification in percentage of cells in SubG0/G1 (hypodiploid cells or 
debris), G0/G1 and G2/M phase for all ENs tested in a time and 
concentration dependent manner (Fig. 3). After 24 h of exposure, none 
of the parameters were changed for EN B (Fig. 3a). For ENs A, A1 and B  
an arrest of the cell cycle in G2/M phase above 35.2 ± 3.7% compared to 
the control (23.1 ± 4.1%) was produced. A significant decrease of the 
G0/G1 cell population (p ≤ 0.05 vs control) was observed for EN A1 and 
B1 at 1.5 μM. No changes in S phase were observed after 24 h of 
exposure (Fig. 3a). As illustrated in Fig. 2B, the exposure for 48 h to ENs 
A, A1 and B resulted in a significant increase of the SubG0/G1 cell 
population. Increase in SubG0/G1 phase was above 15.1 ± 3.2% (control 
5.3 ± 2.0%). A significant decrease in G0/G1 phase (p ≤ 0.05 vs control) 
was observed. Results shown in Figure 2b demonstrated a decrease in 
G0/G1 phase by  EN A, A1 and B1 with percentages ranging from 35.8 ± 
1.1 to 41.0 ± 5.2%, respect to the control (49.3 ± 4.2%). Respect to both 
S and G2/M phases, no changes were observed after all ENs exposure. 
After 72 h of incubation with ENs a significant increase (p ≤ 0.01 for 1.5 
μM concentration vs control and p ≤ 0.000 for 3.0 μM concentration vs 
control) of the SubG0/G1 cell population accompanied by a significant 
(p ≤ 0.05) increase in S phase cell population was observed (Fig. 2c). 
Higher increase in SubG0/G1 phase was observed for EN B1 at 3.0 μM 
concentration (35.8 ± 3.2%) vs control (7.2 ± 1.5%). Similarly, higher 
increase in S phase was observed for EN B1 (20.0 ± 1.3%) as compared to 
control (14.6 ± 2.0%; Fig. 3c). G0/G1 phase decreased after 72 h of ENs 
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A, A1, B and B1 incubation. G0/G1 cell population decreased from 26.1 ± 
1.7% to 35.4 ± 2.5% for EN B1 (at 3.0 μM) and EN A (1.5 μM), 
respectively, compared to the control (Fig. 2c). Respect to the G2/M 
phase, the increase of cell population was observed only for ENs A1  and 
B (41.3 ± 5.3 and 28.3 ± 2.4% vs control 22.2 ± 2.6%).   
3.5 Flow cytometry analysis of apoptosis (and necrosis) 
 As shown in Figure 4, apoptotic/necrotic effect seems to be 
dependent on time of ENs incubation. Apoptotic effect was clearly 
observed at 24 and 48 h of exposure, while necrotic effects were 
observed for ENs A and A1 after 24 h and it was extended to all ENs after 
72 h of incubation.  
After 24 h of incubation with ENs A and A1, apoptotic cell population 
increased from 24.8 ± 3.1 and 33.5 ± 3.7% as compared with 11.7 ± 1.3% 
of control cells (Fig. 4a). After 48 h of incubation, apoptotic cell 
population increased 16.1 ± 4.7 and 22.0 ± 5.6% for ENs A and A1 (1.5 
μM), as compared to control (6.5 ± 1.3%). Apoptotic cells increased with 
ranging values from 12.9 ± 3.0% to 24.2 ± 5.0% for ENs B and B1 
compared with the control (Fig. 4b). After 24 h of incubation, EN A and 
A1 treatment increased by 24.4 ± 3.6 and 26.7 ± 5.5%, as compared to 
12.3 ± 2.8% in control cells (Fig. 4a). After 48 h of incubation, necrotic 
cells increased with ranging values from 19.5 ± 3.2% to 21.5 ± 4.1%, as 
compared to control (14.0 ± 2.0%).  
After 72 h of incubation, necrotic cell population increased for all ENs 
tested. The increase ranged from 15.6 ± 2.2 to 30.9 ± 1.6%, as 
compared with control cells (10.7 ± 1.4%). 
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3.6 Detection of mitochondrial membrane potential (ΔΨm) by 
tetramethyl rhodamine methyl ester [TMRM] method.   
 The evaluation of ΔΨm changes in Caco-2 cells showed a 
significant (p ≤ 0.05) decrease in TMRM fluorescence intensity (%) in a 
dose and time dependent manner (Fig. 5). After 24 of exposure to EN 
A1, cell percentages were significantly (p ≤ 0.05) decreased from 54.8% 
(1.5 μM) and 45.6% (3.0 μM) as compared to the control cells. The ΔΨm 
decreased by 36.6% (at 1.5 μM concentration) for EN A, as compared to 
control (Fig. 5). After 48 h of exposure, the reduction in TMRM intensity 
(%) was produced for all ENs tested, at both concentration tested, 
except for EN B, that significantly (p ≤ 0.05) decreased TMRM intensity 
only after 3.0 μM concentration (44.9%; p≤0.05; Fig. 5). Percentage 
reductions were 33.9% and 43.6% for EN A, 45.2% and 31.9% for EN A1, 
55.5% and 74.4% for EN B1, after 1.5 and 3.0 μM exposure, respectively, 
as compared to the control cells (Fig. 5). All reductions in TMRM 
florescence intensity were different significantly (p ≤ 0.000) from 
control cells after 72 h of exposure. The percentage reduction of TMRM 
intensity was ranging from 91.0% to 98.7%, for all ENs tested (Fig. 5c). 
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Figure 3. Analysis of cell cycle distribution of Caco-2 cells treated with 
ENs A, A1, B and B1 at 1.5 and 3.0 μM for 24 (a), 48 (b) and 72 h (c). 
Data are expressed as mean values ± SD (n = 3). p ≤ 0.05 (*), p ≤ 0.001 
(**), p ≤ 0.000 (***) , indicate a significant difference with the control, p 
≤ 0.05 (#) indicate significant differences between the two 
concentrations tested (1.5 and 3.0 μM).  
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Figure 4. Analysis of apoptosis/necrosis induction in Caco-2 cells 
treated with ENs A, A1, B and B1, at 1.5 and 3.0 μM for 24 (a), 48 (b) and 
72 h (c). Cells were stained with Annexin-FITC and PI to distinguish early 
apoptotic from apoptotic/necrotic cells. Data are expressed as mean 
values ± SD (n = 3). p ≤ 0.05 (*) and p ≤ 0.000 (***) indicate a significant 
difference with the control. 
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Figure 5. Loss of mitochondrial membrane potential (ΔΨm) in Caco-2 cells as detected by flow cytometry 
after TMRM/ To-Pro®-3 double staining. Caco-2 cells were treated with 1.5 and 3.0 μM concentrations of ENs 
A, A1, B and B1, for 24, 48 and 72 h. p ≤ 0.05 (*), p ≤ 0.000 (***), significantly different from the control. 
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3.7 Alkaline comet assay  
 Figure 6 presents the alkaline comet assay data obtained in 
Caco-2 cells after exposure to ENs A, A1, B and B1 for 24 h. B(α)P 20 μM 
was used as positive control. After 24 h of exposure both EN A 
concentrations tested (1.5 and 3.0 μM) and 3.0 μM concentration of EN 
A1 and B1 produced a significant increase in the TM parameter (p ≤ 
0.000; as compared to the control), whereas, with regard to EN A1 at 
1.5 μM and EN B, no significant DNA damage was observed, as compared 
to the control (Fig. 6). 
 
 
Figure 6. Alkaline comet assay (pH > 13) on Caco-2 cells after 24 h 
exposure to 1.5 and 3.0 μM ENs A, A1, B and B1. Migration of DNA is 
reported as median TM. B(α)P (20 μM) was the positive control. The box 
plots show the medians (middle bar), standard deviations, 25% and 75% 
percentiles. p ≤ 0.000 (***) significantly different from the control. (  ) 
Extreme cases and atypical values (○).  
*** 
*** *** 
*** 
*** 
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4. Discussion 
 ENs are naturally contaminant of cereal grains as well as 
processed food in Europe (Jestoi et al., 2008). Concentrations tested in 
this study are included in the range of contamination levels that have 
been reported to be from μg/kg to mg/kg considering several food 
commodities (Prosperini et al., 2013). The selection of 1.5 and 3.0 μM 
concentration was made according to the concentrations determined 
previously in food commodities from Mediterranean Area. In fact, 
according to Meca et al. (2010b), mean levels of ENs A1, B and B1 have 
been reported in maize in the range from 4.34 to 167.7 mg/Kg. 
Considering that the consumption of maize in Southern Europe is 7.7 
Kg/year (FAOSTAT, 2009), the estimated total intake of ENs is ranging 
from 0.3 to 5.2 μmol/day, values that are comparable to the two 
concentrations tested. Moreover, the selection of 1.5 and 3.0 μM was 
due to the fact that they were not cytotoxic to Caco-2 cells, since they 
were the inhibitory concentration 90 (IC90; obtained by the MTT assay). 
It has been demonstrated that ENs exposure induces cytotoxicity under 
in vitro conditions. Results obtained in this study show that ENs A, A1, B 
and B1 are cytotoxic to Caco-2 cells in low concentration ranges in a 
dose and time dependent manner. Similar IC50 values were obtained by 
Meca et al. (2010a, 2011) on Caco-2 cells, human colon carcinoma (HT-
29) and human liver carcinoma (Hep-G2) cells after exposure to A, A1, 
A2, B, B1, B4 and J3, even considering that ENs tested by Meca et al. 
(2010a, 2011) were not supplied commercially; they were isolated and 
purified from Fusarium tricinctum under determined laboratory 
conditions. Similar IC50 values were obtained by other authors in 
different human and mammalian non human cell lines (Lu et al., 2013; 
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Ivanova et al., 2012; Lombardi et al., 2012; Watjien et al., 2009). On 
the other hand, higher effects were obtained for EN A, A1, B, B1, B2 and 
B3 in HepG2, MRC-5 (fibroblast-like foetal lung) and V79 (Chinese 
hamster lung fibroblast) cells (Ivanova et al., 2006; Behm et al., 2009).  
The results of this study demonstrated that, after ENs exposure on 
Caco-2 cells, high production of oxidizing species is obtained. ROS 
generation could be a cause or consequence of the mitochondrial 
alterations. Excessive ROS formation can cause macromolecules 
oxidation, such as membrane lipids, leading to membranes LPO (Ferrer 
et al., 2009). In this study it has been demonstrated that ENs, at the 
higher concentration tested, produce an increase in MDA levels, which, 
in association with ROS generation, plays a role in the molecular events 
leading to cell damage particularly by the induction of LPO. To the best 
of our knowledge, this is the first report about ENs inducing LPO in cell 
cultures. Similar results were obtained by Ferrer et al. (2009) when 
CHO-K1 cells were exposed to BEA which is structurally similar to the 
ENs. They found that BEA increased ROS production almost 182% in 
respect to control at 120 min of exposure. On the other hand, a recent 
study reported that ROS were generated downstream by the EN B-
induced cytotoxic events in the mitochondria of Caco-2 cells (Ivanova et 
al., 2012). This lets us suppose that ROS generation is involved in ENs 
cytotoxicity, as a consequence of an early mitochondrial damage and 
LPO have been produced as a consequence of ROS generation in Caco-2 
cells, after ENs exposure. A previous study reported that one of the 
pathways involved in Caco-2 cells viability reduction induced by 
Fusarium mycotoxins, is LPO (Kouadio et al., 2007). Moreover, ROS, as 
produced by external factors, are known to elicit lysosomal membrane 
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permeabilization (LMP), at the same time ROS can occur after LMP as a 
downstream signal to cell death with lysosomal-mitochondrial cross-talk 
(Repnik and Turk, 2010).  
 ENs are capable to disturb the normal progression of 
proliferating cells (Dornetshuber et al., 2007; Juan-García et al., 2013). 
Cell cycle arrest is a transient condition that may be induced by several 
factors and generally cells spontaneously revert from this condition 
restoring their proliferation rate or becoming apoptotic (or necrotic). 
Moreover, after 24 h, the exposure to ENs A1 and B1 led to a shift of cell 
cycle distribution, getting visible as increased proportion of cells in the 
G2/M phase, while cells in the G0/G1 phase were diminished. On the 
other hand, after 72 h of exposure, ENs A, A1, B and B1 produced an 
arrest of cell cycle in G2/M and they induced a significant increase in 
the S-phase; in addition, the reduction in G0/G1 phase is still 
maintained through all time of exposure almost for all ENs tested as 
well as the increase in SubG1 phase: this suggests the involvement of 
apoptosis in these ENs cell death (Fig. 3).  
 It has been reported that the normal progression of cell cycle 
could be affected by DNA damage events, in particular cells with 
damaged DNA arrest their cell cycle in G2/M or S phase (Abid-Essefi et 
al., 2003). If DNA damage is not repaired cells can undergo apoptosis or 
necrosis. In this study, it has been investigated the possible induction of 
DNA damage by ENs A, A1, B and B1. From the results obtained, ENs A, A1 
and B1 induced DNA damage in a dose dependent manner (Fig.  6).  
 Regarding to ENs A and A1, after 24 h of exposure, the 1.5 and 
3.0 μM concentrations produced an arrest in G2/M phase that could be 
related to the DNA damage induced in Caco-2 cells, as assessed by the 
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comet assay (Fig. 6). Apoptosis has been also induced as well as 
necrosis. This could be due to the fact that under the same stimulus, 
features of both apoptosis and necrosis may coexist in the same cell. 
The apoptotic properties of ENs A and A1 are still maintained after 48 h 
at 1.5 μM, whereas only necrosis is induced by the highest concentration 
tested. Moreover, only necrosis is observed after 72 h of exposure. This 
finding could support the induction of apoptosis and necrosis (Fig. 4) via 
the mitochondrial pathway (Fig. 5). The involvement of mitochondrial 
pathway is confirmed by the TMRM intensity reduction (Fig. 5). A 
significant reduction in TMRM intensity was obtained through all 
concentrations tested (Fig. 5). ROS generation and LPO are produced 
after ENs A and A1 exposure; moreover, no direct relationship could be 
established between LPO and the viability reduction via apoptotic-
mitochondrial pathway.  
 Regarding EN B1, the higher concentration produced a block in 
the G2/M phase of the cell cycle that could be induced by DNA damage. 
No apoptosis or necrosis are produced after 24 h of EN B1 exposure and 
no mitochondrial involvement is observed (Figs 4 and 5). However, EN B1 
induced early generation of ROS and LPO products, which could be 
responsible of cytotoxicity in Caco-2 cells.  
 However, when Caco-2 cells were exposed to ENs A, A1 and B1 
the prolonged exposure (48 h) produced a reduction in cell viability, 
with an increase in apoptotic and apoptotic/necrotic cell percentages 
(Fig. 4b), corroborated by the significant increase in SubG0/G1 
percentage of the cell cycle and by the disruption of mitochondrial 
functionality (Fig. 3b and Fig. 6). After 72 h of exposure, no DNA 
synthesis is produced since an arrest in S-phase is observed, only 
Resultados 
 
 
187 
 
necrotic phenomenon is observed and high alteration of ΔΨm (Figs 3c, 
4c and 6). This is due to the high exposure time that could induce 
necrosis.  
 Different results have been obtained for EN B. The reduction in 
Caco-2 cells viability was lower than the other ENs in this study. EN B 
seems to be least cytotoxic mycotoxin to Caco-2 cells. This may be due 
to the lipophilicity rate of the four ENs tested: EN A>EN A1>EN B1>EN B 
(Tedjiotsop Feudjio et al., 2010). No significant effects after 24 h of 
exposure were observed in cell cycle distribution, apoptosis/necrosis 
induction, DNA damage and ΔΨm disruption. However ROS generation 
and LPO were produced by 3.0 μM EN B concentration. This fact 
confirms that ROS and LPO are not involved in ENs apoptosis induction. 
ROS were generated downstream by the EN B-induced cytotoxic events 
in the mitochondria of Caco-2 cells (Ivanova et al., 2012). The absence 
of EN B genotoxicity is in accordance with recent studies (Behm et al., 
2009; Gammelsrud et al., 2012).  After 48 h of exposure, apoptosis 
induction with the involvement of ΔΨm is observed and culminate in 
necrotic cell death after the highest time of exposure (72 h). The 
induction of necrosis is confirmed by Ivanova et al. (2012) in Caco-2 
cells, however higher doses (25 μM) were tested. Cell cycle is affected 
by EN B with an arrest in G2/M phase (31.0 ± 1.3% of cell population) vs 
control cells (23.0 ± 1.0%) only after 72 h of exposure. According to 
Ivanova et al. (2012), this type of arrest has been described as a 
possible consequence of external stimuli leading to apoptosis by 
activation of the caspase pathway or to non-apoptotic mitotic death. 
 The cell cycle arrest may be an adaptive process in which a 
surveillance mechanism delays or arrests the cell cycle when DNA 
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lesions occur. Other studies have demonstrated the ability of cells to 
delay or arrest their multiplication cycle either in G0/G1 or G2/M in 
order to make repair take place (Abid-Essefi et al. 2003).  
Few data are available about the genotoxicity of ENs and it has been 
demonstrated that EN B and ENs mixture are not genotoxic in vitro 
(Dornetshuber et al., 2009; Gammelsrud et al., 2012; Ivanova et al., 
2012). No data have been published about the genotoxic effects of ENs 
A, A1 and B1 tested individually in cell cultures, up to now. According to 
our data, in this study a potential DNA damaging activity has been found 
after exposure to ENs A, A1 and B1 in Caco-2 cells. The DNA damage can 
be related to the block in G2/M phase of the cell cycle due to a 
checkpoint activated after DNA damage. In addition ENs A, A1, B and B1 
induced initially apoptosis and then necrosis at higher time of exposure 
in a dose-dependent manner in Caco-2 cells. Moreover, it has been 
corroborated that apoptosis was initiated by the so-called mitochondrial 
pathway based on a depolarization of the mitochondrial outer 
membrane.  
 Results obtained shows that several toxicological consequences 
have been induced by ENs A, A1, B and B1 in Caco-2 cells. Cytotoxicity 
could involve early ROS generation that induced LPO oxidative damage. 
In addition, Caco-2 cells undergo apoptosis and necrosis after exposure 
to ENs and the depolarization of ΔΨm is involved in both types of cell 
death induced by ENs. ENs A and A1-induced cytotoxicity involved DNA 
damage, corroborated by the arrest of the cell cycle observed. However 
the same effects cannot be proposed for EN B1 and EN B. Further studies 
on the toxicological effects induced by ENs A, A1, B and B1 are needed.  
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ABSTRACT 
Cytotoxic effects and the possible induction of oxidative stress by 
Fusarium mycotoxin fusaproliferin (FUS) have been investigated in Caco-
2 cells. FUS (0.9 to 30 μM) did not exerted cytotoxic effect after 24, 48 
and 72 h of exposure. Moreover, intracellular reactive oxygen species 
(ROS), which have been determined from 0 to 120 min, were not 
observed. However, at the time 0 of exposure, an increase of 2.2 folds 
respect to control, was produced. Similarly, an induction of lipid 
peroxidation (LPO) was not observed, as compared to control. Our 
results suggest that FUS is not cytotoxic in the concentration tested and 
it do not produce oxidative stress in Caco-2 cells.   
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1. Introduction  
Fusaproliferin (FUS) is a bicyclic sesterterpenic mycotoxin that 
consists of five isoprenic units (Fig. 1). It was originally isolated from a 
pure culture of Fusarium proliferatum (Randazzo et al., 1993). Other 
Fusarium species, such as F. antophilum, F. begoniae, F. bulbicola, F. 
circinatum, F. concentricum, F. succisae, F. udum and F. subglutinans, 
are also capable to produce FUS (Zinedine et al., 2011). Recently, FUS 
has been detected in raw cereals and cereal based products of the 
Mediterranean area, with contamination levels ranging from traces to 
2000 mg/Kg (Zinedine et al., 2011; Meca et al., 2010; Serrano et al., 
2013a,b).  
On the other hand, few studies have been carried out about FUS 
toxicological effects in vitro. It has been shown that FUS and its 
derivates can induce teratogenic effects, e.g. cephalic dichotomy, 
macrocephaly and limb asymmetry, in chicken embryos bioassays 
(Ritieni et al., 1997). The non-covalent interactions between single- and 
doublestranded DNA-oligonucleotides and FUS with 1:1 stoichiometry 
have been reported (Pocsfalvi et al., 2000) which may partly explain the 
teratogenic effects. The interchelatation was not reported to exhibit 
any base sequence preference in the DNA, suggesting an electrostatic 
type of interaction. 
So, the objectives of this study were to determine the 
cytotoxicity of FUS by the MTT assay, to detect intracellular ROS 
production as early stage marker induced oxidative stress and to 
determine the LPO in human adenocarcinoma (Caco-2) cells. 
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Figure 1. Chemical structure of fusaproliferin. 
 
2. Material and methods  
2.1 Reagents  
 The reagent grade chemicals and cell culture components used 
were provided by Sigma Chemical Co. (St Louis, MO, USA). Fetal calf 
serum (FCS) was from Cambrex Company (Belgium). Deionised water 
(resistivity <18 MΩ cm) was obtained using a Milli-Q water purification 
system (Millipore, Bedford, MA, USA).  
 FUS was kindly given by Professor Alberto Ritieni, Department of 
Food Science, University of Naples “Federico II”, Italy and was prepared 
by dissolving 1 mg of the mycotoxin in 1 ml of pure MeOH, obtaining a 
stock solution of 1000 μg/ml (2.4 mM) of FUS, composed by 39.9% of 
FUS and by 60.1% of deacetyl-FUS.  
 Stock  solutions of mycotoxins were prepared in methanol and 
maintained at -20°C. The final concentrations tested were achieved by 
adding the culture medium with mycotoxins and the final methanol 
concentration in medium was 1% (v/v). Total protein content (µg/ml) 
was determined by Bradford method (Bio-Rad DC Protein Assay 
(catalogue number 500-0116) http://www.bio-
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rad.com/LifeScience/pdf/Bulletin_9005.pdf). All other reagents were of 
standard laboratory grade. 
2.2 Cell culture  
 Caco-2 cells (ATCC HTB-37) were maintained in DMEM medium 
supplemented with 25 mM HEPES buffer, 1% (v/v) of NEAA, 100U/mL 
penicillin, 100mg/mL streptomycin and 10% (v/v) FCS inactivated. 
Incubation conditions were pH 7.4, 37°C under 5% CO2 and 95% air 
atmosphere at constant humidity. Culture medium was changed every 
two days. Absence of mycoplasma was checked routinely using the 
Mycoplasma Stain Kit (Sigma-Aldrich, St Louis Mo. USA).  
2.3 Cell viability assay 
 The MTT assay was performed as described by Ruiz et al. (2006) 
with some modifications. 3 x 104 cells/well were seeded in 96-well 
tissue culture plates and after reaching confluence, the exposure 
solutions of FUS (from 0.9 to 30 µM) were added to the plate that was 
incubated at 34 °C for 24, 48 and 72 h. 200 µL of fresh medium 
containing 50 µL of MTT were added. After 4 h of incubation (37°C in 
darkness), the resulting formazan was solubilised in DMSO. The 
absorbance was measured at 570 nm using the ELISA plate reader 
Multiscan Ex (Thermo Scientific, MA, USA). Cell viability was expressed 
in percent relative to the solvent control (1% MeOH). Three independent 
experiments were performed and the 50% inhibitory concentrations 
(IC50) values were calculated from full dose-response curves. 
 
Resultados 
 
 
201 
 
2.4 ROS generation assay 
 The production of ROS was assessed in 96-well black culture 
microplate using the dichloroluorescein (DCF) assay, according to Ruiz 
and George (2004). The diacetate form (DCF-DA), after diffusing in the 
cell membrane, is hydrolysed by intracellular esterases to non-
fluorescent dichlorofluorescein (DCFH), which is trapped inside the cells 
then oxidized to fluorescent DCF through the action of peroxides in the 
presence of ROS. Increases in fluorescence were measured at intervals 
up to 2 h at excitation and emission wavelengths of 485 and 535 nm, 
respectively. Twenty-four replicates were developed. Results are 
expressed as increase in fluorescence in respect to control.  
2.5 Lipid peroxidation assay 
 LPO was measured according to Buege and Aust (1978) based on 
the formation of thiobarbituric acid reactive substances (TBARS). This 
assay is based on the formation of a red adduct (absorption maximum 
532 nm) between TBA and MDA, a final product of the peroxidation 
process. Briefly, 4.8 x 105 cells/well were seeded in 6-well plates and 
exposed to 1.5 and 3.0 µM of FUS for 24 h. Three independent 
experiments were conducted and results are expressed as ng of MDA/mg 
of protein measured by the Bradford method.  
2.6 Statistical analysis of data 
 Statistical analysis of data were carried out using SPSS Statistic 
19.0 (SPSS, Chicago, IL, USA) statistical software package. Data were 
expressed as mean ± SD of three independent experiments. The 
statistical analysis of the results was performed by Student’s t-test for 
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paired samples. The level of p≤0.05 was considered statistically 
significant.  
3. Results and discussion 
 The MTT is one of the most used for preliminary and mechanistic 
cytotoxicity studies of mycotoxins in a great variety of mammalian cell 
lines (Ferrer et al., 2009; Watjen et al., 2009; Meca et al., 2010; Ruiz et 
al., 2011a,b). Concentrations tested of FUS produced a decrease in 
cellular proliferation after 24, 48 and 72 h of exposure. However, no 
IC50 values were reached at any time of exposure (data not shown). 
Logrieco et al. (1996) assessed cytotoxicity of FUS in non neoplastic B-
lymphocyte cell line IARC/LCL 171 and the IC50 obtained was 55 µM after 
48 h exposure by MTT assay. In the study developed in our laboratory, 
the higher FUS concentration tested was 30 µM. No higher concentration 
was determined because of a problem with the quantity supplied.  
 Previous studies reported that several Fusarium mycotoxins exert 
cytotoxic activity by inducing oxidative stress in different mammalian 
cell lines, in terms of reactive oxygen species (ROS) generation and lipid 
peroxidation (LPO; Kouadio et al. 2005; Ferrer et al., 2009; Ruiz et al., 
2011a,b; Bouaziz et al., 2008). In this sense, as far as authors 
knowledge, no studies are available about the induction of oxidative 
stress by FUS. 
 To determine changes in the redox status of Caco-2 cells in 
response to FUS, cells were exposed to 1.5 and 3.0 µM concentrations 
from 0 to 120 min (Fig. 2). FUS did not show any significant increase in 
ROS production respect to the control. However, at the time 0 of 
exposure, an increase of 2.2-times to control can be observed (Fig. 2). 
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Moreover no increase in MDA production was observed (Fig. 3). Results 
clearly showed that FUS did not alter the oxidative status of Caco-2 
cells. The toxicity could be due to other mechanisms different from ROS 
production that have not been investigated here.  
 On the other hand, it is known that FUS is a natural occurring 
Fusarium mycotoxin that can be found in food and feed, so it can 
constitute a potential concern to animal and human health. The toxicity 
is still unclear. However Prosperini et al. (2012) demonstrated a 
relatively high bioavailability of FUS (almost 80%) as determined by 
differentiated Caco-2 cells, that represent a validated international 
model which is used to predict human intestinal absorption. Due that, 
the toxicity to humans and animals is still an existing concern. Other 
mechanistic pathway should be investigated in the future to get 
additional data about FUS toxicity.  
 
 
Figure 2. Time dependence of ROS-induced fluorescence in Caco-2 cells 
exposed to FUS at 1.5 and 3.0 µM. H2-DCFDA was added to Caco-2 cells 
and left for 20 min and then exposed to ENs. Fluorescence of oxidized 
DCF was followed by emission at 535 nm and the excitation at 485 nm. 
Mean ± SD, 24 replicates. p ≤ 0.000 (***), significantly different from the 
control.  
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Figure 3. Lipid peroxidation as measured by MDA production in Caco-2 
cells incubated for 24 h with 1.5 and 3.0 µM of FUS. Results are 
expressed as mean ± SD in ng of MDA/mg of protein measured by 
Bradford method.   
References  
Bouaziz, C., Sharaf el dein, O., El Golli, E., Abid-Essefi, S., Brenner, C., 
Lemaire, C., Bacha, H., 2008. Different apoptotic pathways induced 
by zearalenone, T-2 toxin and ochratoxin A in human hepatoma cells. 
Toxicology, 254, 19-28. 
Buege, J.A., Aust, S.D., 1978. Microsomal lipid peroxidation. Meth. 
Enzymol. 52, 302-310. 
Ferrer, E., Juan-García, A., Font, G., & Ruiz, M. J. (2009). Reactive 
oxygen species induced by beauvericin, patulin and zearalenone in 
CHO-K1 cells. Toxicol. In Vitro, 23, 1504-1509.  
Kouadio, J.H., Mobio, T.A., Baudrimont, I., Moukha, S., Dano, S.D., 
Creppy, E., 2005. Comparative study of cytotoxicity and oxidative 
stress induced by deoxynivalenol, zearalenone or fumonisin B1 in 
human intestinal cell line Caco-2. Toxicology 213, 56-65.  
Logrieco, A., Moretti, A., Fornelli, F., Fogliano, V., Ritieni, A., Caiaffa, 
M.F., Randazzo, G., Bottalico, A., Macchia, L., 1996. Fusaproliferin 
production by Fusarium subglutinans and its toxicity to Artemia 
0 
5 
10 
15 
20 
25 
30 
35 
control 1.5 3.0 
FUS 
n
g
 M
D
A
/m
g
 p
ro
te
in
 
Concentration (µM) 
Resultados 
 
 
205 
 
salina, SF-9 insect cells, and IARC/LCL 171 human B lymphocytes. 
Appl. Environ. Microbiol. 62, 3378-3384. 
Meca, G., Ruiz, M. J., Soriano, J. M., Ritieni, A., Moretti, A., Font, G., 
Mañes, J., 2010. Isolation and purification of enniatins A, A1, B, B1, 
produced by Fusarium tricinctum in solid culture, and cytotoxicity 
effects on Caco-2 cells. Toxicon 56, 418-424. 
Pocsfalvi, G., Ritieni, A., Randazzo G., Dobó, A., Malorni, A., 2000. 
Interaction of Fusarium mycotoxins, fusaproliferin and fumonisin B1, 
with DNA studied by electrospray ionization mass spectrometry. J. 
Agric. Food Chem. 48, 5795-5801.  
Prosperini, A., Meca, G., Font, G., Ruiz, M.J., 2012. Study of the 
cytotoxic activity of beauvericin and fusaproliferin and bioavailability 
in vitro on Caco-2 cells. Food Chem. Toxicol. 50, 2356-2361.   
Ritieni, A., Monti, S.M., Randazzo, G., Logrieco, A., Moretti, A., Peluso, 
G., Ferracane, R., Fogliano, V., 1997. Teratogenic effects of 
fusaproliferin on chicken embryos. J. Agric. Food Chem. 45, 3039-
3043. 
Randazzo, G., Fogliano, V., Ritieni, A., Mannina, L., Rossi, E., Scarallo, 
A., Segre, A. L. (1993). Proliferin, a new sesterpene from Fusarium 
proliferatum. Tetrahedron, 49, 10883-10896.  
Ruiz, M.J., Macáková, P., Juan-García, A., Font, G., 2011a. Cytotoxic 
effects of mycotoxin combinations in mammalian kidney cells. Food 
Chem. Toxicol. 49, 2718–2724. 
Ruiz, M.J., Franzova, P., Juan-García, A., Font, G., 2011b. Toxicological 
interactions between the mycotoxins beauvericin, deoxynivalenol 
and T-2 toxin in CHO-K1 cells in vitro. Toxicon 58, 315-26. 
Ruiz, M.J., Festila, L. E., Fernández, M., 2006. Comparison of basal 
cytotoxicity of seven carbamates in CHO-K1 cells. Environ. Toxicol. 
Chem. 88, 345-354. 
Ruiz-Leal, M., George, S., 2004. An in vitro procedure for evaluation of 
early stage oxidative stress in an established fish cell line applied to 
investigation of PHAH and pesticide toxicity. Mar. Environ. Res. 58, 
631-635. 
Resultados 
 
 
206 
 
Serrano, A.B., Font, G., Mañes, J., Ferrer, E., 2013a. Emerging 
Fusarium mycotoxins in organic and conventional pasta collected in 
Spain. Food Chem. Toxicol. 51, 259–266. 
Serrano, A.B., Font, G., Mañes, J., Ferrer, E., 2013b. Comparative 
assessment of three extraction procedures for determination of 
emerging Fusarium mycotoxins in pasta by LC-MS/MS. Food Control 
32, 105-114. 
Zinedine, A., Meca G., Mañes, J., Font, G., 2011. Further data on the 
occurrence of Fusarium emerging mycotoxins enniatins (A, A1, B, B1), 
fusaproliferin and beauvericin in raw cereals commercialized in 
Morocco. Food Control 22, 1-5.  
 
  
Resultados 
 
 
207 
 
Toxicology Mechanisms and Methods 22 (2012) 687–695 
EFFECT OF POLYPHENOLS ON ENNIATINS-INDUCED CYTOTOXIC 
EFFECTS IN MAMMALIAN CELLS 
G. Lombardi1, A. Prosperini2, G. Font2, M. J. Ruiz2,
*
 
1Dipartmento di Scienze Economico-Estimative e degli Alimenti, Sezione 
di Chimica Bromatologica, Biochimica, Fisiologia e Nutrizione, Facoltà 
di Farmacia. Università degli Studi di Perugia, via San Costanzo (interno 
orto botanico) 06126, Perugia, Italy. 
2Laboratory of Toxicology, Faculty of Pharmacy, University of Valencia, 
Av. Vincent Andres Estelles s/n 46100 Burjassot, Valencia, Spain. 
 
  
                                                          
* Corresponding author: Tel. +34 963543055; FAX: +34 963544954; 
 e-mail address: M.Jose.Ruiz@uv.es 
 
Resultados 
 
 
208 
 
  
 
 
Resultados 
 
 
209 
 
ABSTRACT 
Enniatins (ENs) are fungal secondary metabolites produced by genus 
Fusarium. The ENs exert antimicrobial and insecticidal effect, and has 
also been demonstrated cytotoxic effects on several mammalian cell 
lines. On the other hands, it has been proved that natural polyphenols 
have antioxidant effect. In this study, cell effects at low levels of 
exposure of four ENs (A, A1, B and B1) and five polyphenols (quercetin, 
quercetin-3-β-D-glucoside, rutin, myricetin and t-pterostilbene) present 
in wine; and the cytoprotective effect of these polyphenols exposed 
simultaneously with ENs in Chinese Hamster Ovary (CHO-K1) cells, were 
studied. Cell effects were determined by the MTT test after 24 h of 
exposure. All ENs showed cytotoxic effect. The IC50 obtained ranged 
from 4.5 ± 1.2 to 11.0 ± 2.7 µM. The concentration of polyphenols 
tested ranged from 5 to 50 µM. Polyphenols did not show cytotoxicity 
and the cytoprotective effect of polyphenols varies depending on the EN 
tested. The cytoprotective effect of polyphenols in CHO-K1 cells 
exposed to ENs was as follow: quercetin, from 24 to 84%; quercetin-3-β-
D-glucoside, from 12 to 76%; rutin, from 17 to 83%; myricetin, from 16 
to 92% and pterostilbene from 25 to 100%. All polyphenols protected 
CHO-K1 cells against EN A1 exposure. 
Keywords: Enniatins, polyphenols, cytototixicy, cytoprotective effect, 
CHO-K1 cells. 
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1. Introduction 
 Mycotoxins are fungal secondary metabolites, mainly produced 
by genera Fusarium, Aspergillus, Penicillium, Alternaria and Claviceps 
and the amount of their production depends on different factors such as 
types of crop, climate and storage conditions. Among mycotoxins 
yielded by Fusarium there are enniatins (ENs), beauvericin (BEA), 
fumonisins, trichothecenes, moniliformin (MON) and zearalenone (ZEA; 
Jestoi, 2008; Ferrer et al., 2009; Meca et al., 2010; 2011). Fungal 
contaminants from genus Fusarium infect plants and agricultural 
products. They are present in food and feed and can produce a wide 
range of acute and chronic toxic effects on humans and animals.  
 ENs are lipophilic hexadepsipeptides that can easily incorporate 
in the cellular membrane. ENs exert antimicrobial, insecticidal and 
antihelmintinc effects (Tedjiotsop Feudjio et al., 2010). Moreover, ENs 
form dimeric structures that transport monovalent ions across the 
membranes, especially mitochondrial membranes and uncouple 
oxidative phosphorylation (Wätjen et al., 2009; Tedjiotsop Feudjio et 
al., 2010) and produce cytotoxic effects on mammalian cells (Wätjen et 
al., 2009; Meca et al., 2010; 2011). Polyphenols are widely distributed 
in fresh fruits, berries, black tee, red wine, purple grape juice, 
medicinal herbals, daily nutrition supplements, etc. They are an 
integrate part of the human diet (natural food and food industry) and 
are utilized as a source of starting material in the pharmaceutical 
industry (Zamora-Ros et al., 2008; Ostertag et al., 2010; Chen et al., 
2011; Seibert et al., 2011). Moreover, they have numerous biological 
activities, as cancer-preventive because of their antioxidative, oxygen 
radical scavenging, antiproliferative and anti-inflammatory activities 
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and their stimulation of the immune system. Red wine contain up to 30 
mg/L of flavonols (D’Archivio et al., 2007) and it is the richest source of 
stilbenes (resveratrol and derivatives, ≥ 82%) (Zamora-Ros et al., 2008). 
Moreover, FAO (2007) data demonstrated that the consumption of wine 
in South Europe was 35.60 Kg/person/year. Moreover, beneficial health 
properties have been associated with red wine consumption due to, the 
presence of polyphenols. Dietary polyphenols can protect cell 
constituents against oxidative damage limiting degenerative diseases 
associated to oxidative stress (D’Archivio et al., 2007; Chen et al., 2011; 
Seibert et al., 2011). Among more than 4,000 polyphenols compounds, 
most of the polyphenols are found as glycosides with different sugar 
moieties conjugation with various sugar molecules stabilizes the 
aglycones, increases their water solubility, and affects the 
bioavailability and physiological functions. Polyphenols most frequently 
studied are quercetin and its glycoside rutin (quercetin-3-O-
glucorhamnoside); they exhibit antioxidant, antitumoral, anti-
inflammatory, antiplatelet, and vasoprotector activities (Barcelos et al., 
2011). Quercetin is a major polyphenol ingested daily by dietary intake 
(20-100 mg) (You et al., 2010). Quercetin-3-β-D-glucoside is also a 
glycoside derivative from quercetin which has similar antioxidant 
activity (Razavi et al., 2009). However, is not an abundant flavonol 
glycoside in food, its bioavailability is 50-180% higher than that of 
quercetin (You et al., 2010). Myricetin is a flavonoid also present in 
wine and, it acts as oxygen free radical scavenger and induces 
antioxidant enzymes (Chen et al., 2011). Pterostilbene which is a 
stilbene is found in grape, blue berries (Chakraborty et al., 2010), 
peanuts and red wine (Zamora-Ros et al., 2008; Chakraborty et al., 
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2010). It is an analogue of resveratrol and, has also been shown that has 
beneficial healthily properties. It possess antiproliferative, anti-
inflammatory and antioxidantive effects, and presents 
antihyperglycemic, anticholesterol and hypolipidemic activities 
(Chakraborty et al., 2010; Zamora-Ros et al., 2008). The antioxidant 
activity of polyphenols has been widely investigated, but also their toxic 
and genotoxic effects. Due to the contradicting results about their 
ability to protect mammalian cells from cytotoxicity, studies on the 
level of safety are of great importance. During last decade, a 
remarkable effort has been made forward in vitro studies of mycotoxins 
and polyphenols (Markham et al., 1987; Hundhausen et al., 2005; 
Sergent et al., 2005; Choi et al., 2010; Barcelos et al., 2011). In vitro 
cytotoxicity tests are useful and necessary to define basal cytotoxicity. 
The in vitro MTT assay is an endpoint widely used for preliminary 
screening of Fusarium mycotoxins in a widely variety of mammalian 
cells such as human, monkey and rodent (Ferrer et al., 2009; Meca et 
al., 2010; 2011; Ruiz et al., 2011). CHO-K1 cells were selected because 
they are considered one of the most sensitive cell lines for preliminary 
screening of mycotoxin studies. 
 The aims of this study were to determine the cytotoxic effects of 
ENs A, A1, B and B1, and natural polyphenols quercetin, quercetin-3-β-D-
glucoside, rutin, myricetin and t-pterostilbene at low levels in CHO-K1 
cells; and to assess the cytoprotective effect of these polyphenols 
simultaneously exposed with ENs during 24 h in CHO-K1 cells. 
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2. Materials and methods 
2.1 Reagents 
The reagent grade chemicals and the mainly cell culture 
components used, Ham F-12 medium, penicillin, streptomycin, 
trypsin/EDTA solution, HEPES, 3,4,5-dimethylthiazol-2-yl-2,5-
diphenyltetrazolium bromide (MTT), phosphate buffer saline (PBS), 
glycine, dimethyl sulfoxide (DMSO), sodium bicarbonate and the 
polyphenols were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
The t-pterostilbene (256.30 g/mol; purity ≥ 90%) was synthesized in our 
laboratory following standard Witting and Heck reactions 
(http://www.orgsyn.org).ENs were from Enzo Life Sciences, 
Switzerland. Fetal calf serum (FCS) was from Cambrex Company 
(Belgium). Methanol was obtained from Fisher Scientific (Madrid, Spain). 
Deionized water (<18 MΩ cm resistivity) was from a Milli-Q water 
purification system (Millipore, Bedford, MA, USA). 
The polyphenols selected were quercetin (302.26 g/mol; purity ≥ 
98%), quercetin-3-β-D-glucoside (464.38 g/mol; purity ≥ 90%), rutin 
(610.56 g/mol; purity ≥ 99%) and myricetin (318.24 g/mol; purity ≥ 
96%). Schematic presentation of the formation of polyphenols selected 
in nature is shown in Figure 1. The ENs used, EN A (681.45 g/mol), EN A1 
(667.44 g/mol), EN B (639.41 g/mol) and EN B1 (653.43 g/mol) were up 
to 98% purity. All polyphenols were stored at 2-8 °C and protected from 
light. Stock solutions of ENs and polyphenols were prepared in 
methanol. Final concentration of each EN and polyphenol in the assay 
were achieved by adding the culture medium. The final methanol 
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concentration in the medium was 1% (v/v). Control cultures were 
exposed to the equivalent concentration of methanol. 
2.2 Cell line culture and treatment 
CHO-K1 cells derived from Chinese Hamster Ovary, were cultured 
in monolayer with Ham-F12 media supplemented with 25 mM HEPES 
buffer (pH 7.4), 10% heat inactived FCS, 100 U m-1 penicillin, 100 μg ml-1 
streptomycin, and 2.5 μg ml-1 amphotericin B. Incubation conditions 
were 37 °C and 5% CO2 in a 95% relative humidified atmosphere. 
Absence of mycoplasma was checked routinely using the Mycoplasma 
Stain Kit (Sigma-Aldrich, St. Louis, MO, USA). 
2.3 Determination of cytotoxicity of ENs and polyphenols and 
antioxidant effect of polyphenols in CHO-K1 cells exposed to ENs 
CHO-K1 cells were cultured into 96-well tissue-culture plates by 
adding 200 μL/well of a suspension of 2 x 104 cells/well. Counting of 
cells was performer with a Beckman coulter (Florida, USA). After the 
cells reached 65% confluence, the culture medium was replaced with a) 
fresh medium containing six serial dilutions (serial dilution factor = 2) of 
EN A (from 0.47 to 7.5 μM) and six serial dilutions of ENs A1, B and B1 
(from 0.47 to 15 μM) plus a control; b) fresh medium containing five 
serial dilutions (serial dilution factor = 2) of each polyphenol (from 3.13 
to 100 μM) plus a control, and c) fresh medium containing 
simultaneously the polyphenol (concentrations: 5, 25 and 50 μM) and 
each EN (1.5 and 3 μM) plus a control. The plates were incubated for 24 
h at 37 °C, and the cytotoxicity was determined by the MTT assay.  
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The MTT viability assay was performed as Ruiz et al. (2006). 
Briefly, after exposure of each EN or polyphenol during 24 h, the 
medium containing ENs or polyphenols was removed and cells of each 
well received 50 μL of MTT. The plates were wrapped in foil and 
incubate for 4 h at 37 °C. After the incubation period, the medium 
contained the MTT has removed, and the plate was washed with PBS. 
200 μL of DMSO was added in the plate followed by 25 μL of Sorensen's 
glycine buffer. The absorbance was measured at 570 nm using an ELISA 
plate reader Multiscan EX (Thermo Scientific, MA, USA). Cytotoxicity 
was expressed as a percentage of cell viability relative to control cells.  
2.4 Statistical analysis 
Statistical analysis of data was carried out using PASW statistic 
17.0 (SPSS, Chicago, IL, USA), software package. Data were expressed 
as mean ± SD of three independent experiments. The statistical analysis 
of the result was performed by Student's t-test for paired samples. 
Differences between groups were analyzed statistically with one-way 
ANOVA followed by the Tuckey HDS post-hoc test for multiple 
comparisons. The level of p ≤ 0.05 was considered statistically 
significant.  
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Figure 1. Chemical structure of polyphenols selected in this study. (a) Scheme of the quercetin, quercetin-
3-β-d-glucoside, rutin and myricetin biosynthesis pathway and (b) chemical structure of t-pterostilbene. 
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3. Results 
3.1 Cytotoxic effect of enniatins 
The effects of ENs A, A1, B and B1 in CHO-K1 viability was 
evaluated by the MTT assay after 24 h of exposure. The inhibitory 
activity was quantified as the concentration required for inhibiting cell 
growth by 50% (IC50) under the assay condition. The IC50 values were 
determined graphically from the concentration response curve (Fig. 2). 
As can be observed in Figure 2, ENs reduced cell viability in a dose-
dependent manner as attested by MTT assay. After 24 h of incubation 
the IC50 values of ENs A1, B, and B1 were 8.8 ± 2.29, 11.0 ± 2.65 and 4.5 
± 1.23 μM, respectively. EN A did not show IC50 value in the range of 
concentration tested. Individual ENs diminishes cell viability in 
increasing order: EN A< EN A1 = EN B < EN B1. CHO-K1 cells are more 
sensitive to EN B1 (Fig. 2). The results demonstrated that the EN B1 was 
found to be the most cytotoxic against the cell line tested during the 
incubation period.   
3.2 Cytotoxic and cytoprotective activities of polyphenols 
The effects of polyphenols selected on the growth of CHO-K1 
cells using the MTT assay, as previously described was showed in Figure 
3. Myricetin, quercetin-3-β-D-glucoside and rutin did not decreased cell 
growth respect to the control at tested concentrations. Not cytotoxicity 
for quercetin and t-pterostilbene was observed at lower concentrations 
tested; however, the cell growth inhibitory effect on CHO-K1 cells was 
sensitive at the highest concentration (100 μM). But, no IC50 values were 
obtained for any polyphenol assayed in the range of concentration 
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tested. To investigate whether polyphenols can inhibit cytotoxicity 
induced by ENs, the range was further narrowed down to 5-50 μM. The 
concentrations for antioxidant effect of polyphenol assays were 
selected considering in all cases ≥ 70% cell viability. 
From Figures 4 to 8 is shown that all polyphenols simultaneously 
exposed with EN A1 increased the cytoprotective effect in a dose-
dependent manner. Fig. 4 and Fig. 5 shown cytoprotective effect in 
cells exposed simultaneously with EN B1 (1.5 µM) and quercetin or 
quercetin-3-β-D-glucoside (5 and 25 µM). And, 50 µM of quercetin (Fig. 
4), quercetin-3-β-D-glucoside (Fig. 5) and myricetin (Fig. 7) showed 
higher cell growth in the presence of EN B1 compared with cells exposed 
to EN B1 in medium without these polyphenols. Figure 5 shows that only 
50 µM of quercetin-3-β-D-glucoside led a significant protective effect on 
cells exposed to EN A compared with cells exposed to EN A in medium 
without quercetin-3-β-D-glucoside. According to Seibert et al. (2011), 
higher cytotoxic effect shows higher cytoprotection. Rutin shows a clear 
dose-dependent protective effect in CHO-K1 cell incubated with EN B 
(Fig. 6). Five µM of rutin increased cell growth while higher 
concentrations decreased it when EN B1 was in the medium (Fig. 6). 
Similar effect was observed with 5 µM of t-pterostilbene and EN A (Fig. 
8). On the other hand, stimulation of cell viability when cells are 
exposed to ENs and polyphenols together compared to the viability of 
control cells (cells exposed only to polyphenols) was observed (Fig. 4-8). 
This behaviour, which was previously observed in other cell lines, is a 
relatively common biological phenomenon characterized by low dose 
stimulation and high dose inhibition as a consequence of cell protection 
or adaptive response to mycotoxins exposure (Meca et al., 2011). 
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Figure 2. Cytotoxic effects of enniatin A (─□─), enniatin A1 (    ♦    ), 
enniatin B (··x··) and, enniatin B1 (─··Δ─·· ) in CHO-K1 cells after 24 h 
of exposure by the MTT assay*.  
 
 
 
Figure 3. Cytotoxic effects of polyphenols, quercetin (··□··), quercetin-
3- -D-glucoside (─◊─), t-pterostilbene (─ x─ ─), rutin (─··Δ─·· ) and 
myricetin (    ○   ) in CHO-K1 cells after 24 h of exposure by the MTT 
assay*.  
 
                                                          
*
 Each point represents the mean value of at least three experiments. Data are 
expressed as percentage of the unexposed control using eight replicates per 
concentration. An asterisk indicates a significant difference from control value (p≤0.05). 
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Figure 4. Protective effect of quercetin (Q) in CHO-K1 cells exposed to enniatins*.  
 
 
                                                          
*Medium: cells were exposed with the indicated doses of each EN or 1% methanol (0=as control) in Ham-F12 medium. Q 
at 5, 25 and 50 µM concentration: cells were simultaneously exposed with Q + each EN during 24 h. After 24 h of 
incubation, viability of these cells was measured using the MTT assay. Statistically different from the respective 
negative Q control (0; *p≤0.05 and ***p≤0.001). Statistically different from the medium (ENs treatment in Ham-F12 
medium without Q; #p≤0.05 and ###p≤0.001). Units of ENs (0, 1.5 and 3.0) are in µM. 
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Figure 5. Protective effect of quercetin-3-β-D-glucoside (Q-D-G) in CHO-K1 cells exposed to enniatins*.  
 
 
                                                          
* Medium: Cells were exposed with the indicated doses of each EN or 1% methanol (0=as control) in Ham-F12 medium. 
Q-D-G at 5, 25 and 50 µM concentration: Cells were simultaneously exposed with Q-D-G + each EN during 24 h. After 24 
h of incubation, viability of these cells was measured using the MTT assay. Statistically different from the respective 
negative Q-D-G control (0; *p≤0.05 and ***p≤0.001). Statistically different from the medium (ENs treatment in Ham-F12 
medium without Q-D-G; #p≤0.05, ##p≤0.01 and ###p≤0.001). Units of ENs (0, 1.5 and 3.0) are in µM. 
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Figure 6. Protective effect of rutin (R) in CHO-K1 cells exposed to enniatins*.  
 
 
                                                          
*
 Medium: cells were exposed with the indicated doses of each EN or 1% methanol (0=as control) in Ham-F12 medium. R 
at 5, 25 and 50 µM concentration: cells were simultaneously exposed with R + each EN during 24 h. After 24 h of 
incubation, viability of these cells was measured using the MTT assay. Statistically different from the respective 
negative R control (0; *p≤0.05 and ***p≤0.001). Statistically different from the medium (ENs treatment in Ham-F12 
medium without R; #p≤0.05 and ###p≤0.001). Units of ENs (0, 1.5 and 3.0) are in µM. 
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Figure 7. Protective effect of myricetin (M) in CHO-K1 cells exposed to enniatins*.  
 
 
                                                          
*
 Medium: cells were exposed with the indicated doses of each EN or 1% methanol (0=as control) in Ham-F12 medium. 
M at 5, 25 and 50 µM concentration: cells were simultaneously exposed with M + each EN during 24 h. After 24 h of 
incubation, viability of these cells was measured using the MTT assay. Statistically different from the respective 
negative M control (0; *p≤0.05, **p≤0.01 and ***p≤0.001). Statistically different from the medium (ENs treatment in 
Ham-F12 medium without M; #p≤0.05 and ###p≤0.001). Units of ENs (0, 1.5 and 3.0) are in µM. 
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Figure 8. Protective effect of t-pterostilbene (P) in CHO-K1 cells exposed to enniatins*. 
 
                                                          
*
 Medium: cells were exposed with the indicated doses of each EN or 1% methanol (0=as control) in Ham-F12 medium. P 
at 5, 25 and 50 µM concentration: cells were simultaneously exposed with P + each EN during 24 h. After 24 h of 
incubation, viability of these cells was measured using the MTT assay. Statistically different from the respective 
negative P control (0; *p≤0.05 and ***p≤0.001). Statistically different from the medium (ENs treatment in Ham-F12 
medium without P; #p≤0.05 and ###p≤0.001). Units of ENs (0, 1.5 and 3.0) are in µM. 
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4. Discussion 
 The ENs showed cytotoxic effect on CHO-K1 cells. EN B1 was 
more cytotoxic than ENs A, A1 and B. Cytotoxicity of ENs A, A1, B and B1 
had been previously proved in different cell lines (Ivanova et al., 2006; 
Föllmann et al., 2009; Watjen et al., 2009; Meca et al., 2010, 2011). 
Results obtained by Ivanova et al. (2006) were similar to our results. 
Nevertheless, the IC50 value of EN B in HepG2 (from 206.7 to 435.9 μM) 
by Alamar Blue assay seems in contradiction with our results and all 
results exposed in literature for EN B. The IC50 values obtained for ENs 
by Follman et al. (2009) and Wätjen et al. (2009) were similar to our 
results in CHO-K1 cells. The comparison between results obtained by 
Meca et al. (2010) with Caco-2 cell line and those obtained in this study 
demonstrated that CHO-K1 cells were more sensitive than Caco-2 to ENs 
A1, B and B1. When the results obtained by Meca et al. (2011) were 
compared with those obtained by us, cytotoxic effect of EN B1 observed 
in CHO-K1 cells was at least 5-, 3- and, 4-fold higher than those 
observed in HepG2, HT-29 and Caco-2 cells, respectively. However, EN 
A showed cytotoxic effect in HepG2 cells but not in CHO-K1 cells. In 
summary, all ENs show cytotoxic effect, regardless of the cell type 
studied. 
Previous studies developed with flavonoids in different cell lines 
have shown contradictory results. The protective effect of polyphenols 
may be due to a wide variety of mechanisms, including lightening 
oxidative stress by scavenging free radicals, promoting cellular survival 
by modulating intracellular signals, decreasing toxicities of mycotoxins 
by regulating gene expression or activities of enzymes, etc. In this 
study, the highest concentration of quercetin and t-pterostilbene (100 
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µM) significantly decreased cell viability, but doses lower than 100 µM 
did not cause cytotoxicity. Therefore, doses below 100 µM were applied 
in all subsequent experiments. Although, the selected concentrations 
are related to the wide range of polyphenols intake (18.6 mg to 2.20 
g/day) according to the results obtained by Ostertag et al. (2010). 
Results obtained revealed that co-treatment of quercetin had 
cytoprotective effect in CHO-K1 cells exposed to EN A1 and EN B1 (Fig. 
4). Cytoprotective effect ranged from 24 to 84 % (EN A1) and from 25 to 
43% (EN B1). Co-treatment with quercetin 3-β-D-glucoside (50 µM) 
reduced approximately 12% of EN A-induced cytotoxicity (Fig. 5). With 
respect to EN B1, quercetin 3-β-D-glucoside showed a similar 
cytoprotective effect (from 16 to 38%; Fig. 5). However, during 
simultaneous exposure of quercetin 3-β-D-glucoside and EN A1, higher 
reduction in cytotoxicity was observed (Fig. 5). The reduction was 47% 
and ranged from 68 to 76% after 1.5 and 3.0 µM of ENA1, respectively. 
No changes in cell viability were observed when quercetin 3-β-D-
glucoside and EN B were simultaneously exposed in CHO-K1 cells (Fig. 
5). Rutin had cytoprotective effect in CHO-K1 cells exposed to EN A1 and 
EN B (Fig. 6). After EN B exposure, this effect ranged from 17 to 31 % 
and from 30 to 46% after 1.5 and 3.0 µM of EN B, respectively. Higher 
cytoprotection was observed after EN A1 exposure (Fig. 6). The 
cytoprotective effect ranged from 26 to 35 % and from 57 to 83% after 
1.5 and 3.0 µM ENA1, respectively. On the other hand, 5 and 25 µM of 
myricetin significantly reduce cytotoxicity (16 and 26%) produced by 3.0 
µM of EN B in CHO-K1 cells, respectively (Fig. 7). While, only the highest 
concentration (50 µM) of myricetin reduce 61% and 29% the cytotoxic 
effect induced by 1.5 and 3.0 µM of EN B1, respectively (Fig. 7). Respect 
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to EN A1, the cytoprotective effect of myricetin ranged from 66 to 92% 
and was 25% after 1.5 and 3.0 µM, respectively (Fig. 7). t-Pterostilbene 
had cytoprotective effect in CHO-K1 cells exposed to EN A1 and EN B1 
(Fig. 8). The cytoprotective effect ranged from 78 to 116 % and from 32 
to 101% after 1.5 and 3.0 µM of EN A1 exposures, respectively. 
Cytoprotective effect in CHO-K1 cells was approximately 25% when 5 µM 
of t-pterostilbene and EN B1 were simultaneously incubated. 
Barcelos and coworkers (2011) extracted quercetin (purity > 
99.5%) and rutin (purity > 99.45) from the dried leaves of Dimorphandra 
mollis Benth and determined their cytotoxic and cytoprotective effects 
when were exposed alone or simultaneously with aflatoxin B1 (AFB1) in 
HepG2 cells. The protective results obtained against AFB1-induced DNA 
damage showed that pre-, simultaneous and post-treatment of HepG2 
cells with quercetin and rutin decreased the number of AFB1-induced 
DNA strand breaks. However, these authors proved that quercetin (50 
μg/ml) and rutin (100 μg/mL) were cytotoxic to HepG2 cells, due to 
they increase the intracellular ROS production and act as pro-oxidant 
agents. Similar cytotoxic effects of quercetin (0-500 µM) and rutin (0-
300 µM) were observed by Matsuo et al. (2005) in human lung embryonic 
fibroblasts (TIG-1) and umbilical vein endothelial (HUVE) cells at 
relatively high concentrations. On the other hand, Barcelos and co-
workers (2011) observed that lower concentration of quercetin and rutin 
are efficient ROS scavengers, because of they present a high inhibition 
of ROS generation. Choi et al. (2010) observed that quercetin 
derivatives could diminish oxidative stress, GSH depletion, and lipid 
peroxidation induced by AFB1 in HepG2 cells in vitro, while these 
effects could be not correlated their antioxidant activity. On the other 
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hand, Choi et al. (2010) demonstrated that quercetin was converted to 
various metabolites (meanly glucuronide/sulfate-conjugates) by liver 
enzymes and intestinal microbiota in mice. However, it is unclear 
whether the quercetin conjugates are the metabolites responsible for 
the beneficial effects of quercetin. Barcelos et al. (2011) also 
demonstrated a modulating effect of quercetin and rutin on CYP 
isoenzymes, which are responsible for mycotoxin activation. Therefore, 
they attribute the protective effect to the inhibition of CYP isoenzymes 
and also free radical scavenger activities. Similar effects were observed 
in our work in CHO-K1 cells exposed to ENs. Moreover, in previous 
studies developed in our laboratory, intracellular ROS production and 
lipid peroxidation was produced with 1.5 and 3.0 µM of ENs exposed 
during 24 h in Caco-2 cells (Prosperini et al., 2011). It is accepted that 
hepatic biotransformations play an important role in detoxification of 
polyphenols. Soares et al. (2006) studied the cytotoxic effect for 
quercetin and rutin in McCoy cells in the presence and absence of the 
hepatic S9 microsomal fraction (S9 fraction). The S9 fraction contains 
microsomes and many enzymes of phase I metabolism. Quercetin was 
cytotoxic in a dose-dependent manner in cells without S9 fraction (IC50 
was 83.7 ± 2.57) μg/ml; whereas, the S9 mixture metabolized these 
compounds to less cytotoxic metabolites, and the IC50 > 500 (with S9) 
μg/ml. However, rutin did not show cytotoxic effect at the range of 
concentration tested (15-500 μg/ml) neither with nor without S9 
fraction. On the other hand, effect of quercetin on ochratoxin A (OTA)-
induced cytotoxicity in liver and intestinal cells has also been 
determined (Hundhausen et al., 2005; Sergent et al., 2005). Taken into 
account that cytotoxicity of OTA may be produced by inhibition of 
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protein synthesis, inhibition of various enzymes and formation of DNA 
adducts, and knowing that depletion of cellular glutathione (GSH) 
significantly enhanced the cytotoxic effects of OTA. These authors 
demonstrated that quercetin do not counteract OTA-induced 
cytotoxicity in HepG2 and Caco-2 cells. Similar role of GSH was 
observed for T2 toxin and quercetin both in vivo and in vitro (Markham 
et al., 1987). 
Polyphenol glycosides have been found not to be incorporated 
into cells. Thus rutin and quercetin-3-O-glycoside may be barely 
incorporated into cells due to their higher hydrophilicity and hence have 
no effect (Zielinska et al., 2003; Razavi et al., 2009; You et al., 2010). 
This fact has been observed in our study and others. Oh et al. (2004) 
determined the hepatoprotective activity of four polyphenols extracted, 
isolated and purified from Equisetum arvense L. commonly used in 
traditional medicine in Korea. The polyphenol extracted quercetin-3-O-
glucoside shown free radical and superoxide scavenging effects at 11.2 ± 
0.2 and 91.8 ± 6.2 µM, respectively. However, no hepatoprotective 
effect was observed. As previously described, Oh and co-workers (2004) 
assumed that the increased polarity of quercetin-3-O-glucoside due to 
the presence of sugar moiety, could decrease the cell permeability of 
this polyphenol and therefore its antioxidant effect. Similarly to other 
authors, Marcarini et al., (2011) observed that rutin (10-810 μM) was not 
cytotoxic in HTC hepatic cells, and protect (50 and 75 µM) tissues 
against free radicals (Soares et al., 2006; Barcelos et al., 2011). 
However, the highest concentration (810 µM) of rutin tested showed 
cytotoxic effect due to DNA damage. Razavi et al. (2009) also observed 
this effect when McCoy (Pasteur, C123) cells were exposed to 
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quercetin-3-O-glucoside (100-1000 μg/mL) during 16 h provoked an IC50 
of 215.2 mg/ml (463 μM). Similarly, in our study, rutin and quercetin-3-
β-D-glucoside did not show cytotoxic effect in CHO-K1 cells. Moreover, 
higher concentrations of quercetin-3-β-D-glucoside assayed protect cells 
from ENs A, A1 and B1 exposure; and higher concentrations of rutin 
protect cells from ENs A1 and B. According to Matsumoto et al (2007), a 
possible mechanism of absorption of glycoside forms occurs. They found 
that most of the absorbed glycosides were hydrolyzed rapidly to 
aglycone and its conjugates. This could indicate that by time, rutin or 
quercetin-3-O-glucoside were hydrolyzed to quercetin aglycone and to 
be absorbed by cells, having the antioxidant effect observed. Aherne 
and O’ Brien (1999, 2000) studied the cytotoxicity of quercetin, rutin 
and myricetin (from 2.5 to 200 μM) in CHO, Caco-2, HepG2 and V79 cells 
by NRU and FDA-EtBr assays after 24 h of exposure. Similarly to our 
results, quercetin, rutin and myricetin did not cause cytotoxic effect. 
And, according to these authors, quercetin, rutin and myricetin were 
capable of reducing H2O2-induced DNA damage in vitro. On the other 
hand, Soundararajan et al. (2008) propose a novel model for quercetin-
3-glucoside-mediated cytoprotection against oxidative stress. The 
suggest as additional mechanism the ability of quercetin-like compounds 
to become intercalated between the acyl chains of phospholipids in the 
plasma membrane. Therefore, quercetin-3-glucoside increases the 
resistance of membranes to lipid peroxidation by increasing 
incorporation of this polyphenol into the plasma membrane. The 
effective prevention of losses cell viability was observed at very low 
concentration (0.1 µM). respect to myricetin, Yokomizo and Moriwaki 
(2006) demonstrated the strong radical scavenging activity of myricetin 
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(10 µM) against radicals. However, according to Shih et al. (2009), 
inhibitory effect of myricetin may be through an inactivation of the ERK 
(extracellular signaling-regulating kinase) signaling pathway. A major 
mechanism through which signals from extracellular stimuli are 
transmitted to the nucleus involves action of kinases. These authors 
observed that myricetin was not toxic to human adenocarcinoma A549 
cells from 0 to 20 µM. However, when cells were treated with myricetin 
(30-50 μM, during 24 and 48 h), cell viability significantly decreased by 
inhibiting phosphorylation of ERK. On the other hand, Zhang et al. 
(2009) observed a dose- and time-dependent growth inhibition effect of 
myricetin on esophageal carcinoma KYSE-510 cells via cell cycle arrest 
in the G2/M phase and mitochondrial-dependent apoptosis in a p53-
independent manner.  
About stilbenes, epidemiological studies have demonstrated 
benefit of pterostilbene (presented in the extracts of heartwood of 
Pterocarpus marsupium) in the Ayurvedic medicine (Ruiz et al., 2009). 
Moreover, previous studies have demonstrated that t-pterostilbene is 
cytotoxic because of it inhibits proliferation and induces apoptosis to a 
number of cancer cell lines (Tolomeo et al., 2005; Pan et al., 2007; 
Chakraborty et al., 2010). These authors demonstrated that t-
pterostilbene decreased cell growth in a dose-dependent manner, with 
IC50 values from 10 to 83 µM. Furthermore, they found that the 
cytotoxic effect of t-pterostilbene was due to apoptotic cell death in a 
concentration- and time-dependent manner. Moreover, decrease in the 
mitochondrial transmembrane potential in cells, arrest cells in the 
G0/G1 phase of the cell cycle and the increase in ROS levels after t-
pterostilbene-treated cells contribute to be an early mediator in t-
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pterostilbene-induced apoptosis. On the other hand, Kim et al. (2009) 
extracted and purified pterostilbene from Vitis coignetiae, a wild wine 
whose fruits are consumed and also traditionally used in alcoholic drinks 
and beverages in Korea. They evaluated the potential cytotoxic effects 
of pterostilbene in the range of 0.1-1000 μM during 24 h. And, similarly 
to our results, they found that pterostilbene was not cytotoxic at 
concentrations up to 100 μM. Moreover, they demonstrated that 
pterostilbene prevented H2O2-induced modulations of gap junctional 
intercellular communication via the inactivation of ERK and p38.  
In conclusion, the protective effect of cells against oral cytotoxic 
compounds depends on a balance between antioxidants and pro-oxidant 
components. Increased levels of antioxidants may respond to 
polyphenols in food commodities (as berries, wine, purple grape juice, 
etc.) and dietary supplements (quercetin-rich diets, etc.) which have 
been studied extensively to improve antioxidant reserve and thereby 
help regulate oxidative damage. The results obtained shown a wide 
variety of cytoprotective action from polyphenols, which depends on 
type of polyphenol, concentration in food commodity, simultaneous 
presence and interaction between polyphenols and other contaminants 
(as ENs), etc. So, food commodities containing polyphenols (specially, 
myricetin, quercetin, quercetin-3-β-D-glucoside, rutin and t-
pterostilbene) could contribute to diminish the toxicological risk to 
humans that ENs in these foods can produce. 
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ABSTRACT  
Beauvericin (BEA) is a cyclohexadepsipeptide mycotoxin which has 
insecticidal properties and produces cytotoxic effects in mammalian 
cells. Fusaproliferin (FUS) is a mycotoxin that has toxic activity against 
brine shrimp, insect cells, and teratogenic effects on chicken embryos. 
The aim of this study was to determine the cytotoxicity of BEA and FUS 
in human epithelial colorectal adenocarcinoma HT-29 and Caco-2 cells, 
the transepithelial transport and the bioavailability using Caco-2 cells as 
a simulated in vitro gastrointestinal model of the human intestinal 
epithelium. The inhibitory concentration (IC50) evidenced by BEA in the 
Caco-2 cells was 24.6 and 12.7 μM at 24 and 48 h exposure, 
respectively, whereas the IC50 values evidenced in HT-29 cells were 15.0 
and 9.7 μM, respectively. FUS was cytotoxic, but no IC50 data were 
observed in the range of concentration tested. BEA bioavailability was 
variable from 50.1% to 54.3%, whereas FUS presented a bioavailability 
variable from 80.2% to 83.2%. Results obtained demonstrated a 
potential risk for human health. 
Keywords: Beauvericin, fusaproliferin, cytotoxicity, bioavailability in 
vitro, transepithelial transport, HT-29. 
 
 
Resultados 
 
 
242 
 
1. Introduction 
 Beauvericin (BEA) is a cyclohexadepsipeptide that was first 
identified in a soil-borne entomopathogenic (insect-pathogenic) fungus 
Beauveria bassiana, which was recognized as the causative agent for 
heavy losses of the European sericulture in the 16th and 17th centuries 
(Tang et al., 2005). Nowadays, BEA is considered to be a putative 
mycotoxin (toxic fungal metabolite) that may affect human and animal 
health, since it is also produced by many species of the fungus Fusarium 
that infect important cereal grains such as corn, rice, and wheat (Leslie 
and Summerell, 2006). The potential mycotoxic role of BEA is 
exemplified by results obtained from in vitro studies using cell lines. In 
mammalian cell lines, cell deaths caused by BEA have been suggested to 
involve a Ca2+ dependent pathway, in which BEA induces a significant 
increase in intracellular Ca2+ concentration that leads death cell as a 
result of a combination of both apoptosis and necrosis (Jow et al., 2004; 
Lin et al., 2005). The mechanism of BEA-induced Ca2+ increase, 
however, remains inconclusive. BEA-induced apoptotic changes such as 
DNA fragmentation have been demonstrated to take place in the 
complete absence of extracellular Ca2+, suggesting that BEA triggers 
release of Ca2+ from internal Ca2+ stores. In fact, BEA has since been 
regarded as an apoptotic agent that releases Ca2+ exclusively from 
endoplasmic reticulum (Lin et al., 2005). Furthermore, BEA is a potent 
and specific cholesterol acyltransferase inhibitor in rat liver microsomes 
(Tomoda et al., 1992). The inhibition of cell proliferation by BEA 
exposure, was studied by several authors in rodent (Ferrer et al., 2009), 
monkey, porcine (Klaric et al., 2006), insect (Calò et al., 2003) and 
human cell lines (Ruiz et al., 2011; Lin et al., 2005; Meca et al., 2011) 
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utilizing several determinations techniques as the tetrazolium salt 
(MTT), the trypan blue dye exclusion, Alamar Blue, BrdU and 
sulforhodamine B (SRB) assays. 
 Fusaproliferin (FUS) is produced by two closely related species, 
Fusarium subglutinans and F. proliferatum (Ritieni et al., 1999). Both 
species are important pathogens of maize (Ritieni et al., 1999) and 
other economically important crop plants and may be isolated together 
from the same plant (Moretti et al., 2007). FUS is toxic to Artemia 
salina (Moretti et al., 2007; Tan et al., 2011), IARC/LCL 171 human B 
lymphocytes and SF-9 insect cells (Logrieco et al., 1996) and has 
teratogenic and pathogenic effects on chicken embryos (Ritieni et al., 
1997). The study of the bioavailability of the Fusarium mycotoxins 
including zearalenone (ZEA), fumonisins, ochratoxin A (OTA), 
deoxinivalenol (DON), aflatoxin B1 (AFB1), and enniatins (ENs) has been 
evaluated by many authors (Avantaggiato et al., 2003, 2004; Carolien et 
al., 2005; Videmann et al., 2008; Meca et al., 2012). These authors 
describes the applicability of an in vitro digestion models to measure 
the bioavailability of different mycotoxins contained in food matrices as 
an indicator of oral bioavailability. The aim of this study was to 
evaluate: (a) the cytotoxic effects of the BEA and FUS on Caco-2 and 
HT-29 cell lines, (b) the transepithelial transport and (c) the relative 
bioavailability utilizing the cell line Caco-2, that is, the validated 
international model used to study the intestinal absorption of the 
compounds contained in food. 
 
 
Resultados 
 
 
244 
 
2. Materials and methods 
2.1. Materials 
 Acetonitrile, methanol and ethyl acetate were purchased from 
Fisher Scientific (Madrid, Spain). Deionized water (<18 MΩ cm 
resistivity) was obtained from a Milli-Q water purification system 
(Millipore, Bedford, MA, USA). Chromatographic solvents and water 
were degassed for 20 min using a Branson 5200 (Branson Ultrasonic 
Corp., CT, USA) ultrasonic bath. BEA was purchased by Sigma (Sigma 
Co., St Louis, USA) and FUS, used in this study was produced and 
purified according to the method of Meca et al. (2009). The reagent 
grade chemicals and cell culture components used, Dulbecco’s modified 
Eagle’s medium (DMEM), penicillin, streptomycin, amphotericin B, 
HEPES, Thyazolil Blue Tetrazolium Bromide (MTT), non essential 
aminoacids (NEAA), Hank’s Buffered Salt Solution (HBSS), phosphate 
buffer saline (PBS), Sorensen’s glycine buffer, glucose and dimethyl 
sulfoxide (DMSO) were Sigma products (Sigma Co., St. Louis Mo. USA). 
Fetal calf serum (FCS) was from Cambrex Company (Belgium). 
2.2. Cells culture 
 HT-29 (ATCC HTB-38) and Caco-2 (ATCC HTB-37) cells from 
human epithelial colorectal adenocarcinoma were cultured in 
monolayer in 9 cm2 polystyrene tissue culture dishes with DMEM 
supplemented with 25 mM HEPES, 1% NEAA, 100 U/mL penicillin, 100 
mg/mL streptomycin, 2.5 μg/mL amphotericin B, and 10% heat 
inactivated FCS. Incubation conditions were pH 7.4, 37 °C and 5% CO2 in 
a 95% relative humidity atmosphere. 
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2.3. Cytotoxicity tests 
 Caco-2 and HT-29 cells were cultured into 96-well tissue-culture 
plates by adding 200 μL/well of a suspension of 2 x 104 cells/mL. After 
the cells reached 80% confluence, the culture medium was replaced 
with fresh medium containing BEA and FUS at concentrations ranging 
from 0.6 to 30 μM and incubated for 24 and 48 h at 37 °C. Cytotoxicity 
was determined by the MTT assay. The MTT assay determines the 
viability of cells by the reduction of yellow soluble tetrazolium salt 
(MTT); only in the metabolically active cells, via a mitochondrial-
dependent reaction to an insoluble purple formazan crystal. The MTT 
viability assay was performed as Ruiz et al. (2006). Briefly, after 
exposure to the ENs for 24 and 48 h, the medium containing ENs was 
removed and cells of each well received 50 μL of MTT. The plates were 
wrapped in foil and incubated for 4 h at 37 °C. After the incubation 
period the medium contained the MTT was removed, and the plate was 
washed with PBS. Two hundred microliters of DMSO were added in the 
plate followed by 25 μL of Sorensen’s glycine buffer. The absorbance 
was measured at 570 nm using an ELISA plate reader Multiscan EX 
(Thermo Scientific, MA, USA). The results were expressed in relative 
form to cell culture protein content. The IC50 values, the mean effective 
concentration, of test chemical that modifies each biomarker by 50% 
(positive or negative) in comparison with appropriate untreated 
controls, were determined with linear interpolation. 
2.4. Caco-2 intestinal transport 
 Caco-2 cells were seeded at 25 x 104 cells/cm2 on six-well 
Transwell Permeable Supports (Corning, NY, USA). Traswell insert (6-
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wells) were covered with a monolayer of Caco-2 cells at 37 °C. The 
medium was changed every 2 days, and the cells were allowed to grow 
and differentiate up to 21 days after reaching confluence (Hilgers et al., 
1990). After removal the growth medium from both sides of monolayers, 
the cells were preincubated at 37 °C for 10 min with HBSS–HEPES 
buffer. For this purpose, in the 6 wells permeable supports 1.5 mL of 
HBSS–HEPES buffer were added in the apical compartment and 0.5 mL of 
HBSS–HEPES were added in the basolateral compartment. After medium 
removal, medium containing BEA and FUS in the concentration of 1.5 
and 3.0 μM was added in the apical compartment and natural medium 
to the basolateral compartment (Fig. 1). The monolayers were 
incubated for 4 h at 37 °C. For transport measurements, aliquots of 
incubation medium were taken from the basolateral compartment at 
specified times and samples were collected for immediate analysis by 
direct injection (20 μL) in the liquid chromatography (LC) apparatus. 
2.5. BEA and FUS extraction from apical and basolateral 
compartment 
 BEA and FUS were extracted from the apical and basolateral 
compartment according to the method described by Ambrosino et al. 
(2004). In particular, 1 mL of each sample was dissolved in 3 mL of 
methanol and then filtered through 0.22 μm nylon filter purchased from 
Análisis Vínicos (Tomelloso, Spain). The samples were purified with a 
C18-E solid-phase extraction column (100 mg, Phenomenex, Torrance, 
CA) that had been preconditioned with 3 mL of methanol and 3 mL of 
water, and then eluted with 1 mL of methanol. The eluate was 
completely evaporated under nitrogen at 50 °C and reconstituted with 
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100 μL of methanol. Then, 20 μL of each extract was injected in the LC 
apparatus. The recovery of the extraction method was determined by 
spiking experiments. BEA (Sigma, St. Louis, MO) and FUS were added to 
a no contaminated transport medium in concentration variables from 
0.1 to 10 μM, and then extracted. The calculated recovery (mean ± 
relative standard deviation) of BEA and FUS from the artificially 
contaminated sample was up to 90.7%.  
2.6. BEA and FUS extraction from cells 
 BEA and FUS contained in the cells were determined according to 
Meca et al. (2010) as follows: cells were sonicated in a saline solution 
(0.90% NaCl, v/v) for 30 min. The pellet was suspended in 5 mL of saline 
solution, and 5 mL of ethyl acetate was added. After mixing with a 
vortex for 1 min and centrifuging (4000 rpm for 10 min at 4 °C, 
Centrifuge 5810R, Eppendorf, Germany), the upper layer, 5 mL 
approximately, was evaporated by a rotary evaporator (Buchi, 
Switzerland), resuspended in 1 mL of methanol and analyzed by 
injecting 20 μL into the LC apparatus. 
2.7. LC Analysis of BEA and FUS 
 LC analyses of BEA and FUS were performed using a Shimadzu LC 
system equipped with LC-10AD pumps and a diode array detector (DAD) 
from Shimadzu (Japan). A Gemini (150 x 4.6 mm, 5 μm, Phenomenex, 
Torrance CA) column was used. LC conditions were set up using a 
constant flow at 1.0 mL/min and acetonitrile–water (70:30 v/v) as 
starting eluent system. The starting ratio was kept constant for 5 min 
and then linearly modified to 90% acetonitrile in 10 min. After 1 min at 
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90% acetonitrile, the mobile phase was taken back to the starting 
conditions in four minutes. BEA was detected at 205 nm, and FUS at 261 
nm. Mycotoxin identification was performed by comparing retention 
times and UV spectra of purified extracted samples to pure standards. 
Quantitation of mycotoxins was carried out by comparing peak areas of 
investigated samples to the calibration curve of authentic standards. 
2.8. Statistical analysis 
 All experiments were performed three times. Statistical analysis 
was carried out using analysis of variance (ANOVA), followed by 
Dunnet’s multiple comparison tests. Differences were considered 
significant if p≤0.05. 
3. Results and discussions 
3.1. Cytotoxicity of BEA and FUS 
The results clearly indicated that only one of the mycotoxins object of 
this study have a cytotoxic effects on HT-29 and Caco-2 cells cells in a 
dose dependent manner as attested by the MTT assay (Fig. 2). 
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Figure 1. Graphical representation of the in vitro method utilized for 
the determination of beauvricin and fusaproliferin bioavailability.
*
  
 
 The IC50 evidenced by BEA in the Caco-2 cell line at 24 h of 
exposure was 20.62 ± 6.9 μM, whereas at 48 h exposure the IC50 
expressed by this mycotoxin was 12.75 ± 4.8 μM. On the HT-29 cell line 
the IC50 evidenced for BEA at 24 h was 15.00 ± 6.9 μM, and 9.75 ± 4.4 μM 
at 48 h of exposure. FUS did not showed IC50 values on the two cell line 
tested in the range of the concentration assayed. Tomoda et al. (1992) 
evidenced an IC50 of 11 μM for BEA in the cell line J774 (mouse 
                                                          
* BEA and FUS were introduced in the apical compartment, where Caco-2 cells 
were grown during 21 days on a 0.45 μM filter to simulate the duodenal 
intestinal epithelium. After 4 h incubation the determination of BEA and FUS 
was carried out in: (a) the apical compartment to determine the quantity of 
the mycotoxin no transported by the cells, (b) the basolateral compartment, to 
determinate the concentration of the two mycotoxins that was completely 
absorbed through the cells, that represent the quantity of the mycotoxin 
available to the human organism and (c) the cellular matrix, to evidence 
eventually, the concentration of the two mycotoxin internalized by cells. 
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macrophages) after 24 h of exposure. This data is comparable with the 
IC50 obtained in our study in the Caco-2 cells after 48 h of exposure. 
Similar results were obtained by Calò et al. (2003), that investigated the 
cytotoxicity of BEA on two human cell lines of myeloid origin: the 
monocytic lymphoma (U-937) cells and the promyelocytic leukemia (HL-
60) cells. The U-937 and HL-60 cells in stationary phase were exposed to 
BEA during 4 and 24 h of exposure, respectively. Results demonstrated 
that the viability of both typologies of cells was not affected by BEA at 
concentrations up to 3 μM, after 4 h exposure, whereas a steady decline 
was detected at higher concentrations. Similarly, after an exposure 
time of 24 h, a decline in viability was observed in cultures exposed to 
BEA at a concentration of 10 μM or higher. IC50 at 24 h of exposure was 
30 μM and 15 μM for U-937 cells and HL-60 cells, respectively. Jow et al. 
(2004) investigated the cytotoxic effect of BEA on the human leukemia 
cell line (CCRF-CEM) using the MTT assay, during 24 h. The IC50 value for 
BEA in CCRF-CEM cells was 2.46 μM. This cell line is 6.5-fold more 
sensible to the action of this mould secondary metabolite, respect at 
the cells employed in this study. Ferrer et al. (2009), evaluated the 
cytotoxicity of BEA on Chinese hamster ovary cell line (CHO-K1), by MTT 
and Neutral Red assays (NR) at 24 h of exposure. The IC50 value 
evidenced was 17.22 μM (NR assay) and 12.08 μM (MTT assay). The 
cytotoxicity of three Fusarium mycotoxins (beauvericin, deoxynivalenol 
and T-2 toxin) has been investigated using the NR assay, after 24, 48 
and 72 h of incubation by Ruiz et al. (2011). The IC50 values ranged from 
6.77 to 11.08 μM, 3.30 to 10.00 μM and 0.004 to 0.005 μM for 
beauvericin, deoxynivalenol and T-2 toxin, respectively. Few 
publications are available in the literature on the biological activity of 
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the FUS. In particular, the LC50 of FUS to brine shrimp, A. salina, is 53 
μM, and its CC50 (cytotoxic concentration 50%) to the lepidopteran 
Spodoptera frugiperda cell line (SF-9) and on the human nonneoplastic 
B-lymphocyte cell line IARC/LCL 171 are 70 and 55 μM, respectively 
(Logrieco et al., 1996). Moreover in a toxicity test with chicken 
embryos, FUS causes cephalic dichotomy, macrocephaly, and limb 
asymmetry when 1 or 5 mM pure FUS water/DMSO (38:62 v/v) solution 
was inoculated into the air sacs of the fertilized eggs (Ritieni et al., 
1997). 
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Figure 2. Effects of beauvericin on (a) Caco-2 and (b) HT-29 cell lines 
after 24 h (black line) and 48 h (gray line) of exposure. Viability was 
determinate by the MTT assay. (***) p ≤ 0.000, significantly different 
from the control.  
 
3.2. Transepithelial transport and bioavailability of BEA and FUS 
 Caco-2 cell monolayers were used in the design and development 
of a simulated in vitro gastrointestinal extraction model in order to 
assess the oral absorption of BEA and FUS. Unidirectional BEA and FUS 
transport was assessed from the apical to basolateral side of 
differentiated cell monolayers (Fig. 2). Transport efficiencies were 
*** 
*** 
*** 
a) 
b) 
*** 
*** 
*** 
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expressed as the percentage of BEA or FUS concentration initially 
loaded into the apical side and detected on the basolateral side at 
incubation of 1, 2, 3, and 4 h. Analytical LC chromatograms of the two 
mycotoxins present in the apical, basolateral side and retained inside 
cell monolayers are presented in the Figure 3 and Figure 4. The 
transport profiles of BEA and FUS, from the apical toward basolateral 
compartment are showed in the Table 1. As evidenced in Table 1, 
transepithelial transport of BEA during the four hour was lower than the 
absorption values evidenced by FUS. At the end of the absorption 
process the two mycotoxins were determinate also in the cellular matrix 
to know the eventually concentration of the BEA and FUS internalized 
by cells. As regards the FUS, this mycotoxin was not absorbed 
(internalized) by the cells in the range of concentration tested, 
whereas, as is possible to observe in Figure 5, during the assay carried 
out with 1.5 μM of BEA concentration, 0.50 ± 0.05 μM of it which 
represents the 33% of the mycotoxin added at the beginning of the 
experiment was detected in the cellular matrix. Similar concentration 
of BEA (0.44 ± 0.03 μM) were internalized by the cells, when the 
mycotoxin was used in the concentration of 3.0 μM, which represent the 
14.6% of the mycotoxin added (Fig. 5). The results obtained 
demonstrated that, the total quantity of FUS bioavailable absorbed 
resulted higher than the BEA considering the same mycotoxin 
concentrations added to the transwell plate. Moreover, as can be 
observed in Table 1, at 1.5 μM concentration, the quantities expressed 
in percentage of each mycotoxin absorbed is higher respect to the 
bioavailability value at 3.0 μM. This phenomenon can be related to 
many factors. BEA and FUS have a chemical structure very different, in 
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particular the presence of amino acids groups in the BEA lateral chain 
can be responsible of the internalization of this mycotoxin by Caco-2 
cells, or its interaction between the mycotoxin and some component of 
the cell membrane. Inversely, the terpenic structure of the FUS, and 
the absence of aminoacids group in the lateral chain can be responsible 
of the great bioavailability of this compound. On the other hand the 
molecular weight of the FUS is early the half of the molecular weight of 
the BEA, and considering that there is a directly correlation between 
low molecular weight and bioavailability of organic compounds 
(Fernández-García et al., 2009), this reason can be another explication 
of the different bioavailability values evidenced by the compounds 
evaluated in this study. The last aim of this study was to evaluate the 
bioavailability of BEA and FUS by an in vitro gastrointestinal model. 
More than a decade ago, Caco-2 cells grown on permeable supports 
were introduced as an experimental tool for mechanistic studies of 
intestinal drug transport. Caco-2 model is considered as a model to 
study passive drug absorption across the intestinal epithelium due to the 
good correlation obtained between data on oral absorption in humans 
and the results in Caco-2 model (Artursson and Karlsson, 1991). Several 
factors spurred the development of Caco-2 and similar cell models. 
Avantaggiato et al. (2003, 2004), evaluated the intestinal absorption of 
DON and nivalenol (NIV) in feed by an in vitro gastrointestinal model. 
During transit of the spiked feed through the gastrointestinal model, 
DON and NIV were simultaneously absorbed in the small intestinal 
compartments (jejunum and ileum). The intestinal absorption of DON 
was approximately 2.4 times higher than NIV both in the jejunal and in 
the ileal compartment, being 51% and 21% of the intake for DON and 
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NIV, respectively. The higher absorption of DON in comparison to NIV 
may be due to its higher hydrophobicity. Carolien et al. (2005) describes 
the applicability of an in vitro digestion model allowing the 
measurement of the bioaccessibility of ingested mycotoxins from food 
as an indicator of oral bioavailability. Bioaccessibility of AFB1 from 
peanut slurry and OTA from buckwheat was 94% and 100%, respectively. 
Videmann et al. (2008) studied the bioavailability and the transport of 
the mycotoxin ZEA in human intestinal Caco-2 cells, utilizing 
concentration of the toxin of 10 and 200 μM with an incubation time of 
8 h. The intestinal absorption of ZEA was of 40% respect at the initial 
concentration and early 10% lower than the mean value obtained with 
ENs in this study. 
 
Table 1. Transport profile of beauvericin and fusaproliferin in Caco-2 
cell monolayers after different incubation time. The values are 
expressed in percentage (%). 
Mycotoxin Concentration 
(μM) 
Transport profile (%) 
Incubation time (h) 
  1 2 3 4 
BEA 1.5 15.8±1.2 27.0±0.5 39.9±0.6 54.3±1.1 
 3.0 18.4±1.1 23.1±1.0 34.6±0.9 50.1±1.1 
FUS 1.5 25.5±1.2 38.2±1.0 71.9±1.1 83.2±0.8 
 3.0 22.1±0.7 36.5±1.5 69.3±0.9 80.2±1.0 
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Figure 3. LC–UV chromatograms of the beauvericin and fusaproliferin 
presents in (a) the apical compartment, (b) the cell matrix and (c) the 
basolateral compartment side of cell monolayers. 
 
BEA 
a) 
FUS 
BEA 
b) 
FUS 
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Figure 4. Bioavailability of beauvericin and fusaproliferin, added to the 
trans well plate at 1.5  and 3.0 μM concentration. Results are mean ± SD 
(n = 3). 
 
 
Figure 5. Beauvericin concentration detected inside Caco-2 cells at the 
end of the transepithelial transport process (mean ± SD of three 
independent experiments). 
 
4. Conclusions 
 Considering the data produced in this study it is possible to 
conclude that BEA and FUS showed cytotoxicity in Caco-2 cells at all 
time of exposure tested. The data evidenced in this study demonstrated 
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that the intake of food contaminated by these bioactive compounds can 
represent a potential risk for the human health. 
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ABSTRACT  
Fusarotoxins enniatins (ENs) can represent a potential risk as natural  
contaminants of cereal commodities. However, only their bioaccessible 
fraction can exert a toxicity. The purpose of this study was to 
determine the ENs A, A1, B, and B1 bioaccessibility added in 1.5 and 3.0 
μmol/g concentrations in breakfast cereals, cookies, and breads using a 
simulated in vitro gastrointestinal extraction model. Bioaccessibility 
values ranged between 40.4 ± 1.9 and 79.9 ± 2.8%. The lower values 
were 50.1, 40.4, 43.9, and 46.3% in wheat bran with fibers, and the 
higher values were 79.9, 64.2, 69.8, and 73.6% in white loaf bread for 
the ENs A, A1, B, and B1, respectively. Food composition, compounds 
structure, and presence of natural adsorbing materials can influence the 
ENs bioaccessibility. Application of a simulated in vitro gastrointestinal 
method is a good procedure to assess oral ENs bioaccessibility in 
cookies, breakfast cereals, and bread. 
Keywords: enniatins, bioaccessibility, in vitro gastrointestinal model, 
HPLC 
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1. Introduction  
 The Food and Agriculture Organization (FAO) estimates that as 
much as 25% of the world’s animal feedstuffs is contaminated by some 
extent by mycotoxins (FAO, 2004). Any step of the food production 
chain is susceptible to mold and mycotoxins contamination: before 
harvesting, between harvesting and drying, and during storage. 
Furthermore, they are persistent in the final products (Bullerman and 
Bianchini, 2007). The co-occurrence of mycotoxins in a food matrix is 
also common (Santini et al., 2012). The most common pathogen of 
maize, grain, and small grain in temperate regions of the world is 
Fusarium spp., whose strains may produce cyclic hexadepsipeptidic 
secondary metabolites such as enniatins (ENs). ENs are composed of 
three alternating D-α-hydroxyisovaleryl and three N-methyl-L-amino 
acid residues. They possess antimicrobial, insecticidal, phytotoxic, and 
cytotoxic properties (Jestoi, 2008) and inhibit cholesterol 
acyltransferase (Tomoda et al., 1992). The large array of biological 
activities can be related to their ionophoric properties based on the 
ability to incorporate into cell membranes forming cation-selective 
pores with high affinity for K+, Mg2+, Ca2+, and Na+ (Kamyar et al., 2004). 
Their occurrences have been amply demonstrated (Jestoi et al., 2004; 
Uhlig et al., 2006; Meca et al., 2010a, Oueslati et al., 2011) but the 
potential risk related to the ingestion of contaminated commodities is 
still not clear. The most important exposure routes for human and 
animals for ENs are via oral ingestion. It is therefore important to be 
able to assess the amount of ENs that is potentially available for 
absorption in the stomach and/or intestines, that is, bioaccessible, or to 
be excreted. However, the total amount of ENs ingested (intake) does 
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not always reflect the bioaccessible amount of them. The 
bioaccessibility describes the fraction of a contaminant, that is 
mobilized from food matrices during gastrointestinal digestion and 
theoretically subsequently available to intestinal absorption 
(Versanvoort et al., 2005). So, to study the oral bioaccessibility as part 
of an overall estimation in assessing the chemical risk coming from 
food-borne ENs is an important issue. Because of this, during the past 
decade, there has been an increasing interest in the use of in vitro 
methodologies, such as in vitro digestion models that simulate, in a 
simplified manner, the human digestion process in the mouth, stomach, 
and small intestine, to enable bioaccessibility investigations of 
contaminants from their food matrix during transit in the 
gastrointestinal tract (Versanvoort et al., 2005; Avantaggiato et al., 
2004). These in vitro models attempt to recreate the aspects of human 
gastrointestinal physiology, such as chemical composition of digestive 
fluids, pH, and residence time periods typical for each compartment 
(Versanvoort et al., 2005). Moreover, these in vitro models are simple, 
rapid, low-cost, and without ethical implications, although a number of 
comparative studies have suggested that bioaccessibility results are 
largely dependent on the specific in vitro conditions used, including 
differences in solid solution ration, the method of mixing, the pH values 
of the gastric and intestinal juices and their compositions, food 
contaminants, and food matrices (Hur et al., 2011). Previous studies 
focused on determining the bioaccessible part of several mycotoxins 
after simulated human gastrointestinal extraction, confirming the 
usefulness of these in vitro methodologies to predict intestinal 
absorption of mycotoxins (Versanvoort et al., 2005; Avantaggiato et al., 
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2003; Avantaggiato et al., 2004). Versanvoort et al. (2005) used a 
simplified digestion process of three steps, where physiologically based 
conditions of the mouth, stomach, and small intestine were applied.  
 The aims of the present study were (1) to apply an in vitro 
gastrointestinal model as it is related to the human digestive system; 
(2) to determine the bioaccessibility of ENs A, A1, B, and B1 from 
artificially spiked grain-based products (specifically breakfast cereals, 
cookies, and breads) by using the in vitro gastrointestinal model; and 
(3) to finally appreciate the role of oral bioaccessibility in assessing EN 
risks to human. 
2. Matherials and methods  
2.1 Materials and Reagents  
 Methanol, acetonitrile, and ethyl acetate were purchased from 
Fisher Scientific (Madrid, Spain). Deionized water (<18 MΩ cm 
resistivity) was obtained from a Milli-Q water purification system 
(Millipore, Bedford, MA). Chromatographic solvents and water were 
degassed for 20 min using a Branson 5200 (Branson Ultrasonic Corp., CT) 
ultrasonic bath. Potassium chloride (KCl), potassium thiocyanate 
(KSCN), monosodium phosphate (NaH2PO4), sodium sulfate (Na2SO4), 
sodium chloride (NaCl), sodium bicarbonate (NaHCO3), urea, α-amilase, 
hydrochloric acid (HCl), pepsin, pancreatin, and bile salts were 
obtained from Sigma-Aldrich (Madrid, Spain). The ENs (A, A1, B, and B1) 
utilized in this study were produced and purified in our laboratory 
following the method of Meca et al. (2009) for the production of the 
fusaproliferin. All ENs were >97% purity. They were stored at 4 °C in 
methanol, protected from light.  
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2.2 Samples  
 Fourteen samples of grain-based products were collected from 
Spanish food markets and stored at 4 °C until analysis. Some types of 
cookies, breads, and breakfast cereals, free from contamination, as 
determined previously, have been chosen for this study: 
• Four types of cookies: cookie with chocolate, cookie with fibers, 
cookie with oat, and cookie without fibers. 
• Five types of bread: integral loaf bread, integral loaf bread without 
sugar, milk bread, multicereals loaf bread, and white loaf bread. 
• Five types of breakfast cereals: corn flakes, muesli with fruits, 
wheat bran with fibers, wheat with chocolate, and wheat with 
honey. 
 Samples (3 g) were spiked with EN A, A1, B, and B1 at final 
concentrations of 1.5 and 3.0 μmol/g and left in darkness overnight to 
allow methanol evaporation. Detailed types and the nutritional 
compositions of the above-mentioned samples are shown in Table 1. 
 
 
 
 
 
 
 
Resultados 
 
 
268 
 
Table 1. Nutrients nutritional properties of the analyzed samples 
referred to 100 g of product (as reported in nutritional labels). 
Sample Fiber (g) Fat (g) Carbohydrates (g) Protein (g) 
Cookie with chocolate 5.6 23.0 57.7 5.4 
Cookie with fibers 3.0 11.5 68.2 9.0 
Cookie with oats 4.3 19.2 60.3 7.6 
Cookie without fibers 5.1 12.8 62.5 9.6 
Corn flakes 3.0 0.7 74.5 8.0 
Integral loaf bread 5.0 3.5 36.4 10.0 
Integral loaf bread 
without sugars 
5.0 3.0 37.3 11.0 
Milk bread 2.0 15.0 22.7 10.0 
Multicereals loaf bread 6.0 5.5 36.4 11.0 
Muesli with fruits 6.4 16.3 57.8 8.1 
Wheat bran with fibers 24.0 3.5 45.5 13.5 
Wheat with chocolate 6.0 3.0 68.2 9.0 
Wheat with honey 5.3 1.7 67.3 8.6 
White loaf bread 3.0 3.0 41.8 9.0 
 
2.3 In Vitro gastrointestinal model 
 An in vitro gastrointestinal procedure was adapted from the 
method developed previously by Gil-Izquierdo et al. (2002) with slight 
modifications. The method consists of three sequential steps: first an 
initial saliva addition to simulate the mouth compartment. The mouth is 
the point where the process of mechanical grinding of foodstuffs takes 
place at a pH of 6.5. The pH was adjusted with 0.1 N HCl. In this step, 3 
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g of sample spiked with ENs (A, A1, B, and B1) at 1.5 and 3.0 μmol/g was 
mixed with 6 mL of artificial saliva (composed of 89.6 g/L KCl, 20.0 g/L 
KSCN, 88.8 g/L NaH2PO4, 57.0 g/L NaSO4, 175.3 g/L NaCl, 84.7 g/L 
NaHCO3, 25.0 g/L urea, and 290.0 mg of α-amilase). The mixture was 
put in a plastic bag, containing 40 mL of water, and was homogenized 
by a Stomacher IUL Instruments (Barcelona, Spain) for 30 s. Larger 
components were broken down into smaller fragments, thereby 
increasing the surface area of food particles for swallowing and 
digestion. The second step consisted of pepsin/HCl digestion to simulate 
the hydrochloric acid environment of the stomach (pH 1−5). The 
presence of pepsine acts to breakdown protein, thereby aiding 
dissolution of the foodstuffs. For this purpose, 0.5 g of pepsin (14,800 
U) prepared in 0.1 HCl was added to the mixture, and the pH was 
adjusted to 2.0. The mixture was incubated at 37 °C in an orbital shaker 
(Infors AG CH-4103, Bottmingen, Switzerland) at 250 rpm for 2 h. The 
last step was the digestion in the small intestine(s) by intestinal juices 
composed of enzymes (trypsin, pancreatin, and amylase), bile salts, and 
bicarbonate. The breakdown of food in the small intestine(s) means that 
the components are more amenable to absorption. The enzymes used in 
intestinal juice were pancreatin (8 mg/mL) and bile salts (50 mg/mL) in 
a 1:1 (v/v) solution ratio; the pH of intestinal juice was adjusted to 6.5 
with 0.5 N NaHCO3 (0.5 N); the mixture was incubated for 2 h at 37 °C 
in an orbital shaker (250 rpm). Immediately, aliquots of 30 mL of the 
mixture were centrifuged (Centrifuge 5810R, Eppendorf, Germany) at 
4000 rpm and 4 °C for 1 h, and the ENs present in the saliva/pepsin/HCl 
and pancreatin−bile digestions were extracted and analyzed by high-
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performance liquid chromatography−diode array detection (HPLC-DAD), 
as described by Meca et al. (2010b). 
2.4 Analysis of ENs  
 The extraction of ENs (A, A1, B, and B1) contained in 
gastroduodenal fluids were carried out as Meca et al. (2012a). Briefly, 
5mL of each mixture obtained as previously described was put in a 20 
mL test tube and extracted three times with 5 mL of ethyl acetate 
utilizing a vortex VWR international (Barcelona, Spain) for 1 min and 
centrifuged (Centrifuge 5810R, Eppendorf, Germany) at 4000 rpm and 4 
°C for 10 min. After the organic phase was completely evaporated in a 
rotary evaporator (Buchi, Switzerland), the residues were dissolved in 1 
mL of methanol and analyzed by LC-DAD. All samples were filtered 
through a 0.22 μm syringe filter Phenomenex prior to injection (20 μL) 
into the column.  
 LC-10AD pumps and a DAD detector Shimadzu (Japan) were used 
to perform HPLC analysis of ENs. LC separation was carried out on a 
Gemini (150 mm × 4.6 mm, 5 μm) analytical column Phenomenex 
(Madrid, Spain). The analytical separation was performed using gradient 
elution with water as mobile phase A and acetonitrile as mobile phase 
B. After an isocratic step of 70% B for 5 min, the gradient was linearly 
modified to 90% B in 10 min. After 1 min, the mobile phase was taken 
back to the starting conditions in 4 min. The flow rate was maintained 
at 1.0 mL/min. ENs were detected at 205 nm. EN identification was 
performed by comparing retention times and UV spectra of purified 
samples to pure standards. A further confirmation was performed by 
coinjecting pure standards together with each sample. Quantification of 
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ENs was carried out by comparing peak areas of investigated samples to 
the calibration curve of the standards. Recovery (%) studies in intestinal 
fluid were performed during routine analysis by spiking the samples with 
standard solutions of each ENs at 1.5 and 3.0 μmol/g concentrations.  
2.5 Method validation 
 The analytical method was validated according to the European 
Directive 2002/26/EC for methods of analysis of mycotoxins in 
foodstuffs (EC, 2002). Recovery experiments were carried out on 
fortified intestinal fluid (free from contamination) (n = 5) by spiking ENs 
A, A1, B, and B1 at a level ranging from 0.3 to 50 μg/g. Mean recoveries 
(%) were as follows: 88.6 ± 2.4, 84.2 ± 4.3, 86.6 ± 2.7, and 89.5 ± 3.1% 
for EN A, A1, B, and B1, respectively. Interday variation values (through 
five different days) ranged from 1.8 to 3.1%. Intraday variation values 
were in the range of 6.4−10.1%. These values did not exceed 15%, which 
is the maximum variation for certification exercises for several 
mycotoxins. The detection limits (LOD) and the limit of quantification 
(LOQ) values were calculated according to s/n = 3 and s/n = 10, 
respectively. The LODs obtained for EN A, A1, B, and B1 were 215, 140, 
145, and 165 μg/kg, respectively, whereas the LOQs were 600 μg/kg for 
EN A, 400 μg/kg for ENs A1 and B, and 500 μg/kg for EN B1.  
2.6 Statistical Analysis 
 Statistical analysis of data was carried out using the PSAW 
Statistic 19.0 (SPSS, Chicago, IL) statistical software package. Data were 
expressed as means ± SDs of three independent experiments. The 
statistical analysis of the results was performed by Student’s t test for 
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paired samples. Differences between mycotoxins were analyzed 
statistically with analysis of variance (ANOVA) followed by the Tukey’s 
HDS posthoc test for multiple comparisons. The level of p ≤ 0.05 was 
considered statistically significant.  
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Table 2. Bioaccessibility (%) of the ENs A, A1, B and B1, spiked with 1.5 and 3.0 µM concentration in 
different breakfast cereals, cookies and breads digested by an in vitro simulated gastrointestinal model*.  
 Bioaccesibility (%) 
Sample EN A (µM) EN A1 (µM) EN B (µM) EN B1 (µM) 
 1.5 3.0 1.5 3.0 1.5 3.0 1.5 3.0 
Cookie with 
chocolate 59.2±2.7 a,1 55.3±2.7 a,1 47.8±2.9 b,1 44.6±2.4 b,1 52.0±2.9 b,1 48.5±2.5 b,1 54.7±2.6 a,1 51.1±2.5 a,b,1 
Cookie with 
fibbers 64.4±3.1 a,2 66.6±2.2 a,2 52.0±2.1 b,1 51.9±2.8 b,2 56.5±2.8 c,1,2 56.4±2.9 c,2 59.5±2.8 c,1 59.4±2.7 c,2 
Cookie with 
oats 55.2±3.5 a,1,5 52.2±2.6 a,1 44.6±3.3 b,2 46.8±3.1 b,1,2 48.4±3.1 a,b,1 51.1±2.2 a,b,1,3 51.0±3.3 a,b,1 53.8±3.3 a,1,2 
Cookie 
without 
fibbers 72.0±3.3 a,3 70.7±2.5 a,2 58.2±3.1 b,3 57.1±2.4 b,3 63.2±2.9 c,2 62.1±2.6 b,c,4 66.6±3.1 a,c,2 65.4±3.1 c,3 
Corn flakes 
72.1±3.4 a,3 70.7±3.3 a,2,3 58.2±2.2 b,3 57.1±3.1 b,3 63.3±2.1 c,2 62.0±3.2 b,c,4 66.6±2.6 a,c,2 65.4±3.4 c,3 
Integral loaf 
bread 72.2±2.3 a,3 71.6±2.9 a,2,3 58.3±2.2 b,3 57.5±3.4 b,3 63.4±3.2 c,2 62.5±2.1 c,4 66.7±3.5 c,2 65.8±3.4 c,3 
Integral loaf 
bread 
without 
sugars 72.2±2.1 a,3 71.8±3.3 a,2,3 58.3±2.6 b,3 58.0±2.4 b,3 63.3±3.3 c,2 63.0±2.7 c,4 66.7±3.7 c,2 66.4±3.1 c,3,4 
Milk bread 
62.1±3.1 a,2 57.6±2.1 b,1 50.6±2.3 c,1 46.1±2.1 d,1,2 55.0±2.2 b,1 50.2±3.3 c,d,1 57.9±2.1 b,1 52.8±3.2 b,c,d,1 
Multicereals 
loaf bread 75.0±2.8 a,3,4 70.0±3.1 b,2 60.3±2.7 c,3 56.9±2.1 c,3 65.1±3.5 d,2 61.9±2.4 c,4 69.1±2.8 b,2,3 65.2±2.7 b,c,d,3 
Muesli with 
fruits 64.2±2.6 a,2 66.6±2.2 a,2 62.9±1.7 a,3 62.1±2.5 a,4 68.3±3.3 a,2 67.6±3.2 a,4 72.0±3.2 a,2,3 71.1±2.2 a,3 
Wheat bran 
with fibbers 50.1±3.1 a,5 52.2±3.1 a,1 40.4±1.9 b,2 47.0±2.7 a,1 43.9±3.4 a,b,3 51.1±3.4 a,1 46.3±3.1 a,4 53.8±3.1 a,1,2 
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Bioaccesibility (%) 
Sample EN A (µM) EN A1 (µM) EN B (µM) EN B1 (µM) 
 
1.5 3.0 1.5 3.0 1.5 3.0 1.5 3.0 
Wheat with 
chocolate 70.2±2.4 a,3 67.1±1.9 a,2 62.0±1.8 b,3 57.2±2.2 c,3 67.4±3.1 a,2 62.1±2.1 b,4 71.0±3.3 a,2,3 
65.5±3.2 
a,b,3 
Wheat with 
honey 76.0±2.1 a,3,4 70.0±3.8 b,2,3 61.3±2.4 c,3 56.3±3.3 d,3 66.6±2.7 b,2 61.5±2.3 c,4 70.2±2.4 b,2,3 64.8±2.2 b,3 
White loaf 
bread 79.9±2.8 a,4 76.9±3.4 a,3 64.2±2.4 b,3 58.1±2.2 c,3 69.8±2.9 d,2 64.1±3.1 b,3,4 73.6±2.2 d,3 
67.5±3.3 
b,d,3,4 
 
* Values are expressed as mean ± SD (n=4). The significance of the differences between each ENs and each 
food samples was assayed by on-way ANOVA followed by Tukey test for multiple comparisons. a,b,c,d Within a 
line, values with different letters are significantly different (p ≤ 0.05). 1,2,3,4,5 Within a column, values with 
different number are significantly different (p ≤ 0.05). Control values (%) obtained from the experiments of 
the analytical method: EN A (88.6 ± 2.4%), EN A1 (84.2 ± 4.3%), EN B (, 86.6 ± 2.7%) and EN B1 (89.5 ± 3.1%). 
All EN extracted from food samples were statistically different (p ≤ 0.05) from the respective control. 
Table 2. Continued.  
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3. Results and Discussion  
 Results obtained after the application of the in vitro 
gastrointestinal method for determining ENs bioaccessibility in different 
breakfast cereals, cookies, and breads are shown in Table 2. 
Bioaccessibility values were from 50.1 ± 3.1 to 79.9 ± 2.8% for EN A, 
from 40.4 ± 1.9 to 64.2 ± 2.4% for EN A1, from 43.9± 3.4 to 69.8 ± 2.9% 
for EN B, and from 46.3 ±3.1 to 73.6 ± 2.2% for EN B1. As shown in Table 
2, the bioaccessibility of ENs was statistically significant (p≤0.05) from 
their respective controls.  
 Concerning EN A, the mean bioaccessibility value added at 1.5 
and 3.0 μmol/g concentrations in the commercial samples was similar, 
that is, 67.5 ± 2.7 and 65.7 ± 2.8%, respectively (Table 2). Regarding EN 
A1 spiked at 1.5 and 3.0 μmol/g, the mean bioaccessibility obtained was 
55.7 ± 2.2 and 54.1 ± 2.7%, respectively (Table 2). As can be observed in 
Table 2, the ENs of the B group, the mean bioaccessibility values 
obtained for the EN B were also comparable between 1.5 μmol/g of EN 
B added (60.4 ± 2.6%) and 3.0 μmol/g of EN B added (58.9 ± 2.9%). 
However, when samples were spiked with EN B1 at 1.5 and 3.0 μmol/g, 
the mean bioaccessibility value that resulted was significantly different. 
These values were 67.3 ± 2.7 (1.5 μmol/g of EN B1) and 62.0±2.5% (3.0 
μmol/g of EN B1). The order of mean values obtained when mycotoxins 
had been spiked at 1.5 μmol/g was as follows: 67.5 ± 2.7% (EN A) = 67.3 
± 2.7% (EN B1) > 60.4 ± 2.6% (EN B) > 55.6 ± 2.2% (EN A1). When 
mycotoxins had been spiked at 3.0 μmol/g, the order of mean values 
obtained was 65.6 ± 2.8% (EN A) = 62.0 ± 2.5% (EN B1) = 58.9 ± 2.9% (EN 
B) > 54.0 ± 2.7% (EN A1). The wheat bran with fibers was the type of 
sample that showed the minimum bioaccessibility values for all of the 
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ENs tested, ranging from 40.4 ± 1.9 for EN A1 to 50.1 ± 3.1% for EN A 
(Table 2). In the same way, the wheat loaf bread showed high 
bioaccessibility values for all ENs tested (Table 2). For this type of 
sample, the higher values were observed for EN A. 
 Results show that not the total amount of mycotoxins ingested is 
available to intestinal absorption. The reduction in recoveries could be 
related to the digestion process and the use of different pH values that 
can reduce mycotoxins levels as stated for aflatoxin (Karaka and Nas, 
2009). Moreover, according to Versanvoort et al. (2005) it is possible 
that bioaccessibility may be underestimated because of a compound 
saturation that can occur in the chyme, a situation not possible in vivo 
where a compound, when it is released from the food matrix, is 
transported across the intestinal epithelium into the body, keeping the 
compound concentration low in the chyme.  
 Considering the mean recoveries (%) of ENs tested (Table 2) and 
the recoveries (%) obtained from method validation (section 2.5), it is 
possible to observe that with the in vitro-simulated gastrointestinal 
extraction method, the initial bioactive EN concentrations present in 
the 14 sample analysis have been reduced statistically significant (F3,92 
= 13.98, p≤0.001, Table 2) of 35% for EN A1, followed by EN B1 with a 
reduction of 25−31%, EN B of 31%, and EN A of 25% (p≤0.05) as compared 
to the extraction of ENs in the control. Differences in bioaccessibility 
(%) can be related to the structure of ENs. ENs are compounds with a 
cyclic aminoacidic structure, differentiated by the presence in the 
lateral chain of methyl, ethyl, propyl, and butyl groups (Figure 1). The 
presence of these groups can be responsible for the difference in the 
absorption of these compounds (Tedjiotsop Feudjio et al., 2010).  
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Enniatin R1 R2 R3 
A CH(CH3)CH2CH3 CH(CH3)CH2CH3  CH(CH3)CH2CH3 
A1  CH(CH3)CH2CH3 CH(CH3)CH2CH3  CH(CH3)2 
B CH(CH3)2 CH(CH3)2 CH(CH3)2 
B1 CH(CH3)2 CH(CH3)2 CH(CH3)CH2CH3 
Figure 1. Enniatins chemical structures. 
  
 It has been reported that mycotoxins bioaccessibility could 
depend on several factors, such as chemical structure, food 
composition, pH used in the in vitro digestion process, and food 
matrices (Kabak et al., 2009; Karaka and Nas, 2009). Differences in 
bioaccessibility (%) shown in Table 2 also could be explained by the food 
composition of samples. Previous studies had demonstrated that the 
bioaccessibility of nutrients, as well as toxic compounds, can be 
affected by the food matrix (Hornero-Ménedez et al., 2007; Vitali et al., 
2008). In this case, the amount and type of fibers (Table 1) could be 
responsible as natural absorbing materials. In cereal-based foods, there 
are normally some natural compounds, such as dietary fibers, that could 
combine some bioactive compounds as mycotoxins or polyphenols, 
reducing their percent of bioaccessibility (Harris et al., 1998; Harrington 
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et al., 2001). In Table 1 is shown fiber, fat, carbohydrates, and protein 
compositions of each product. The sample white loaf bread, where 
higher bioaccessibility values were obtained (Table 2), is one of the 
lowest fiber contents (3 g/100 g of product), whereas wheat bran with 
fibers, where the lower bioaccessibility values were observed, is the 
highest fiber contents (24 g/100 g of product) sample. As can be 
observed, the bioaccesibility from wheat bran with fibers was 
statistically significantly (F3,92 = 14.30, p≤0.001, Table 2) for ENs A, A1, 
B, and B1 with respect to those in the white loaf bread. For wheat bran 
with fibers, the bioaccessibility of all ENs spiked at 1.5 μmol/g 
concentration is 1.6-fold higher than those obtained in white loaf bread. 
In the case of mycotoxins, the inclusion of dietary fibers has been 
demonstrated to protect against toxicoses resulting from numerous 
xenobiotic compounds and can be applied in food and feed as a cost-
effective method to detoxify them from mycotoxins (Kabak et al., 2006; 
Aoudia et al., 2008).  
 Nevertheless, the bioaccessibility of mycotoxins can be affected 
by interactions with other food components. Mycotoxins can bind food 
matrix components, mainly proteins and lipids, and be released by in 
vitro digestion as previously determined for other mycotoxins (Dall’Asta 
et al., 2010). As can be observed in Table 2, for all ENs at both 
concentrations tested, low recovery values can be found in cookies with 
chocolate and cookies with oats that are both nutritionally rich in lipid 
components with the highest percentages of fat, with 23.0 g/100 g of 
sample and 19.2 g/100 g of sample, respectively. When comparing the 
sample with a lower proportion of fat (corn flakes) to the samples with 
the highest (cookies with chocolate or with oats), the bioaccessibility 
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for those samples with high fat content was statistically significantly 
(F3,22 = 3.92, p≤0.01) for ENs A, A1, B, and B1 with respect to those 
with a low fat content. The bioaccessibility in corn flakes spiked at 1.5 
μmol/g concentration of all ENs was 1.3-fold higher than those obtained 
in cookies with chocolate or with oats. It could be assumed that ENs 
interacting with the fat components of food are not released totally 
since the in vitro gastrointestinal digestion characteristics (such as the 
time period that food may spend in each step and the chemical 
composition of saliva, gastric juice, duodenal juice, and bile juice) are 
kept constant for all samples analyzed, even if the fat content is not 
the same (Hur et al., 2011). Moreover, considering their 
physical−chemical properties, it could be possible to hypothesize that 
ENs are retained in lipid/bile micelles (Xing et al., 2008).  
 The same ENs bioaccessibility was evaluated by Meca et al. 
(2012a) in artificially contaminated (1.5 and 3.0 μmol/g) wheat crispy 
bread after applying an in vitro-simulated gastric and duodenal 
digestion. The amount (%) of all mycotoxins tested contained ranged 
from 69.0 ± 2.1 to 91 ± 1.1% in gastric fluid and from 68.6 ± 2.9 to 87.3 
± 2.9% in duodenal fluid, considering both spiking concentrations. ENs 
bioaccessibility values obtained from our study were slightly lower to 
those obtained by Meca et al. (2012a). Moreover, in our study, only ENs 
recovered in gastrointestinal fluids obtained after simulated digestion 
have been taken into account since in vivo food digestion and 
absorption mainly take place in the small intestine (Oomen et al., 
2002). However, as obtained in our study, EN A, spiked at 3.0 μmol/g, 
was the most bioaccessible mycotoxins as in the gastric fluid (91.0 ± 
1.2%), as in duodenal fluid (87.3 ± 2.9%). EN A1, considering both spiking 
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concentrations, was the lowest bioaccessible mycotoxins concerning the 
gastric fluid (69.0 ± 2.1 and 73.0 ± 2.3% for 1.5 and 3.0 μmol/g spiking, 
respectively), whereas concerning duodenal fluid, the lowest values 
were obtained for EN B spiked at 1.5 μmol/g (68.6 ±2.9%) and EN A1 
spiked at 3.0 μmol/g (70.0 ± 1.7%). Concerning other Fusarium toxins, it 
was shown that higher values of 92.6 ± 1.2 and 90 ± 1.3% of cyclic 
hexadepsipeptidic beauvericin (BEA) intake through artificially 
contaminated wheat (5 and 25 mg/L, respectively) were released from 
the food matrix to the bioaccessible fraction by the same in vitro 
digestion method as used in our study (Meca et al., 2012b). 
 The bioaccessibility of the trichothecenes deoxynivalenol (DON) 
was determined from dried pasta samples applying an in vitro digestion 
model both for adults and for children. The children’s digestion model 
was basically the same as that of adults with slight modifications (the 
pH of the stomach was 3.0, the quantity of pepsin used for the gastric 
digestion was 0.02 g, and the amounts of pancreatin and bile salts were 
0.0005 and 0.03 g, respectively). Referring to values obtained from our 
study, lower bioaccessibility values were obtained since the DON 
percentages in the gastric fluid ranged from 2.12 to 41.5%, while after 
the duodenal process, they ranged from 1.1 to 24.1% (Raiola et al., 
2012). Avantaggiato et al. (2003; 2004) studied the intestinal absorption 
of zearalenone (ZEA), nivalenol (NIV), and DON using an in vitro 
gastrointestinal model that simulates the metabolic processes of the 
gastrointestinal tract of healthy pigs. This model avoided the use of 
animals simulating in vivo experiments by its multicompartimental 
dynamic computer-controlled system. Approximately 32% of ZEA intake 
through artificially contaminated wheat (4.1 mg/kg) was released from 
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the food matrix to the bioaccessible fraction during 6 h of digestion, 
and it was rapidly absorbed at the intestinal level. The intestinal 
absorptions recorded using the same model were 51 and 21% for DON 
and NIV ingested through spiked wheat samples, respectively. Later 
intestinal absorption of 105% for FB1, 89% for FB2, 87% for OTA, 74% for 
DON, 44% for AFB1, and 25% for ZEA were determined by the same 
laboratory model (Avantaggiato et al., 2007).  
 Similarly, Versanvoort et al (2005) demostrated the 
bioaccessibility obtained for AFB1 (94%) and OTA (100%) from peanuts 
and buckwheat. They evidenced that these mycotoxins were released 
from the food matrix during the simulated in vitro model toward the 
intestinal fluid (Versanvoort et al., 2005).  However, these results were 
partly in contrast with Kabak et al. (2009) who studied the 
bioaccessibility by the in vitro digestion model of AFB1 and OTA from 
different food products. They found similar bioaccessibility values for 
AFB1 (90%), but different values for OTA (30%).  
 The results obtained from this study and in the literature 
concerning in vitro digestion methods are unlikely comparable. 
Differences in the types of in vitro methods, operating procedures, pH 
used, mycotoxins structures, and food compositions could contribute to 
differences in bioaccessibility. The last factor aforementioned can 
affect the bioaccessibility of ENs since they could build up complexes 
with food components (Baert et al., 2007; Zhou et al., 2008; Ortega et 
al., 2011).  However, evidence of a strong correlation between in vitro 
bioaccessibility and in vivo bioavailability data has been observed 
previously for different mycotoxins (Versanvoort et al., 2005) although 
no in vivo data are still available about ENs bioaccessibility. Therefore, 
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for this purpose, more quantitative data are required. Further research 
should be performed to ensure that in vitro data are in agreement with 
in vivo methods for ENs present in food samples. In this way, 
bioaccessibility data obtained by the in vitro models proposed in this 
study can be incorporated to the whole data related to the cytotoxicity 
of mycotoxins in the literature and contribute to the risk assessment for 
Fusarium mycotoxins present in food and feed ENs A, A1, B, and B1. 
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4. DISCUSIÓN GENERAL 
 La citotoxicidad de las micotoxinas de Fusarium BEA, ENs A, A1, 
B y B1 se evaluó en las líneas celulares Caco-2 y HT-29, de origen 
humano, y en las células CHO-K1, de origen animal. Asimismo, ya que su 
toxicidad puede aumentar cuando se encuentran simultáneamente y su 
posible interacción puede llevar a efectos sinérgicos, aditivos o 
antagónicos, se evaluaron los efectos de las combinaciones sobre la 
viabilidad celular en células Caco-2 y a los datos obtenidos se aplicó un 
método matemático para evaluar el tipo de interacción. Considerando 
el efecto citotóxico obtenido tras la exposición de las líneas celulares a 
las micotoxinas de forma individual y combinada, se evaluó su 
biodisponibilidad a través del uso de las células Caco-2, ya que para 
ejercer su acción tóxica tienen que ser biodisponible. Con el objetivo de 
conocer los mecanismos de toxicidad de las micotoxinas se estudió el 
estrés oxidativo mediante la generación de especies reactivas del 
oxígeno (ROS) y la peroxidación lipídica (LPO) tras la exposición a las 
mismas de las células Caco-2.  
 Teniendo en cuenta el incremento de LPO y ROS producido por 
las micotoxinas en células Caco-2 tras 24 h de exposición, el siguiente 
objetivo fue determinar el papel de los sistemas de defensa celular en 
al detoxificación de las micotoxinas. Para ello se estudian el papel del 
glutatión (GSH) considerado el antioxidante celular más importante en 
los sistemas biológicos y el papel de antioxidantes ingeridos a través de 
la dieta. En este último caso, se ensayan 4 polifenoles (quercetina, 
quercetina-3-β-d-glucósido, miricetina) y un estilbeno (t-pterostilbeno).  
Confirmando el papel de las micotoxinas en el estrés oxidativo el 
siguiente objetivo que se planteó fue evaluar los efectos toxicológicos a 
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través de la evaluación de posibles alteraciones del ciclo celular, 
inducción de apoptosis y necrosis, alteración del potencial de 
membrana mitocondrial (ΔΨm) y daño a nivel del DNA en células Caco-
2. Por último, teniendo en cuenta que la mayor ruta de exposición a las 
micotoxinas es por ingestión de alimentos contaminados, se aplicó un 
método de digestión in vitro, el cual fue optimizado previamente por 
nuestro grupo de investigación, para evaluar la biodisponibilidad y 
bioaccesibilidad de las micotoxinas por métodos in vitro. 
4.1 Citotoxicidad de las micotoxinas individuales  
 Las células HT-29, Caco-2 y CHO-K1 se exponen a diferentes 
concentraciones de micotoxinas durante 24, 48 y 72 h. los parámetros 
de citotoxicidad utilizados fueron el método de la sal de tetrazolio 
(MTT) basado en la determinación de la viabilidad celular a través de la 
alteración del funcionamento mitocondrial y el método del Rojo Neutro 
(NR) que se basa en la alteración lisosomal tras la exposición a 
sustancias toxicas.  
Las células HT-29, Caco-2 y CHO-K1 se exponen a las micotoxinas 
durante 24 h. Los valores de inhibición del crecimiento celular en el 
punto medio (IC50) obtenidos se encuentran en el rango de 1,3 ± 0,6 a 
20,6 ± 6.9 μM. La toxicidad aumenta según el siguiente orden: EN A1>EN 
A>EN B1>EN B. Las micotoxinas se exponen durante 48 h a las células 
Caco-2 y HT-29. Los valores de IC50 se encuentran entre 6.8 ± 1.6 a >15 
μM segun el siguiente orden de toxicidad: EN A>EN A1>EN B1>BEA>EN B. 
Las micotoxinas se exponen durante 72 h a las células Caco-2. Los 
valores de IC50 se encuentran en el rango de 1.3 ± 0.6 a 11.7 ± 2.4 μM. 
Los valores de IC50 aumentan en el orden: EN A1>EN A>EN B1>BEA>EN B. 
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Por el método de NR se detecta la citotoxicidad de las ENs y BEA en 
células Caco-2 tras 24, 48 y 72 h de exposición. El rango de IC50 
obtenido se encuentra más bajo en comparación con el método del 
MTT, con valores de 0.46 ± 0.1 a >15 μM. Tras 24 h de exposición el 
orden de toxicidad aumenta según el siguiente orden: EN A>EN 
A1>BEA>EN B1>EN B. Tras 48 y 72 h de exposición los valores de IC50 
aumentan según el orden: EN A=EN A1>BEA>EN B1=EN B y EN A=EN A1>EN 
B1>EN B>BEA, respectivamente.    
 La FUS no muestra valores de IC50 durante los tres tiempos de 
exposición y concentraciones ensayados (de 0,9 a 30 μM). 
Los resultados muestran que las micotoxinas objeto de este estudio 
ejercen su acción citotóxica alterando principalmente la función 
mitocondrial, aunque también pueden afectar a los lisosomas. Las 
micotoxinas que presentan mayor toxicidad son las ENs A y A1 en las 
células Caco-2 mientras que en las células CHO-K1 resultan ser más 
toxicas las ENs del grupo B (EN B1 y EN B).  
4.2 Efectos citotóxicos de las mezclas de micotoxinas  
 La presencia simultánea de varias micotoxinas en los alimentos 
es de gran importancia. Su combinación podría causar mayor riesgo para 
la salud humana respecto a la exposición  de una sola micotoxina, ya 
que pueden producir efectos aditivos, antagonistas o sinérgicos. Por lo 
tanto, uno de los objetivos del estudio fue evaluar los efectos sobre la 
viabilidad celular después de la exposición a las micotoxinas en 
combinaciones binarias, terciarias y cuaternaria. Teniendo en cuenta los 
objetivos del estudio se selecciona el método MTT porque pone de 
manifiesto la acción sobre la función mitocondrial, considerada ésta 
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fundamental en las funciones básicas celulares. Se utilizan las células 
Caco-2 como modelo de epitelio intestinal y las cuatro ENs A, A1, B y B1, 
ya que estudios previos en nuestro grupo de investigación han 
demostrado su presencia simultánea en varios alimentos.  
 A los resultados obtenidos se aplica un método matemático, el 
método de las isobolas basado en el índice de combinación (CI) 
introducido por Chou (2006) y Chou y Talalay (1984), que se utilizó 
originalmente para estudiar las interacciones de fármacos en clínica. 
Actualmente, este método resulta ser adecuado para determinar el tipo 
de interacción entre mezclas de dos o más micotoxinas (Ruiz et al, 
2011a,b).  
 Los resultados obtenidos muestran que las mezclas binarias 
reducen la viabilidad de las células Caco-2 de forma dosis dependiente 
de acuerdo con el siguiente orden: ENs A+A1 (48%)=ENs A1+B1 (47%)>ENs 
A1+B (35%)=ENs A+B (32%)>ENs B+B1 (26%). Todas las mezclas terciarias y 
la cuaternaria reducen la viabilidad celular en un 40%. Aplicando el 
método de las isobolas se observa que cuando la fracción requerida para 
inhibir la viabilidad celular es baja, todas las combinaciones muestran 
un efecto antagónico, que sólo se mantiene a dosis más elevadas para la 
combinación ENs B+B1. Por otra parte, se observa adición para todas las 
micotoxinas cuando la fracción afectada es media o alta, con excepción 
de las mezclas de ENs A1+B, ENs A1+B1 y ENs A1+A+B1 que muestran 
sinergismo a las dosis más altas ensayadas. Estos resultados son de gran 
relevancia en cuanto en término de identificación de peligros y 
evaluación de la seguridad ya que se observa que a dosis bajas las ENs 
compiten por ejercer su efecto en el lugar de unión, pero a mayor 
concentración el efecto puede suponer un mayor riesgo ya que las ENs 
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interactúan para producir efectos sinérgicos son de mayor 
preocupación. Se podría especular que los efectos sinérgicos obtenidos 
de las tres mezclas dependen de una potenciación de los efectos 
citotóxicos debido a las estructuras lipófilas de las ENs que se encuentra 
en el orden EN A>EN A1>EN B1>EN B, lo que les permite ser fácilmente 
incorporados en las membranas celulares y ejercer su acción citotóxica 
(Tedjiotsop Feudjio et al., 2010). Además la EN A1, presente en las tres 
mezclas, resultó ser la más citotóxica para las células Caco-2 y posee 
una buena actividad en la formación de poros, como la EN B1 (Kamyar et 
al., 2004). Se podría suponer que las ENs del grupo B puedan inducir una 
"acción facilitadora" o “complementaria” en combinación con las ENs 
del grupo A, lo que significa que la acción secundaria de las ENs del 
grupo B aumenta la acción toxica de las ENs del grupo A, cuando los 
compuestos actúan en la misma diana en diferentes sitios, o en sitios 
solapados o en diferentes dianas de una misma vía de toxicidad (Jia et 
al., 2009). Estos resultados pueden contribuir al conocimiento del tipo 
de toxicidad de las ENs teniendo en cuenta el hecho de que las ENs no 
están todavía legisladas ni individualmente ni en combinación en los 
alimentos. El siguiente paso necesario es determinar los efectos en vivo 
con el fin de ayudar a definir y optimizar los límites máximos legales de 
ENS en los alimentos.   
4.3 Mecanismo de estrés oxidativo: generación de especies reactivas 
del oxígeno y peroxidación lipídica   
 Teniendo en cuenta que las micotoxinas BEA, ENs y FUS son 
citotóxicas y biodisponibles por absorción intestinal, se plantea el 
siguiente objetivo: determinar si las micotoxinas son citotóxicas debido 
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a su capacidad de generar especies reactivas del oxígeno (ROS) y 
peroxidación lipídica (LPO). Los resultados de este estudio demuestran 
que la BEA y las ENs son capaces de inducir generación de ROS dosis y 
tiempo dependientes. La exposición a BEA y ENs A, A1, B y B1 desde 0 a 
120 minutos produce un incremento significativo de ROS (medido por la 
sonda fluorescente H2-DCFDA) que varía de 1,4 a 2,6 veces respecto al 
control. El incremento es mayor para EN A1=EN A>EN B1>BEA>EN B.  
 La exposición de las células Caco-2 a FUS no produce aumento de 
generación de ROS durante los 120 minutos ensayados. Únicamente se 
observa un incremento significativo de 2,2 veces respecto al control 
inmediatamente tras la exposición de la FUS a células Caco-2 (0 min).  
 Una de las consecuencias más estudiadas producidas por ROS es 
la LPO de los lípidos de membrana, cuyos productos son citotóxicos 
(Kouadio et al., 2007; Ferrer et al., 2009). Tras la exposición de las 
células Caco-2 a BEA, ENS y FUS durante 24 h, los resultados obtenidos 
muestran que la exposición a la BEA y ENs induce LPO. La LPO aumenta 
en células expuestas a estas micotoxinas desde 48% a 207% respecto a 
las células no expuestas a micotoxinas. La inducción de LPO sigue el 
orden: BEA>EN A>EN A1=EN B1>B. FUS no produce un aumento 
significativo de LPO respecto al control.  
 Los resultados de generación de ROS y LPO muestran que las 
micotoxinas ensayadas, excepto la FUS producen estado oxidativo de las 
células Caco-2, confirmando el mayor potencial citotóxico de estas 
micotoxinas en las células de mamífero.  
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4.4 Mecanismos de defensa frente al estrés oxidativo 
4.4.1 Glutatión intracelular  
 Teniendo en cuenta del incremento de LPO y ROS producido por 
la BEA en células Caco-2 tras 24 h de exposición, el siguiente objetivo 
fue determinar los niveles intracelulares de glutatión (GSH) como 
mecanismo de defensa frente al estrés oxidativo causado por las 
micotoxinas.  
 El GSH participa en la destoxicación celular ya que  puede 
eliminar los radicales libres, reducir los peróxidos o conjugarse con 
compuestos electrófilos. La reducción de GSH durante el estrés 
oxidativo tiene un papel significativo en la capacidad antioxidante 
celular y es un marcador indicativo de estrés oxidativo. Los resultados 
muestran que la BEA disminuye significativamente los niveles de GSH 
(31%) y aumenta los del GSSG (20%) respecto al control, confirmando el 
papel del GSH en la defensa celular frente a la BEA.  
4.4.2 Antioxidantes de la dieta  
 Los polifenoles provenientes de la dieta pueden proteger a las 
células contra los agentes que inducen daño oxidativo (Lombardi et al., 
2012). Ya que las células CHO-K1 se consideran uno de los modelos 
celulares más sensibles en estudios preliminares sobre las micotoxinas, 
en este estudio se plantea evaluar el efecto citoprotector que ejercen 
los polifenoles tras la exposición a las ENs a las células CHO-K1. Los 
resultados muestran un efecto citoprotector de los polifenoles cuyo 
grado depende de las ENs y de los polifenoles ensayados. Los cinco 
polifenoles ensayados (quercetina, quercetina-3-β-d-glucósido, rutina, 
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miricetina y t-pterostilbeno) protegen a las células CHO-K1 cuando se 
exponen a la EN A1. La quercetina, quercetina-3-β-d-glucósido, 
miricetina y t-pterostilbeno protegen a las células de la EN B1. Mientras 
que la quercetina y quercetina-3-β-d-glucósido protegen a las células de 
la EN A; la rutina y miricetina de la EN B. El efecto citoprotector 
expresado como aumento en porcentaje de reducción de mortalidad 
celular tras exposición de las células a las ENs junto con los polifenoles 
de forma individual, se encuentra en un rango de 25 a 116% para el t-
pterostilbeno frente a las EN A1 y B1; entre 16 a 92% para la miricetina 
frente a las ENs A1, B y B1; entre 17 a 83% para la rutina frente a las ENs 
A1 y B; entre 12 a 76% para la quercetina-3-β-d-glucósido junto a las ENs 
A, A1 y B1; y entre 24 a 43% para la quercetina junto a las ENs A1 y B1. 
Los antioxidantes de la dieta y su papel citoprotector en la prevención 
de la toxicidad de las micotoxinas presentan una atención creciente en 
los últimos años para evaluar el potencial beneficioso de estos 
compuestos en la dieta. Puesto que las micotoxinas son contaminantes 
comunes de los alimentos y los piensos, todas las sustancias que son 
capaces de reducir los efectos tóxicos de las micotoxinas son de gran 
interés. Por lo tanto, el uso de los antioxidantes podría ser una 
estrategia efectiva para la protección frente a la acción de las 
micotoxinas y para reducir la toxicidad y así mejorar la seguridad de los 
alimentos. 
4.5 Ciclo celular   
 De los resultados obtenidos se deduce que las ENs A, A1, B1 y 
BEA, tras 24 h de exposición producen una parada en la fase mitótica 
G2/M, con un aumento de la población celular que se encuentra en el 
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rango de 23 a 35% respecto al control (19%). El porcentaje aumenta 
según el orden: EN B1>EN A1>BEA>EN A. Una reducción de la fase G0/G1 
concomitante con un aumento de la población en G2/M se observa para 
las ENs A1 y B1 y BEA. El porcentaje disminuye según el orden BEA>EN 
B1>EN A1 en un rango de 32 a 38% respecto al control (45%). Los 
parámetros del ciclo celular no se ven afectados tras exposición a la EN 
B. Tras 48 h de exposición las ENs A1 y B1 producen un aumento de la 
fase hipoploide (o debris; 15% frente al 5% del control) que indica la 
presencia de células apoptoticas. Se mantiene la reducción de las 
células en la fase G0/G1 en un mismo que a las 24 h, siendo el orden EN 
A>EN A1>EN B1>BEA. Un aumento en la fase G2/M se observa para la BEA 
(21% respecto al control 17%). Tras 72 h de exposición se observa una 
reducción de la fase G0/G1 que va desde 26 a 36% respecto al control 
(44%) en un orden de: EN B1>EN A=BEA>EN A1. Un aumento del 
porcentaje celular de la fase SubG0/G1 (36%) respecto al control (8%) 
en el orden: EN B1>EN A1>EN B=EN A y un aumento de la fase G2/M en el 
caso de las ENs A1 y B y BEA en un rango de 28 a 33% respecto al control 
(22%) y en el orden de: BEA>EN A1>EN B. Además, la BEA y las ENs A y B1 
producen un aumento de la fase S en un rango de 19 a 23% respecto al 
control (15%) en el orden de: EN B1>BEA>EN A. La BEA muestra una 
disminución en la fase G0/G1 del ciclo celular, acompañada de un 
aumento de células en la fase G2/M a los tres tiempos de exposición. De 
acuerdo con Noda et al. (2001), este tipo de parada  podría ser una 
consecuencia del desequilibrio redox a nivel celular inducido por la BEA 
en células Caco-2, según cuanto determinado por LPO y GSH. Por otra 
parte, de acuerdo con (Abid Essefi et al., 2003) la parada en las fase 
G2/M y S pueden ser debidas a un daño a nivel del ADN, lo que se 
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observa tras 24 h de exposicion a la ENs A, A1 y B1 y tras 72 h de 
exposicion a todas las micotoxinas ensayadas.   
4.6 Inducción de apoptosis y necrosis  
 La parada del ciclo celular en la fase G2/M se ha descrito como 
posible consecuencia de un estímulo externo que induce apoptosis y 
como un proceso de adaptación que retarda el ciclo celular frente a un 
daño a nivel del DNA (Abid-Essefi et al., 2003; Ivanova et al., 2012). 
Tras 24 h de exposición a las ENs A, A1 y BEA se observa un aumento del 
porcentaje (de 25 a 34%) de células en apoptosis temprana respecto al 
control (12%) según el orden: BEA=EN A1>EN A. Para estas micotoxinas 
se observa también un incremento del porcentaje de células 
apoptoticas/necroticas (de 25 a 31%) respecto al control (12%) en el 
orden: BEA=EN A1=EN A. La inducción simultanea de apoptosis y necrosis 
responde a que un mismo estímulo puede producir, en una misma 
célula, los 2 tipos de muerte celular. Tras 48 h de exposición, las 
micotoxinas inducen células en apoptosis temprana en porcentajes que 
van desde 13 a 26% respecto al control (7%) en el orden siguiente: 
BEA=EN B1>EN A1>EN A>EN B. Las ENs A, A1 y B1 inducen un incremento 
de la población de células necróticas (22% respecto al control=14%). 
Tras 72 h de exposición sólo se observa necrosis para todas las 
micotoxinas ensayadas (de 16 a 27%) en el siguiente orden: EN B>EN 
B1>EN A1=EN A=BEA. Tras 24 h de exposición únicamente BEA y las ENs A 
y A1 causan apoptosis en las células Caco-2. El incremento de células 
apoptoticas para las micotoxinas alcanza el 180% frente al control. Este 
efecto se incrementa en 1,8 veces a las 48 h implicando a todas las 
micotoxinas ensayadas. Respecto a la necrosis, las ENs A y A1 muestran 
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necrosis a todos los tiempos ensayados (incremento aproximadamente 
del 160% frente al control), mientras que el resto de micotoxinas causan 
necrosis al mayor tiempo de exposición. Sin embargo, a diferencia de la 
apoptosis, el porcentaje de células necroticas aumenta con el tiempo 
de exposición. Tras 72 h de exposición no se observa apotosis si no sólo 
necrosis debido al largo tiempo de exposición de las células a las 
micotoxinas. La muerte celular por apoptosis y necrosis se relaciona a 
un imbalance el el estado redox celular (Gotoh et al., 2002), lo que se 
observa tras 24 h de exposicion a la BEA. Por otra parte la muerte 
celular por apoptosis y necrosis se relaciona a un dano a nivel del ADN, 
lo que se observa por las ENs A y A1. En el caso de la EN B1 se observa 
induccion de LPO y dano a nivel del ADN, aunque no se pudo establecer 
una directa relacion con la induccion de apoptosis y necrosis en celulas 
Caco-2.  
4.7 Detección del potencial de membrana mitocondrial  
 Teniendo en cuenta que la mitocondria tiene un papel 
importante en el proceso de apoptosis y necrosis, ya que libera factores 
implicados en la inducción de apoptosis en las células, en este estudio 
se planteó el objetivo de evaluar el ΔΨm tras la exposición a la BEA y 
ENs en las células Caco-2. Tras 24 h de exposición, la alteración del 
ΔΨm es inducida por las ENs A y A1 y por la BEA en el rango de 19 a 29%, 
aunque la EN A resulta alterar el potencial de membrana únicamente a 
la mayor concentración (3,0 μM). Tras 48 h de exposición, todas las 
micotoxinas reducen el porcentaje (11 a 30%) de células positivas con 
alteración del ΔΨm a todas las concentraciones ensayadas, excepto la 
EN B que solo induce alteración del ΔΨm a 3,0 μM. Tras 72 h de 
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exposición, el potencial de membrana mitocondrial fue reducido 
drásticamente (91 a 98%). Todas las micotoxinas ensayadas reducen el 
potencial de membrana mitocondrial. Esta reducción aumenta al 
aumentar de la dosis y el tiempo de exposición. El incremento en la 
alteración de la membrana mitocondrial fue del 30% a las 24 h hasta 98% 
a las 72 h. Lo resultados mostran que la BEA y las ENs ensayadas 
producen un daño a nivel mitocondrial que esta implicado en la 
inducción de apoptosis y necrosis en células Caco-2, de acuerdo con 
Juan-Garcίa et al. (2013).    
4.8 Determinación del daño a nivel del DNA por el ensayo Cometa  
 La parada de las fases G2/M y S del ciclo celular se correlaciona 
con daños a nivel del DNA, el cual, si no se repara por mecanismo 
celulares, pueden inducir apoptosis. En este estudio se evalúa un 
posible daño producido por las ENs y BEA a nivel del DNA como las 
roturas de la cadena simple o doble del DNA, sitios álcali-lábiles y 
rotura de cadena simple asociada a la reparación incompleta por 
escisión, por el ensayo Cometa. Con este ensayo se analiza el 
incremento de DNA en la cola conocido como momento de la cola (TM). 
Este parámetro se considera útil para describir la heterogeneidad de la 
respuesta dentro de la población celular, ya que su cálculo (producto 
del porcentaje de DNA en la cola y longitud de la cola) considera las 
variaciones de distribución del DNA dentro de la cola. Tras 24 h de 
exposición se observa un incremento del momento de la cola 
significativo para la EN A, la EN A1 (3,0 μM) y la BEA (12.0 μM), con un 
porcentaje de DNA en la cola que aumenta de 164 hasta 196% respecto 
al control. La inducción del daño al ADN se relaciona a la parada en la 
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fase G2/M y S, lo que se observa para las ENs A y A1, tras 24 h de 
exposicion y para todas las micotoxinas tras 72 h de exposición. Por otra 
parte la parada en la fase G2/M producida por la BEA tras 24 h de 
exposición se relaciona al imbalance en el estado redox de las células 
producido por ella.   
4.9 Transporte y biodisponibilidad de beauvericina y fusaproliferina  
 Considerando el efecto citotóxico obtenido tras la exposición de 
las micotoxinas de forma individual y combinada, se plantea el objetivo 
de evaluar la biodisponibilidad de las micotoxinas y que el epitelio 
intestinal es la primera barrera para la absorción y metabolismo de 
xenobióticos, tales como las micotoxinas, después de la administración 
oral se utilizan células Caco-2 para estudiare este parámetro. La línea 
celular Caco-2, las cuales una vez diferenciadas se aceptan como 
sistema in vitro de absorción intestinal humano (Artursson y Karlsson, 
1991). La biodisponibilidad se refiere a la proporción de un nutriente 
ingerido que se absorbe y se utiliza para la función fisiológica normal 
y/o almacenamiento (Versanvoort et al., 2005).  
En este estudio se evalúa la biodisponibilidad de BEA y FUS, ya 
que la biodisponibilidad de las ENs ya se ha determinado en células 
Caco-2 previamente por nuestro grupo de investigación.  
Tanto la BEA como la FUS se transportan a través del modelo in 
vitro de absorción con células Caco-2. Los porcentajes de transporte 
desde la capa apical a la basolateral  en el modelo in vitro fueron 
mayores para la FUS (83.2 ± 0.8%) que para la BEA (54.3 ± 1.1%). Sin 
embargo la FUS no se absorbe por las células Caco-2 diferentemente de 
la BEA, lo que demuestra el menor paso de esta a través de la 
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membrana transepitelial y su retención en el interior de las células 
Caco-2, cuyo porcentaje varía de 15 a 33% dependiendo de la 
concentración de BEA. Las diferencias obtenidas entre la FUS y la BEA 
puede deberse a la diferencia en la estructura química de estas 
micotoxinas, particularmente del grupo aminoácidos de la BEA (ausente 
en la FUS) que facilita la interacción y paso a través de la membrana 
celular. Otro factor que puede influir en el menor porcentaje de 
transporte de BEA es el peso molecular, ya que la BEA presenta un peso 
molecular que duplica lo de la FUS.  
 Aunque no podemos simplemente extrapolar los resultados 
obtenidos en este en estudio in vitro a la situación in vivo de una 
exposición aguda/crónica de los seres humanos a las micotoxinas, este 
estudio puede proporcionar información sobre la proporción de 
micotoxinas que pueden estar disponibles a nivel intestinal y alcanzar 
los órganos diana donde realizar su función toxica.  
4.10. Estudio de bioaccesibilidad de las micotoxinas  
 Teniendo en cuenta que la mayor ruta de exposición a las 
micotoxinas es por ingestión de alimentos contaminados, el último 
objetivo del trabajo fue aplicar un método de digestión in vitro, el cual 
fue optimizado previamente por nuestro grupo de investigación, para 
evaluar la bioaccesibilidad de las ENs.  
El término de bioaccesibilidad describe la fracción de las ENs, 
que se libera de la matriz alimentaria, tras el proceso de digestión 
gastrointestinal y teóricamente disponible para la absorción inestinal 
(Versanvoort et al., 2005). La optimización del método de digestión in 
vitro muestra que las ENs son bioaccesibles en un rango que varia entre 
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54,1 ± 2,7 y 67,5 ± 2,7%, y en el siguiente orden: EN A=EN B1>EN B>EN 
A1, considerando las dos concentraciones ensayadas (1,5 y 3,0 μmol/g). 
La aplicación del método de digestión in vitro permite determinar la 
bioaccesibilidad de las ENs desde diferentes productos comerciales a 
base de cereales. En total se utilizaron 14 productos que incluyen 
cuatro tipos de galletas: galletas con chocolate, galletas con fibra, 
galletas con avena y galletas sin fibras; cinco tipos de pan: pan de 
molde integral, pan integral sin azúcar, pan de leche, pan multicereales 
y pan blanco; cinco tipos de cereales para el desayuno: copos de maíz, 
muesli con frutas, salvado de trigo con las fibras, trigo con chocolate y 
trigo con miel. Los valores medios obtenidos de bioaccesibilidad, en las 
14 muestras ensayadas, demuestran una reducción en la 
bioaccesibilidad de las ENs que fue del 35% para la EN A1, del 25-31% 
para la EN B1, del 31% para la EN B y del 25% para la EN A respecto al 
control. Los datos muestran que el contenido de las ENs en el alimento, 
tras la digestión intestinal se reduce, lo cual es de gran interés en el 
momento de evaluar la fracción disponible en la absorción por parte del 
hombre y/o animal. Sin embargo, hay que considerar las diferencias en 
los tipos de métodos in vitro, en los procedimientos, pH utilizados, 
estructura de las micotoxinas y la composición de los alimentos ya que 
todo ello podría contribuir a variar  los valores de bioaccesibilidad 
obtenidos. Aunque, los datos obtenidos por los modelos in vitro de 
bioaccesibilidad pueden ser incorporados a los datos enteros 
relacionados con la citotoxicidad de micotoxinas en la literatura y 
contribuir a su evaluación del riesgo.  
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CONCLUSIONS 
1) BEA and ENs A, A1, B and B1 exerted cytotoxic effects in a dose and 
time dependent manner in Caco-2, HT-29 and CHO-K1 cells. CHO-K1 
cells were more sensitive to ENs of B group, whereas Caco-2 cells were 
more sensitive to ENs of A group. the order of toxicity was EN B1>EN 
B=EN A1>EN A and EN A1>EN A>EN B1>BEA>EN B, respectively. FUS did 
not show cytotoxic effects in both Caco-2 and HT-29 cell lines at any 
concentration tested.  
2) The cytotoxic effect of EN A1 in the following combinations: ENs 
A1+B, ENs A1+B1 and ENs A+A1+B1 in a dose and time dependent manner 
in Caco-2 cells. Antagonsim was observed in Ens B+B1 combination at 
low concentrations tested.  
3) Oxidative stress was observed after exposure to BEA and ENs in Caco-
2 cells in the following increasing order: EN A1=EN A>EN B1>BEA>EN B.  
4) LPO was produced as a consequence of oxidative damage induced by 
BEA and ENs in the order: BEA>EN A>EN A1=EN B1>EN B.  However no 
oxidative damage was induced in Caco-2 cells by FUS.  
5) BEA reduced GSH levels and increased GSSG levels in Caco-2 cells, 
confirming the involvement of GSH in BEA detoxification. 
6) Polyphenols demonstrated cytoprotective effects in CHO-K1 against 
ENs cytotoxicity in the increasing order: t-pterostilbene > myricetin > 
rutin > quercetin 3-β-glucoside > quercetin.  
7) Sub-toxic concentration of BEA and ENs (1.5 and 3.0 μM) arrested the 
cell cycle in Caco-2 cells predominantly in G2/M phase. The G2/M phase 
arrest is related to oxidative imbalance induced after ROS production by 
BEA and to DNA damage induced by EN A and EN A1. 
8) Apoptosis and necrosis cell death was observed after BEA and ENs 
exposure in Caco-2 cells.  
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9) The mitochondrial membrane potential was altered after BEA and ENs 
exposure, contributing to Caco-2 cell death.  
10) High bioavailability percentages of BEA and FUS were determined 
through the Caco-2 cells monolayer. FUS was more bioavailable than 
BEA.  
11) ENs bioaccessibility was reduced after applying the in vitro digestion 
method. The bioaccessibility was in the following order: EN A=EN B1>EN 
B>EN A1.   
12) The in vitro data obtained in this study can be incorporated to the 
whole data related to the cytotoxicity of BEA, ENs and FUs in literature 
and together with in vivo studies could contribute to the future risk 
assessment for these minor Fusarium mycotoxins.  
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1. Reactivos 
 Todos los reactivos y componentes de los cultivos celulares 
utilizados: medios Dulbecco’s modified Eagle’s (DMEM; 4,5 g/L) y Ham-
F12, penicilina, estreptomicina, HEPES, bromuro de 3[4,5-dimetiltiazol-
2-il]-2,5-difeniltetrazolio (MTT), rojo neutro (NR), tampón 
glicina de Sorensen, tampón fosfato salino (PBS), aminoácidos no 
esenciales (NEAA), Trizma base, Triton X-100, glucosa, dimetilsulfóxido 
(DMSO), ácido tiobarbitúrico (TBA), sal de mesilato de deferoxamina 
(DFA), di-ter-butil-metilfenol (BHT), 1,1,3,3 tetrametoxipropano, 2',7'-
diclorodihidrofluoresceína diacetato (H2-DCFDA), yoduro de propidio 
(PI), RNasa, BEA (783,95 g/mol), Na-EDTA, agarosa, agarosa de baja 
temperatura de fusión (LMA), benzo (α) pireno (B(α)P), solución salina 
de Hank (HBSS), quercetina (pureza ≥ 98%, peso molecular: 302,26 
g/mol), quercetina-3-β-D-glucosido (pureza ≥ 90%, peso molecular: 
464,38 g/mol), rutina (pureza ≥ 99%, peso molecular: 610,56 g/mol) y 
miricetina (pureza ≥ 96%, peso molecular: 318,24 g/mol) se obtuvieron 
de Sigma Chemical Co (St Louis, MO, EE.UU.). T-pterostilbeno (pureza ≥ 
90%, peso molecular: 256,30 g/mol) se obtuvo en nuestro labboratorio 
según la reacción standard de Witting y Hens (http://www.orgsyn.org). 
Suero fetal bovino (FCS) se obtuvo de Cambrex Company (Belgium). 
Agua desionizada (resistividad <18 mΩ cm) se obtuvo del sistema de 
agua ultrapura Milli-Q (Millipore, Bedford, MA, EE.UU.). NaOH se obtuvo 
de Guinama (España). NaCl y etanol fueron de Merck KGaA (Alemania). 
CaCl2 y formaldehído de Scharlau Chemie SA (Barcelona, España). 
Metanol y ácido acético glacial se obtuvieron de VWR International (LLC, 
Pennsylvania, EE.UU.). Anexina V-FITC coniugada humana 
recombinante, éster metílico de tetrametil rodamina (TMRM), To-Pro-
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3® yoduro y el protonóforo carbonilcianuro p-
trifluorometoxifenilhidrazona (FCCP) de Invitrogen, (EE.UU.). 
Acetonitrilo y acetato de etilo se adquirieron de Fisher Scientific 
(Madrid, España). Urea, α-amilasa, KCl, KSCN, NaH2PO4, Na2SO4, 
NaHCO3, HCl, pepsina, pancreatina, y sales biliares se obtuvieron de 
Sigma-Aldrich (Madrid, Spain). Los disolventes cromatográficos y el agua 
se desgasificaron durante 20 minutos utilizando el baño ultrasónico 5200 
Branson (Branson Ultrasonic Corp., CT, EE.UU.).  EN A (pureza: ≥ 97%, 
peso molecular: 681,9 g/mol), EN A1 (pureza: ≥ 97%, peso molecular: 
667,9 g/mol), EN B (pureza: ≥ 90%, peso molecular: 639,4 g/mol) y EN 
B1 (pureza: ≥ 97%, peso molecular: 654,9 g/mol) se obtuvieron de Enzo 
Life Sciences, Suiza.  
FUS fue producida y purificada en el laboratorio de acuerdo con el 
método desarrollado por Meca y col. (2009). Las soluciones madre de 
BEA y ENs A, A1, B and B1 se prepararon en metanol y se mantuvieron a -
20 °C. Las concentraciones finales ensayadas se obtienen en medio de 
cultivo. La concentración final de metanol en la disolución de trabajo 
de BEA, FUS y ENs fue de 1% (v/v). El contenido total de proteína 
(mg/ml) se determinó mediante el método de Bradford (Bio-Rad ensayo 
de proteínas DC (número de catálogo 500-0116) 
http://www.bio-rad.com/LifeScience/pdf/Bulletin_9005.pdf). 
2. Cultivos celulares   
 Las células Caco-2 (ATCC HTB-37) derivadas de adenocarcinoma 
de colon humano, se mantuvieron en medio DMEM con alto contendido 
de glucosa (4.5 g/L) a pH 7.4, suplementado con piruvato (1mM), 
tampón HEPES 25 mM, 1% (v/v) de NEAA, 100 U de penicilina, 100 
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mg/ml de estreptomicina y 10% (v/v) de FCS inactivado. El 
mantenimiento de las células se llevó a cabo en frascos de 75 cm2  a los 
que se adicionó 10 mL de medio. El medio de cultivo se cambió cada dos 
días.  
 Las células CHO-K1 derivadas de ovario de hámster chino, se 
cultivaron en monocapa con Ham-F12 suplementado con 25 mM de 
tampón HEPES (pH 7.4), 10% de FCS inactivado, 100 U/ml de penicilina, 
100 mg/ml de estreptomicina, y 2.5 g/ml de anfotericina B. El 
mantenimiento de las células se llevó a cabo en placas de cultivo de 75 
cm2  a los que se adicionó 5 mL de medio.  
 Las células HT-29 (ATCC HTB-38) epiteliales de adenocarcinoma 
colorrectal humano se cultivaron en monocapa en placas de cultivo de 
poliestireno de 9 cm2 de tejidos con DMEM suplementado con 25 mM 
HEPES, 1% NEAA, 100 U/ml de penicilina, 100 mg/ml de estreptomicina, 
2.5 mg/ml de anfotericina B, y 10% FCS inactivado.  
Todas las células se incubaron a 37 °C, en atmósfera con un 95% de 
humedad relativa y con un flujo de CO2 del 5%. 
La ausencia de micoplasma se comprobó rutinariamente usando el kit de 
tinción de Mycoplasma (Sigma-Aldrich, St Louis Mo. EE.UU.). 
3. Citotoxicidad in vitro 
 Los ensayos de MTT y NR se realizaron como se describe por Ruiz 
y col. (2006) con algunas modificaciones. Las células se sembraron en 
placas de 96 pocillos mediante la adición de 200 μL/pocillo de una 
suspensión celular de 3 x 104 células/pocillo para las Caco-2 y HT-29 y 
de 2 x 104 células/pocillo. Cuando las células alcanzaron su confluencia, 
el medio de cultivo se reemplazó con medio fresco conteniendo las 
Metodologίa 
 
 
318 
 
diluciones seriadas de BEA y ENs, que se encontraban en el rango de 
3,125 a 25 μM para la BEA, de 0,9 a 15 μM para las ENs A1, B y B1 y desde 
0,45 a 7,5 μM para la EN A, de 0,9 a 30 μM para la FUS y medio fresco 
contenteniendo  diluciones seriadas de cada polifenol (de 3,13 a 
100 μM) y medio fresco conteneindo simultáneamente el polifenol (a 
una concentración de 5, 25 y 50 μM) y cada EN (1.5 y 3.0 μM).  
 Para el ensayo de NR, tras 24, 48 y 72 h de incubación de las 
células con diferentes concentraciones de micotoxinas (factor de 
dilución = 2), el medio con las micotoxinas se desechó y se añadieron 
200 μL de solución NR (50 mg/ml; pre-incubado a 37 °C durante 24 h) a 
cada pocillo y tras 3 h de incubación a 37 °C, las placas se lavaron con 
PBS, las células se fijaron con solución de formaldehído-CaCl2, y se 
extrajo el NR mediante la adición de una solución de ácido 
acético/etanol (1:50). 
 Las placas se agitaron suavemente durante 5 min para lograr la 
disolución completa del colorante antes de medir la absorbancia medida 
a 540 nm con un lector automático de placas ELISA Multiscan EX 
(Thermo Scientific, MA, EE.UU.). La viabilidad celular se expresó en 
porcentaje respecto al control celular con 1% de MeOH. Las dosis medias 
de inhibición del crecimiento celular (IC50) se calcularon a partir de la 
curva dosis-respuesta.  
 Para el ensayo del MTT, tras 24, 48 y 72 h de exposición con las 
concentraciones seriadas de micotoxinas, el medio con las micotoxinas 
se desechó y se añadió a cada pocillo 200 μL de medio fresco con 50 μL 
de MTT. Después de 4 h de incubación (37 °C y en la oscuridad), el 
formazano resultante se solubilizó con DMSO. La absorbancia se midió a 
570 nm utilizando un lector de placas de ELISA Multiscan Ex automática 
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(Thermo Scientific, MA, EE.UU.). La viabilidad celular se expresó en 
porcentaje en relación al control (1% de MeOH). Los valores de IC50 se 
calcularon a partir de curvas de dosis-respuesta. 
4. Diseño experimental y evaluación de los efectos de las 
combinaciones de micotoxinas 
 Se sembraron 3 x 104 células/pocillo en placas de cultivo de 96 
pocillos. Cuando las células alcanzaron la confluencia, se adicionaron 
cinco diluciones (factor de dilución en serie = 2) de EN A, A1, B y B1 y sus 
combinaciones de dos, tres y cuatro micotoxinas y se expusieron 
durante 24 h. Las concentraciones fueron de 0,3 a 5 μM con una relación 
1:1. Las concentraciones de las mezclas terciarias fueron de 0,3 a 2,5 
μM con una relación 1:1:1 y las concentraciones para la mezcla 
cuaternaria fueron de 0,3 a 2,5 μM con una relación 1:1:1:1. El ensayo 
de MTT se llevó a cabo como el descrito anterioremnte según Ruiz y col. 
(2006). 
 Los resultados se analizaron usando la ecuación de efecto-
medio/índice combinado (CI)-isobolograma descrito por Chou (2006) y 
Chou y Talalay (1984) que se basa en el principio de ley de acción de 
masas que demuestra que hay una relación unívoca entre la dosis y el 
efecto que produce, independientemente del número de sustratos o de 
productos y del mecanismo de  acción o de inhibición. Este método 
realiza las curvas dosis-efecto para cada compuesto y sus combinaciones 
en múltiples concentraciones diluidas usando la ecuación de efecto 
medio: 
  
  
 =  
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Donde D es la concentración del producto, Dm es la dosis media efectiva 
(ej., IC50, EC50, o LD50) que inhibe el 50% de del crecimiento celular, fa 
es la fracción afectada por la concentración D (ej., porcentaje de 
inhibición/100), fu es la fracción no afectada (por lo tanto, fa = 1 - fu), 
y m es el coeficiente que informa del tipo de relación dosis-efecto que 
tiene lugar. Así cuando m = 1, m > 1, y m < 1 indica que la curva dosis-
efecto es hiperbólica, sigmoidal y negativo sigmoidal, respectivamente 
(Chou and Talalay, 1984). Por lo tanto el método tiene en cuenta los 
parámetros de potencia (Dm) y de pendiente (m). La ecuación de efecto 
medio para compuestos individuales se puede modificar y aplicar a 
múltiples micotoxinas. Y la ecuación se convierte en: 
[(fa)1,2/(fu)1,2]
1/m = D1/(Dm)1 + D2/(Dm)2 + (D)1(D)2/(Dm)1(Dm)2 
 Cuando dos componentes se combinan y se realizan varias 
diluciones, la mezcla de los dos compuestos se comporta como un tercer 
compuesto en la relación dosis efecto. Por lo tanto, y= log 
[(fa)1,2/(fu)1,2] frente a x = log [(D)1+(D)2] da valores de  m1,2, (Dm)1,2, y 
r1,2.  
 Chou y Talalay (1984) introdujeron el termino (CI)x para 
cuantificar el sinergismo, adición o antagonismo de dos componentes: 
CI=D1/(Dx)1 + D2/(Dx)2 = (D)1/(Dm)1[fa/(1-fa)]
1/m1
  + (D)2/(Dm)2[fa/(1-
fa)]1/m2 
Donde en el denominador (Dx) 1 se refiere a D1 analizado 
individualmente y que inhibe un x% del sistema, y (Dx)2 a D2 analizado 
individualmente y que inhibe un x% del sistema. Y la ecuación general 
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para la combinación de n-compuestos con una inhibición de x% se 
convierte en: 
      
 = 
    
     
 
    =  
                   
 
   
                             
    
 
    
Donde (CI) es el índice de combinación para n-compuestos (ej., 
micotoxinas) a x% de inhibición (ej., proliferación inhibición); (Dx)1-n es 
la suma de los n-compuestos que ejercen x% de inhibición en la 
combinación, {[Dj]/ ∑
n
1 [D]} es la proporción de la concentración de cada 
uno de los n compuestos que ejerce el x% de inhibición en combinación; 
y (Dm)j {(fax)j/[1-(fax)j]}
1/mj es la concentración de cada compuesto 
individualmente que ejerce el x% de inhibición. De esta ecuación, CI <1, 
=1 y >1 indica sinergismo, efecto aditivo y antagonismo, 
respectivamente. 
5. La generación de especies reactivas del oxígeno intracelular 
 La producción de ROS intracelular se monitorizó en las células 
Caco-2 mediante la adición de la H2-DCFDA según Ruiz-Leal y George 
(2004). Brevemente, 3x104 células/pocillo se sembraron en microplacas 
de 96 pocillos de color negro. Una vez que las células alcanzaron el 80% 
de confluencia, el medio de cultivo se reemplazó por 20 μM de H2-
DCFDA durante 20 min. A continuación, se retiró el medio con H2-DCFDA 
y se lavó dos veces con PBS antes de la adición de las micotoxinas. Se 
ensayaron dos concentraciones diferentes de BEA, ENs y FUS (1.5 y 3.0 
μM). La selección de estas dos concentraciones, se hizo de acuerdo a los 
resultados obtenidos previamente en nuestro laboratorio, y por 
encontrarse por debajo de los valores de IC50 obtenidos en las células 
Caco-2 por los metodos de MTT Y NR. El método utilizado se basa en la 
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oxidación de 2',7'-dichlorofluorescin (DCFH) a diclorofluoresceína 
fluorescente. Este método es muy sensible y proporciona una medida 
directa de la generación de especies oxidantes intracelulares. El 
diacetato de DCFH (DCFH-DA) se absorbe por las células y es 
desacetilado por las esterasas intracelulares produciendo DCFH que se 
oxida a DCF. El aumento de fluorescencia se relaciona con el aumento 
de ROS que se lee en un lector de placa multipocillos (Wallace Victor2, 
1420 Multilaber Counter, Perkin Elmer, Turku, Finland), a intervalos de 
0 a 120 min a una longitud de onda de excitación y emisión de 485 y 535 
nm, respectivamente. Los resultados se expresaron como incremento de 
fluorescencia respecto al control (1% MeOH).  
6. Determinación de la peroxidación lipídica 
 La determinación de la peroxidación lipídica (LPO) se determinó 
por el método de Buege y Aust (1978), basado en la formación de 
substancias reactivas con el ácido tiobarbitúrico (TBARS). Este ensayo se 
basa en la formación de un aducto rojo (con máxima absorción 532 nm) 
entre TBA y MDA, un producto final del proceso de peroxidación. De 
forma resumida, se sembraron 4,8 x 105 células/pocillo en placas de 6 
pocillos. Tras alcanzar el 80% de confluencia, las células fueron tratadas 
con BEA, ENs y FUS, a las concentraciones de 1,5 y 3,0 μM durante 24 h. 
Tras este periodo, se retiró el medio y las células se lavaron con PBS, se 
tripsinizaron y fueron recogidas en 20 μM de Tris y 0,1% de Triton. Las 
células se homogeneizaron con un UltraTurrax T8 (IKA-Werke GmbH & 
Co. KG, Germany), y se adicionó 1 mL de TBA al 0,5%, 5 µL de 
desferroxamina 1,5 mM y 5 µL de butil hidroxitolueno al 3,75%. Tras 
agitación, las muestras se pusieron a baño maría (100 °C) durante 20 
Metodologίa 
 
 
323 
 
min. Inmediatamente se sumergieron las muestras en hielo, se 
centrifugaron a 1283xg durante 20 minutos y se midió la absorbancia a 
532 nm (Perkin Elmer UV/Vis Lambda 2 versión 5,1). Los resultados se 
expresaron como ng de MDA/mg de proteína medida por el método de 
Bradford. 
7. Determinación de glutatión intracelular oxidado (GSSG) y reducido 
(GSH). 
 La determinación de glutatión reducido (GSH) se ensayó de 
acuerdo a Maran y col. (2009). Brevemente, 10 µL del homogenizado 
celular se colocaron en placas de cultivo negras de 96 pocillos, con 200 
µL de tampón GSH (Na2HPO4 0,1M-EDTA 0,005M) a pH 8 y 10 µL de 
solución o-ftaldehído (OPT),  se mezclaron y se incubaron en oscuridad, 
a temperatura ambiente, durante 15 min. La concentración de GSH se 
determinó en un lector de placa multipocillos (Wallace Victor2, 1420 
Multilaber Counter, Perkin Elmer, Turku, Finland) a 345 nm de longitud 
de onda de excitación y 425 nm de longitud de onda de emisión.  
 La determinación de glutatión oxidado (GSSG) se ensayó de 
acuerdo con Maran y col. (2009). Este método está basado en que la 
reacción del OPT con el GSSG provoca una intensa fluorescencia 
perceptible a pH 12. En un tubo Eppendorf se mezclaron 25 µL de 
homogenizado celular con N-etilmaleimida (NEM; 25 μL; para evitar la 
reducción del GSSG) y NaOH para alcanzar el pH adecuado (pH 12) y se 
incubaron en oscuridad y a temperatura ambiente durante 20 min. A 
continuación, se adicionaron 10 µL de la mezcla en cada uno de los 96 
pocillos, 200 µL de NaOH 1N y 10 µL de solución O-ftalaldehido (OPT), 
se homogenizaron y se incubaron en oscuridad, a temperatura 
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ambiente, durante 15 min. La concentración de GSH se determina en el 
lector de placa multipocillos (Wallace Victor2, 1420 Multilaber Counter, 
Perkin Elmer, Turku, Finland) a 345 nm de longitud de onda de 
excitación y 425 nm de longitud de onda de emisión.  
8. Análisis del ciclo celular 
 El ciclo celular es una secuencia de sucesos que conducen al 
crecimiento de la célula y posteriormente a la división celular. Mediante 
la utilización del yoduro de propidio (PI), que se une a la doble cadena 
de ADN, y la técnica de citometría de flujo (FC) es posible cuantificar el 
contenido de ADN y por consiguiente, los efectos sobre la distribución 
del ciclo celular. Tres fases distintas se pueden distinguir en una 
población de células proliferantes, dependiendo del contenido de ADN: 
fase G0/G1, que corresponde a las células inactivas que entran en la 
división celular, con una copia de ADN (2n); la fase S, momento en el 
cual se sintetiza DNA; y la fase G2/M, que corresponde a todas aquellas 
células que se preparan para dividirse y estan en la fase de mitosis, con 
dos copia de DNA (4n). Por otra parte, hay una fase, SubG0/G1, que 
permite identificar las células muertas (células hipoploididicas o 
debris).  
 El análisis del ciclo celular se realizó mediante tinción del DNA 
con PI como se ha descrito previamente en la literatura (Van Olphen y 
Mittal, 2002) con algunas modificaciones. En placas de 6 pocillos se 
sembraron 4,8 x 105 células por pocillo. Tras 24, 48 y 72 h de exposición 
a BEA y ENs A, A1, B and B1 (1,5 y 3,0 μM), las células Caco-2 se 
tripsinizaron y se colocaron en hielo durante 30 min con 860 μL de 
medio fresco que contenía 29 ng/mL de solución de tinción PI de 
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Vindeløv, lo cual fue preparado como sigue: para 500 mL se pesan 10 
mg de RNAsa A (700 U/L), 0,1 mL de Nonidet P-40, 0,1% de Triton X-
100, 10 mM de Tris, 10 mM de NaCl y 50 g/ml de PI en PBS. Se 
analizaron diez mil células por muestra por un citómetro de flujo CLR 4 
EPICS XL MCL (Coulter Corporation) con longitudes de onda de 
excitación y de emisión de 488 nm y 620 nm, respectivamente. Los 
datos de los histogramas se extrajeron mediante ajuste rectangular de 
las fases del ciclo celular (CYLCHRED or MODIFIT software, Beckton 
Dickinson, Milán, Italy).  
El bajo coeficiente de variación (CV) obtenido en este estudio fue 
resultado de una alta resolución conseguida por la alineación apropiada 
de los láseres. Se realizaron cuatro replicas por muestra para cada 
exposición a BEA y ENs.  
9. Análisis de la apoptosis y necrosis por citometría de flujo 
 En general la muerte celular occurre a través de dos mecanismos 
moleculares: necrosis y apoptosis. El paso final de la necrosis se 
caracteriza por lisis de las membranas y liberación del contenido 
celular. Mientras que la apoptosis es una muerte celular genéticamente 
controlada. Una de las características de la apoptosis es la 
externalización de la fosfatidilserina (PS) en la capa externa de la 
membrana plasmática. La diferencia entre la población de células en 
apoptósis (temprana o tardía), necrosis y células muertas fueron 
identificada por doble tinción con Anexina V-FITC/PI (Vermes et al., 
1995). 
 La Anexina V es una proteína Ca2+-dependiente que se une a los 
fosfolípidos de membrana. Posee una elevada afinidad para la PS, se 
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unirá a todas aquellas células que externalizan PS hacia el lado 
extracelular de la membrana plasmática. PI se une específicamente al 
ADN de doble cadena de las células necróticas/muertas. Las células 
viables con membranas intactas excluyen el PI, mientras que las 
membranas de células muertas y dañadas son permeables al PI. Las 
células viables serán Anexina V-FITC-/PI-, las células en apoptósis 
temprana (pro-apoptóticas/apoptóticas) serán Anexina V-FITC+/PI-, las 
células en apoptosis tardía, que han completado el proceso de apoptosis 
e inician el proceso necrótico (apoptosis/necrosis) son Anexina V-
FITC+/PI+ y las células necróticas serán Anexina V-FITC-/PI+.  
 Para este ensayo, se sembraron 4,8 x 105 células/pocillo en 
placas de 6 pocillos. Tras 24, 48 y 72 h de exposición a 1,5 y 3,0 μM de 
BEA y ENs A, A1, B and B1, las células se tripsinizaron y se 
resuspendieron en 360 μL de tampón HepesCa2+ preparado como se 
indica a continuación: 10 mM de HEPES-NaOH (pH 7.4), 135 mM de NaCl 
y 2.5 mM de CaCl2. Tras 30 min de incubación a 4 °C en oscuridad, las 
células se analizaron por citómetrίa de flujo, BD FACSCanto con el 
software FACSDiva v 6.1.3 (BD Biosciences). Se adquirieron al menos 
10.000 células por muestra. Se detectó fluorescencia en el canal FL-1 
(verde, 530 nm) y FL-2 (naranja-rojo, 585 nm), emitida por FITC y PI, 
respectivamente. Las poblaciones celulares se analizaron a partir de los 
histogramas divididos en cuatro cuadrantes correspondientes a las 
células en apoptósis temprana (Q1), apoptoticas/necroticas (Q2), 
viables (Q3), necroticas (Q4). Las células Caco-2 tratadas con 1% de 
MeOH se consideraron como control. 
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10. Detección del potencial de membrana mitocondrial (ΔΨm) por el 
método de tetrametil éster de rodamina [TMRM]. 
 Las mitocondrias tienen un papel clave en el proceso de 
apoptosis (Kroemer et al., 1998). La inducción de la apoptosis conduce a 
la pérdida del potencial de membrana mitocondrial (ΔΨm; Zamzami y 
col., 1995). El ΔΨm se puede controlar en las células vivas utilizando un 
número de diferentes colorantes sensibles al potencial (rodamina 123, 
3,3’ dihexiloxacarbocianina yoduro (DiOC 6(3), 5,5’,6,6’-
tetraclorometil-X-rosamina (CMXRos) y tetrametil rodamina metil éster 
(TMRM; Kroemer y col., 1998). TMRM es un marcador fluorescente, 
catiónico lipofílico, que atraviesa libremente la membrana plasmática y 
se acumula dentro de las mitocondrias, dependiendo de su ΔΨm 
(Tsipser y col., 2012). La doble tinción de TMRM con To-Pro®-3, un 
marcador impermeable a la membrana nuclear, se puede utilizar para 
caracterizar la integridad de la membrana plasmática y, como 
consecuencia, la viabilidad celular. Se evaluaron los cambios del ΔΨm, 
tras la exposición a BEA y ENs A, A1, B and B1 (1,5 y 3,0 μM) usando la 
doble tinción TMRM y To-Pro®-3 como describe Tsiper y col. (2012). El 
ionóforo cianuro de carbonilo paratrifluorometoxifenilhidrazona (FCCP) 
se utilizó para optimizar el análisis del cambio ΔΨm (por disminución de 
la señal TMRM) y la viabilidad celular por aumento de la señal To-Pro®-
3. Brevemente, las células Caco-2 se sembraron en placas de 6 pocillos 
a una densidad de 4,8 x 105 células/pocillo. Tras la exposición a BEA y 
ENs (1,5 y 3,0 μM, las células se tripsinizaron y resuspendieron en medio 
de cultivo (500 μL) donde se incluyó una mezcla de los dos marcadores 
con una concentración final de 140 nM y 160 nM para TMRM y para To-
Pro®-3 respectivamente. Tras 30 min de incubación a 37 °C en 
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oscuridad, las intensidades de fluorescencia de TMRM (λex = 548 nm y 
λem = 573 nm) y de To-Pro®-3 (λex = 642 nm y λem = 661 nm) se midieron 
en un citómetro de flujo FACSCanto (Beckton-Dickinson, Italia). Las 
poblaciones celulares se analizaron a partir de los histogramas divididos 
en dos cuadrantes correspondientes a las células positivas (P5) y 
negativas (P6) al TMRM y en cuatro cuadrantes correspondientes a 
células positivas (Q2+Q4) y negativas (Q1+Q3) al To-Pro®-3. Las células 
Caco-2 tratadas con 1% de MeOH se consideraron como control. Los 
datos de los histogramas obtenidos se analizaron utilizando el software 
FACSDiva v 6.1.3 (BD Biosciences). El porcentaje de células teñidas por 
TMRM y To-Pro®-3 se calculó a partir de 10.000 células.  
11. Ensayo del cometa alcalino (pH>13) 
 La inducción del daño en las cadenas simples como las roturas de 
la doble cadena de DNA se determinó utilizando el ensayo del cometa 
alcalino (pH>13), de acuerdo con el método descrito previamente (Singh 
y col., 1988; Marabini y col., 2011), con algunas modificaciones. Las 
células Caco-2 se sembraron en placas de 6 pocillos a una densidad de 
4,8 x 105 células/pocillo. Después de alcanzar el 60% de confluencia, las 
células fueron tratadas con BEA a las concentraciones de 1,5, 3,0 y 12,0 
μM y con las ENs A, A1, B y B1, a las concentraciones de 1,5 y 3,0 μM, 
durante 24 h. Posteriormente, 2 x 104 células/mL se suspendieron en 
agarosa de bajo punto de fusión (LMA; 0,5% de PBS) pre-calentado (37 
°C) y 80 μL de la suspensión se transfirieron rápidamente a láminas 
previamente preparadas con agarosa (1% PBS) que se cubrieron con un 
cubreobjetos (24x36 mm). Transcurridos 10 min después de la 1ª 
gelificación a 0 °C, se retiró el cubreobjetos con cuidado y se añadió 
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una segunda capa de 80 μL de LMA. Después de la 2ª gelificación 
durante 10 min a 0 °C, se retiró el cubreobjetos con cuidado y las 
láminas se sumergieron en la solución de lisis (2.5 M NaCl, 100 mM Na-
EDTA, 10 mM Tris, 250 mM NaOH, 10% DMSO and 1% Triton X-100, recién 
preparado) durante 30 min a 0 °C. Las láminas se retiraron de la 
solución de lisis, se lavaron con tampón de neutralización (Tris 0,4 M, 
pH 7,5) y se incubaron en tampón de electroforesis fresco (NaOH 300 
mM, 1 mM de Na-EDTA), durante 20 min a temperatura ambiente para 
permitir que el ADN se desenrollase. La electroforesis se llevó a cabo a 
continuación, a temperatura ambiente en tampón de electroforesis 
fresco durante 40 min (25 V, 300 mA). Después de la electroforesis, las 
láminas se lavaron suavemente con tampón de neutralización fresco (5 
min), se dejaron secar durante toda la noche a 4 °C y a continuación se 
tiñeron con 500 μL de PI (20 μg/mL en H2O). Las láminas se visualizaron 
con un microscopio de fluorescencia (Nikon Eclipse E800), equipado con 
cámara (NIKON DXM1200F) para la captura de imagines. Un mínimo de 
50 células individuales fueron seleccionadas al azar y se analizaron 
mediante el uso de Automatic Comet Assay by TriTek CometScoreTM 
freeware 
 (http://autocomet.com/index.php?id=cometscorepro). El daño en el 
DNA de las células Caco-2 se expresó como la mediana del momento de 
la cola (TM). El TM fue elegido como el parámetro efectivo, calculado 
de acuerdo con la ecuación: TM = TL x Tail DNA% donde TL es la 
longitud de la cola, i.e. la distancia (μm) entre el centro de la cabeza 
de la cometa y el punto final de la cola. Todos los parámetros fueron 
proporcionados por TriTek CometScoreTM. El DNA de la cola se expresa 
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como un porcentaje del contenido total de DNA basado en la intensidad 
de fluorescencia total. 
12. Transporte intestinal al a través de las células Caco-2 
 Los ensayos de transporte de la BEA y FUS, a través del epitelio 
intestinal simulado usando células Caco-2 diferenciadas, necesarios para 
evaluar la biodisponibilidad de las micotoxinas, se llevaron a cabo en 
placas bicamerales de 6 pocillos Transwell® (Transwell Permeable 
Soportes, Corning, NY, EE.UU.). Las células Caco-2 se sembraron a una 
densidad de 25 x 104 células/cm2 adicionando 1,5 mL de medio de 
cultivo a la cámara apical y 2 mL a la cámara basal. Las placas se 
incubaron a 37°C, 5% CO2 y 95% de humedad relativa, cambiando el 
medio de cultivo cada 2 días hasta alcanzar la diferenciación de las 
células Caco-2, a los 21 días de incubación. 
 Una vez alcanzada la diferenciación celular, se retiró el medio 
de mantenimiento y se sustituyó tanto en el compartimento apical (1,5 
mL) como en el basal (0,5 mL) por una solución salina tamponada (HBSS) 
enriquecida con 10 mM de HEPES. Las placas se incubaron a 37 °C 
durante 10 min previamente al inicio del ensayo de transporte. A 
continuación, se substituyó el medio, por la solución de HBSS-HEPES 
conteniente las micotoxinas (BEA y FUS) a una concentración de 1,5 y 
3,0 μM en el compartimiento apical. En el compartimento basolateral se 
adiciono la solución de HBSS-HEPES. Las placas se incubaron durante 4 
horas a 37 °C. 
 Cada hora se tomaron alícuotas de 100 μL de medio de cultivo 
del compartimento basolateral y se analizan por cromatografía líquida 
(LC). 
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 La diferenciación de las células Caco-2 se evaluó midiendo la 
difusión del rojo fenol a través de la monocapa en las muestras control 
de las placas Transwell®. Para ello, después de lavar cada pocillo 3 
veces con PBS, se adicionaron 1,5 mL de PBS en la cámara basal y 2 mL 
de DMEM en la cámara apical. Después de 1h de incubación a 37 °C se 
recogió el volumen de la cámara basal y se ajustó el pH (=11) con NaOH 
(1M). Se midió espectrofotométricamente la absorbancia a 558-559 nm. 
El porcentaje de rojo fenol resultó inferior al 5% confrontando con una 
recta de calibrado patrón (115-5644 μM) de rojo fenol.  
12.1 Extracción de beauvericina y fusaproliferina de los 
compartimientos apical y basolateral 
 BEA y FUS se extrajeron de los compartimientos apical y 
basolateral de acuerdo con el método descrito por Ambrosino y col. 
(2004). Resumido, 1 ml de cada pocillo se disolvió en 3 ml de metanol y 
después se filtró a través de filtro de nylon de 0,22 micras (Análisis 
Vínicos, Tomelloso, España). Las muestras se purificaron con una 
columna de extracción en fase sólida C18-E (100 mg, Phenomenex, 
Torrance, CA) previamente activada con 3 ml de metanol y 3 ml de agua 
que se eluyen con 1 ml de metanol. El eluato se evapora 
completamente con nitrógeno a 50 °C y el residuo se reconstituyó con 
100 μL de metanol. A continuación, 20 μL de cada extracto se inyectó 
en el LC. La recuperación del método de extracción se determinó 
mediante experimentos de adición. BEA y FUS se añadieron a un medio 
de transporte no contaminado en concentraciones variables desde de 
0,1 a 10 μM, y después se extrajo. La recuperación calculada (media ± 
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desviación estándar relativa) de BEA y FUS en las muestras 
contaminadas artificialmente fue por encima del 90,7%. 
12.2. Extracción de BEA y FUS a partir de las células 
 BEA y FUS contenidas en las células se determinaron de acuerdo 
a Meca y col. (2010a) como se muestra a continuación: las células se 
sometieron a ultrasonidos en una solución salina (0,90% de NaCl, v/v) 
durante 30 min. El precipitado se suspendió en 5 ml de solución salina, y 
se añadieron 5 ml de acetato de etilo. Se mezclaron (1 min) en un 
vortex y se centrifugaron a 4,000 rpm durante 10 min a 4 °C (Centrífuga 
5810R, Eppendorf, Alemania). El sobrenadante se evaporo 
aproximadamente hasta 5 mL, en un evaporador rotatorio (Büchi, 
Suiza), y se resuspendió en 1 ml de metanol. Los eluatos se  analizaron 
por LC.  
12.3. Determinación de beauvericina y fusaproliferina por 
cromatografía líquida 
 La determinación por LC de BEA y FUS se realizó utilizando un 
sistema Shimadzu LC equipado con bombas LC-10AD y un detector de 
red de diodos (DAD) de Shimadzu (Japón). Se utilizó una columna 
Géminis (150 x 4,6 mm, 5 micras, Phenomenex, Torrance CA). Las 
condiciones de LC fueron establecidas usando un flujo constante a 1.0 
mL/min y se usó acetonitrilo-agua (70:30 v/v) como sistema eluyente de 
principio. La relación del principio se mantuvo constante durante 5 min 
y luego se modificó hasta alcanzar el 90% de acetonitrilo durante 10 
min. Después de 1 min a 90% de acetonitrilo, la fase móvil se llevó a las 
condiciones del principio durante 4 min. BEA se detectó a 205 nm y FUS 
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a 261 nm. La identificación de micotoxinas se realizó mediante la 
comparación de tiempos de retención y espectros UV de muestras 
purificadas extraídas a los estándares puros. La cuantificación de 
micotoxinas se llevó a cabo mediante la comparación de áreas de los 
picos de las muestras investigadas con la curva de calibración de 
patrones auténticos. 
13. Modelo gastrointestinal in Vitro 
 El procedimiento gastrointestinal in vitro fue adaptado del 
método desarrollado previamente por Gil-Izquierdo y col. (2002) con 
ligeras modificaciones. El método consta de tres pasos secuenciales: 
primero una adición inicial de saliva para simular el compartimento de 
la boca. La boca es el punto en el que el proceso de molienda mecánica 
de los alimentos se lleva a cabo a un pH de 6.5. El pH se ajustó con HCl 
0.1 N. En este paso, 3 g de muestra enriquecida con las ENs (A, A1, B y 
B1) a 1.5 y 3.0 μmol/g se mezcló con 6 ml de saliva artificial 
(compuesta de 89,6 g/L de KCl, 20.0 g/L KSCN, 88.8 g/L de NaH2PO4, 
57.0 g/L de NaSO4, 175.3 g/L de NaCl, 84.7 g/l de NaHCO3, 25.0 g/L de 
urea, y 290.0 mg de α-amilasa). La mezcla se puso en una bolsa de 
plástico, con 40 mL de agua, y se homogeneizó mediante un Stomacher 
(IUL Instruments; Barcelona, España) durante 30 s. Los componentes 
más grandes se descomponen en fragmentos más pequeños, lo que 
aumenta el área superficial de las partículas de alimentos para la 
deglución y la digestión. El segundo paso consistió en una digestión con 
pepsina/HCl para simular el entorno del ácido clorhídrico del estómago 
(pH 1-5). La presencia de pepsina actúa para descomponer las 
proteínas, ayudando de ese modo la disolución de los alimentos. Para 
este propósito, se añadió 0.5 g de pepsina (14.800 U) preparada en HCl 
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(0.1 M) a la mezcla, y el pH se ajustó a 2.0. La mezcla se incubó a 37 °C 
en un agitador orbital (Infors AG CH-4103, Bottmingen, Suiza) a 250 rpm 
durante 2 h. El último paso fue la digestión en el intestino delgado (s) 
por los jugos intestinales compuestos de enzimas (tripsina, pancreatina, 
y amilasa), sales biliares, y bicarbonato. La descomposición de los 
alimentos en el intestino delgado (s) significa que los componentes son 
más susceptibles a la absorción. Las enzimas utilizadas en el jugo 
intestinal fueron pancreatina (8 mg/mL) y sales biliares (50 mg/mL) a 
partes iguales (1:1; v/v); el pH de los jugos intestinales se ajustó a 6.5 
con 0.5 N de NaHCO3; la mezcla se incubó durante 2 horas a 37 °C en un 
agitador orbital (250 rpm). Inmediatamente, se centrifugaron alícuotas 
de 30 ml (Centrífuga 5810R, Eppendorf, Alemania) a 4.000 rpm y 4 °C 
durante 1 h, y la ENs presentes en los fluidos de saliva/pepsina/HCl y 
pancreatina−bilis digeridos se extrajeron y analizaron por cromatografía 
líquida con detector de diodos (HPLC-DAD), tal como describe Meca y 
col. (2010b). 
13.1 Análisis de las enniatinas.  
 La extracción de las ENs (A, A1, B y B1) contenidas en los fluidos 
gastroduodenales se llevó a cabo según  Meca y col. (2012). 
Brevemente, 5 mL de cada mezcla obtenida como se ha descrito 
anteriormente se puso en un tubo de ensayo de 20 mL y se extrajo tres 
veces con 5 mL de acetato de etilo utilizando un agitador rotatorio 
(VWR International; Barcelona, España) durante 1 min y se centrifugó 
(centrífuga 5810R, Eppendorf, Alemania) a 4.000 rpm y 4 °C durante 10 
min. Después la fase orgánica se evaporó completamente en un 
evaporador rotatorio (Büchi, Suiza), los residuos se disolvieron en 1 mL 
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de metanol y se analizaron por LC-DAD. Todas las muestras se filtraron a 
través de filtros de 0.22 μm Phenomenex de jeringa antes de su 
determinación cromatográfica. La separación de las micotoxinas por LC 
se llevó a cabo con una columna analítica Gemini (150 mm x 4,6 mm, 5 
mM) Phenomenex (Madrid, España). La separación analítica se realizó 
usando un gradiente de elución con agua como fase móvil A y 
acetonitrilo como fase móvil B. Después de una etapa isocrática de 70% 
de B durante 5 min, el gradiente se modificó linealmente hasta 90% de B 
en 10 min. Después de 1 min, la fase móvil se llevó a las condiciones del 
principio en 4 min. La velocidad de flujo se mantuvo a 1,0 mL/min. Las 
ENs se detectaron a 205 nm. Las identificación de las ENs se realizó 
mediante la comparación de tiempos de retención y los espectros UV de 
muestras purificadas de los estándares puros. La confirmación se realizó 
mediante la co-inyeccion de estándares puros junto con cada muestra. 
La cuantificación de las EN se llevó a cabo mediante la comparación de 
áreas de los picos de las muestras investigadas con una curva de 
calibración de los estándares. Los estudios de recuperación (%) en el 
fluido intestinal se realizaron por adición de las muestras con soluciones 
estándar de cada una de las ENs en concentraciones de 1,5 y 3,0 
μmol/g. 
 13.2 Validación del método 
 El método analítico se validó de acuerdo con la Directiva 
Europea 2002/26/CE sobre los métodos de análisis de micotoxinas en los 
productos alimenticios (CE, 2002). Los experimentos de recuperación se 
llevaron a cabo en los fluidos intestinales fortificados (libres de 
contaminación) (n = 5) por adición de las EN A, A1, B, B1 y en un nivel 
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que oscilaba desde 0.3 hasta 50 μg/g. Las medias de las recuperaciones 
(%) fueron las siguientes: 88.6 ± 2.4, 84.2 ± 4.3, 86.6 ± 2.7, y 89.5 ± 
3.1% para la EN A, A1, B, and B1, respectivamente. Los valores de 
variación interdiaria (n=5) fueron desde 1.8 hasta el 3.1%. Los valores 
de variación intradiaria estaban en el rango de 6.4 hasta 10.1%. Estos 
valores no superaban el 15%, que se considera la variación máxima. Los 
límites de detección (LOD) y el límite de cuantificación (LOQ) se 
calcularon de acuerdo con s/n = 3 s/n = 10, respectivamente. Los LODs 
obtenidos para las ENs A, A1, B, and B1 fueron 215, 140, 145, y 165 
μg/kg, rspectivamente, mientras que los LOQs fueron 600 μg/kg para la 
EN A, 400 μg/kg para las ENs A1 and B, y 500 μg/kg para la EN B1.  
14. Estudio estadístico 
 El análisis estadístico se llevó a cabo usando el paquete software 
SPSS statistic 19.0 (SPSS, Chicago, IL, USA). Los resultados se expresaron 
como media ± SD. El análisis estadístico de los resultados se realizaron 
con la t-Student para muestras emparejadas. Las diferencias entre los 
grupos se analizaron estadísticamente con ANOVA seguido de Tukey HSD 
y Dunnet post hoc tests para la comparación múltiple. El valor de p 
0.05 se consideró estadísticamente significativo.  
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Anexos II- Difusión de resultados  
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